
<html lang="en"     class="pb-page"  data-request-id="d387b786-80cf-4b44-b717-1163f80e464b"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/jm901830p;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2010.53.issue-6;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Bis(morpholino-1,3,5-triazine) Derivatives: Potent Adenosine 5′-Triphosphate Competitive Phosphatidylinositol-3-kinase/Mammalian Target of Rapamycin Inhibitors: Discovery of Compound 26 (PKI-587), a Highly Efficacious Dual Inhibitor" /></meta><meta name="dc.Creator" content="Aranapakam M.  Venkatesan" /></meta><meta name="dc.Creator" content="Christoph M.  Dehnhardt" /></meta><meta name="dc.Creator" content="Efren  Delos Santos" /></meta><meta name="dc.Creator" content="Zecheng  Chen" /></meta><meta name="dc.Creator" content="Osvaldo  Dos Santos" /></meta><meta name="dc.Creator" content="Semiramis  Ayral-Kaloustian" /></meta><meta name="dc.Creator" content="Gulnaz  Khafizova" /></meta><meta name="dc.Creator" content="Natasja  Brooijmans" /></meta><meta name="dc.Creator" content="Robert  Mallon" /></meta><meta name="dc.Creator" content="Irwin  Hollander" /></meta><meta name="dc.Creator" content="Larry  Feldberg" /></meta><meta name="dc.Creator" content="Judy  Lucas" /></meta><meta name="dc.Creator" content="Ker  Yu" /></meta><meta name="dc.Creator" content="James  Gibbons" /></meta><meta name="dc.Creator" content="Robert T.  Abraham" /></meta><meta name="dc.Creator" content="Inder  Chaudhary" /></meta><meta name="dc.Creator" content="Tarek S.  Mansour" /></meta><meta name="dc.Description" content="The PI3K/Akt signaling pathway is a key pathway in cell proliferation, growth, survival, protein synthesis, and glucose metabolism. It has been recognized recently that inhibiting this pathway migh..." /></meta><meta name="Description" content="The PI3K/Akt signaling pathway is a key pathway in cell proliferation, growth, survival, protein synthesis, and glucose metabolism. It has been recognized recently that inhibiting this pathway migh..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 18, 2010" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm901830p" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm901830p" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm901830p" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm901830p" /></link>
        
    
    

<title>Bis(morpholino-1,3,5-triazine) Derivatives: Potent Adenosine 5′-Triphosphate Competitive Phosphatidylinositol-3-kinase/Mammalian Target of Rapamycin Inhibitors: Discovery of Compound 26 (PKI-587), a Highly Efficacious Dual Inhibitor | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm901830p" /></meta><meta property="og:title" content="Bis(morpholino-1,3,5-triazine) Derivatives: Potent Adenosine 5′-Triphosphate Competitive Phosphatidylinositol-3-kinase/Mammalian Target of Rapamycin Inhibitors: Discovery of Compound 26 (PKI-587), a Highly Efficacious Dual Inhibitor" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/large/jm-2009-01830p_0009.jpeg" /></meta><meta property="og:description" content="The PI3K/Akt signaling pathway is a key pathway in cell proliferation, growth, survival, protein synthesis, and glucose metabolism. It has been recognized recently that inhibiting this pathway might provide a viable therapy for cancer. A series of bis(morpholino-1,3,5-triazine) derivatives were prepared and optimized to provide the highly efficacious PI3K/mTOR inhibitor 1-(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea 26 (PKI-587). Compound 26 has shown excellent activity in vitro and in vivo, with antitumor efficacy in both subcutaneous and orthotopic xenograft tumor models when administered intravenously. The structure−activity relationships and the in vitro and in vivo activity of analogues in this series are described." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm901830p"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm901830p">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm901830p&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm901830p&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm901830p&amp;href=/doi/10.1021/jm901830p" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 2636-2645</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm901868z" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm901291r" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Bis(morpholino-1,3,5-triazine) Derivatives: Potent Adenosine 5′-Triphosphate Competitive Phosphatidylinositol-3-kinase/Mammalian Target of Rapamycin Inhibitors: Discovery of Compound <b>26</b> (PKI-587), a Highly Efficacious Dual Inhibitor</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Aranapakam+M.++Venkatesan">Aranapakam M. Venkatesan</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christoph+M.++Dehnhardt">Christoph M. Dehnhardt</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Efren++Delos+Santos">Efren Delos Santos</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zecheng++Chen">Zecheng Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Osvaldo++Dos+Santos">Osvaldo Dos Santos</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Semiramis++Ayral-Kaloustian">Semiramis Ayral-Kaloustian</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gulnaz++Khafizova">Gulnaz Khafizova</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Natasja++Brooijmans">Natasja Brooijmans</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert++Mallon">Robert Mallon</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Irwin++Hollander">Irwin Hollander</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Larry++Feldberg">Larry Feldberg</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Judy++Lucas">Judy Lucas</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ker++Yu">Ker Yu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James++Gibbons">James Gibbons</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+T.++Abraham">Robert T. Abraham</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Inder++Chaudhary">Inder Chaudhary</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tarek+S.++Mansour">Tarek S. Mansour</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Chemical Sciences</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Oncology</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Drug Metabolism</span></div><div class="aff-info" id="wr"><span class="aff-text">Wyeth Research, 401 N. Middletown Road, Pearl River, New York 10965</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: (845) 602-4023. Fax (845) 602-5561. E-mail: <a href="/cdn-cgi/l/email-protection#5f293a31343e2b3e1f28263a2b37713c3032"><span class="__cf_email__" data-cfemail="c2b4a7aca9a3b6a382b5bba7b6aaeca1adaf">[email protected]</span></a> or <a href="/cdn-cgi/l/email-protection#592f3c3732382d386f6060193e34383035773a3634"><span class="__cf_email__" data-cfemail="1365767d78726772252a2a53747e727a7f3d707c7e">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm901830p&amp;href=/doi/10.1021%2Fjm901830p" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 2636–2645</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 18, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>11 December 2009</li><li><span class="item_label"><b>Published</b> online</span>18 February 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 March 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm901830p" title="DOI URL">https://doi.org/10.1021/jm901830p</a></div><div class="article_header-article-copyright"><strong>Copyright © 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2636%26pageCount%3D10%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAranapakam%2BM.%2BVenkatesan%252C%2BChristoph%2BM.%2BDehnhardt%252C%2BEfren%2BDelos%2BSantos%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D6%26contentID%3Djm901830p%26title%3DBis%2528morpholino-1%252C3%252C5-triazine%2529%2BDerivatives%253A%2BPotent%2BAdenosine%2B5%25E2%2580%25B2-Triphosphate%2BCompetitive%2BPhosphatidylinositol-3-kinase%252FMammalian%2BTarget%2Bof%2BRapamycin%2BInhibitors%253A%2BDiscovery%2Bof%2BCompound%2B26%2B%2528PKI-587%2529%252C%2Ba%2BHighly%2BEfficacious%2BDual%2BInhibitor%26numPages%3D10%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2645%26publicationDate%3DMarch%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm901830p"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">4515</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">121</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm901830p" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Bis(morpholino-1,3,5-triazine) Derivatives: Potent Adenosine 5′-Triphosphate Competitive Phosphatidylinositol-3-kinase/Mammalian Target of Rapamycin Inhibitors: Discovery of Compound 26 (PKI-587), a Highly Efficacious Dual Inhibitor&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Aranapakam&quot;,&quot;last_name&quot;:&quot;M. Venkatesan&quot;},{&quot;first_name&quot;:&quot;Christoph&quot;,&quot;last_name&quot;:&quot;M. Dehnhardt&quot;},{&quot;first_name&quot;:&quot;Efren&quot;,&quot;last_name&quot;:&quot;Delos Santos&quot;},{&quot;first_name&quot;:&quot;Zecheng&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Osvaldo&quot;,&quot;last_name&quot;:&quot;Dos Santos&quot;},{&quot;first_name&quot;:&quot;Semiramis&quot;,&quot;last_name&quot;:&quot;Ayral-Kaloustian&quot;},{&quot;first_name&quot;:&quot;Gulnaz&quot;,&quot;last_name&quot;:&quot;Khafizova&quot;},{&quot;first_name&quot;:&quot;Natasja&quot;,&quot;last_name&quot;:&quot;Brooijmans&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;Mallon&quot;},{&quot;first_name&quot;:&quot;Irwin&quot;,&quot;last_name&quot;:&quot;Hollander&quot;},{&quot;first_name&quot;:&quot;Larry&quot;,&quot;last_name&quot;:&quot;Feldberg&quot;},{&quot;first_name&quot;:&quot;Judy&quot;,&quot;last_name&quot;:&quot;Lucas&quot;},{&quot;first_name&quot;:&quot;Ker&quot;,&quot;last_name&quot;:&quot;Yu&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;Gibbons&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;T. Abraham&quot;},{&quot;first_name&quot;:&quot;Inder&quot;,&quot;last_name&quot;:&quot;Chaudhary&quot;},{&quot;first_name&quot;:&quot;Tarek&quot;,&quot;last_name&quot;:&quot;S. Mansour&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;18&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;2636-2645&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm901830p&quot;},&quot;abstract&quot;:&quot;The PI3K/Akt signaling pathway is a key pathway in cell proliferation, growth, survival, protein synthesis, and glucose metabolism. It has been recognized recently that inhibiting this pathway might provide a viable therapy for cancer. A series of bis(morpholino-1,3,5-triazine) derivatives were prepared and optimized to provide the highly efficacious PI3K/mTOR inhibitor 1-(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea 26 (PKI-587). Compound 26 has shown excellent activity in vitro and in vivo, with antitumor efficacy in both subcutaneous and orthotopic xenograft tumor models when administered intravenously. The structure−activity relationships and the in vitro and in vivo activity of analogues in this series are described.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901830p&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901830p" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901830p&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901830p" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901830p&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901830p" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm901830p&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901830p&amp;href=/doi/10.1021/jm901830p" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm901830p" /></input><a href="/doi/pdf/10.1021/jm901830p" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm901830p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm901830p%26sid%3Dliteratum%253Aachs%26pmid%3D20166697%26genre%3Darticle%26aulast%3DVenkatesan%26date%3D2010%26atitle%3DBis%2528morpholino-1%252C3%252C5-triazine%2529%2BDerivatives%253A%2BPotent%2BAdenosine%2B5%25E2%2580%25B2-Triphosphate%2BCompetitive%2BPhosphatidylinositol-3-kinase%252FMammalian%2BTarget%2Bof%2BRapamycin%2BInhibitors%253A%2BDiscovery%2Bof%2BCompound%2B26%2B%2528PKI-587%2529%252C%2Ba%2BHighly%2BEfficacious%2BDual%2BInhibitor%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D6%26spage%3D2636%26epage%3D2645%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292201" title="Scaffolds">Scaffolds</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/6" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/medium/jm-2009-01830p_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/large/jm-2009-01830p_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901830p&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The PI3K/Akt signaling pathway is a key pathway in cell proliferation, growth, survival, protein synthesis, and glucose metabolism. It has been recognized recently that inhibiting this pathway might provide a viable therapy for cancer. A series of bis(morpholino-1,3,5-triazine) derivatives were prepared and optimized to provide the highly efficacious PI3K/mTOR inhibitor 1-(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea <b>26</b> (PKI-587). Compound <b>26</b> has shown excellent activity in vitro and in vivo, with antitumor efficacy in both subcutaneous and orthotopic xenograft tumor models when administered intravenously. The structure−activity relationships and the in vitro and in vivo activity of analogues in this series are described.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73224" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73224" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Phosphatidylinositol-3-kinases (PI3Ks<a class="ref internalNav" href="#fnabbrev" aria-label="a">a</a>) <div class="NLM_fn" id="fnabbrev">a<p class="last">Abbreviations: PI3K, phosphoinositide 3-kinase; mTOR, mammalian target of rapamycin; Akt, protein kinase B; PIP2, phosphatidylinositol bisphosphate(4,5); PIP3, phosphatidylinositol triphosphate(3,4,5); PTEN, phosphatase and tensin homologue; RTK, receptor tyrosine kinase; PH, pleckstrin homology; mTORC1, mammalian target of rapamycin complex 1; mTORC2, mammalian target of rapamycin complex 2; PDK1, 3-phosphoinositide-dependent kinase 1; S, serine; T, threonine; ATP, adenosine 5′-triphosphate; Her2+, human epidermal growth factor receptor 2+; ELISA, enzyme-linked immunosorbent assay; DELFIA, dissociation-enhanced lanthanide fluorescent.</p></div> are lipid kinases that phosphorylate phosphatidylinositol diphosphate (PIP2) to its corresponding phosphatidylinositol triphosphate (PIP3). It has been recognized recently that the PI3K/Akt signaling pathway is a key pathway in cell proliferation, growth, survival, protein synthesis, and glucose metabolism.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5 ref6">(1-6)</a> The product of PI3K activity, namely, PIP3, acts as a second messenger responsible for the activation of the downstream kinase Akt.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> PI3Ks are categorized as class IA, class IB, class II, and class III enzymes, based on sequence homology and substrate preferences. The <u class="uu">PI</u>3<u class="uu">K</u> related <u class="uu">k</u>inases (PIKKs) include mTOR, ATR, ATM, SMG1, and DNA-PK. PIKKs share a conserved kinase domain with PI3Ks and regulate cellular response to nutrient levels and environmental stress. The class IA subgroup consists of PI3Kα, PI3Kβ, and PI3Kδ isoforms. Among these three isoforms, the gene encoding the PI3Kα subunit, PIK3CA, is mutated and/or overexpressed in breast, ovarian, colorectal, brain (glioblastoma), and gastric cancers.<a onclick="showRef(event, 'ref6 ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref6 ref9 ref10 ref11">(6, 9-11)</a> Additionally, the PIP3 lipid phosphatase, <u class="uu">p</u>hosphatase and tensin homologue deleted on chromosome <u class="uu">ten</u> (PTEN), is frequently inactivated in numerous late stage tumors, causing elevated levels of PIP3 with consequent deregulation of the PI3K/Akt pathway signaling.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5 ref6">(1-6)</a> This also contributes to oncogenesis.<a onclick="showRef(event, 'ref7 ref8 ref12'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref12">(7, 8, 12)</a> Therefore, inhibiting PI3Kα is an attractive strategy for cancer therapy. Furthermore, it has been demonstrated that the PI3K pathway is paradoxically activated following selective mTOR inhibition, thus providing a compelling rationale for developing dual PI3K/mTOR kinase inhibitors.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a></div><div class="NLM_p">Toward this end, several pharmaceutical companies and academic institutions have been concentrating their efforts on the development of small molecule PI3K/mTOR inhibitors.<a onclick="showRef(event, 'ref2 ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref2 ref15 ref16 ref17">(2, 15-17)</a> Among the various small molecule inhibitors, BEZ-235 <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) is the most advanced clinical candidate.<a onclick="showRef(event, 'cit19a cit19b'); return false;" href="javascript:void(0);" class="ref cit19a cit19b">(19a, 19b)</a> It inhibits PI3K and mTOR in an ATP-competitive manner. This compound is also reported to inhibit cancer cell proliferation, causing cell cycle arrest at the G1 phase.<a onclick="showRef(event, 'cit19a cit19b'); return false;" href="javascript:void(0);" class="ref cit19a cit19b">(19a, 19b)</a> Another compound that inhibits all class I PI3K isoforms, but with significantly lower potency against mTOR, is <b>2</b> GDC-0941.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> This compound was reported by Genentech and has entered phase I clinical studies. Another pan PI3K inhibitor that has gone into the clinic is Semafore compound, SF1126.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Highly selective mTOR inhibitors based on a pyrazolopyrimidine scaffold such as <b>3a</b> were reported by Zask et al.<a onclick="showRef(event, 'cit21a cit21b'); return false;" href="javascript:void(0);" class="ref cit21a cit21b">(21a, 21b)</a> and recently entered clinical development. We also recently described a dual PI3K/mTOR inhibitor <b>3</b> (PKI-402) based on a triazolopyrimidine scaffold that has potent in vivo efficacy.<a onclick="showRef(event, 'cit21c'); return false;" href="javascript:void(0);" class="ref cit21c">(21c)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/medium/jm-2009-01830p_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/large/jm-2009-01830p_0010.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Previously known phosphatidylinositol-3-kinase inhibitors and selective mammalian target of rapamycin inhibitor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/large/jm-2009-01830p_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901830p&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In the present article, we describe the design, synthesis, and identification of a highly potent bis(morpholino-1,3,5-triazine) derivative <b>26</b> (PKI-587) as a PI3K/mTOR inhibitor. Compound <b>26</b> decreases cell survival and proliferation and increases apoptosis in both in vitro and in vivo models. It shows compelling antitumor efficacy in subcutaneous and orthotopic human xenograft tumor models when administered intravenously (iv) as a single agent.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52022" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52022" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The 2,4-bismorpholino-1,3,4-triazine derivatives <b>8</b>−<b>30</b>, which are exemplified in the present article, were prepared starting from the commercially available cyanuric chloride <b>4</b>, as outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Initially the two chlorines in cyanuric chloride <b>4</b> were replaced with 2 equiv of morpholine <b>5</b> in the presence of triethylamine at 0 °C to yield <b>6</b> in almost quantitative yield. The third chlorine in compound <b>6</b> was displaced by a 4-aminophenyl moiety using Suzuki coupling reaction with 4-aminophenylboronic acid pinacol ester to yield <b>7</b>. Compound <b>7</b> was reacted with various alkyl and aryl isocyanates to yield <b>8</b>−<b>14</b>, <b>17</b>, <b>18</b>, and <b>21</b>. Alternatively, urea derivatives <b>15</b>, <b>16</b>, <b>19</b>, and <b>20</b> were obtained by reacting the intermediate <b>7</b> with triphosgene/triethylamine and the corresponding amines. In order to introduce amides bearing water solubilizing amine functionality, intermediate <b>7</b> was reacted with methyl 4-isocyanatobenzoate in dichloromethane at room temperature to give <b>21</b> in good yield. The ester group was hydrolyzed with 5 N NaOH in tetrahydrofuran/methanol at reflux temperature to yield <b>22</b>. The acid derivative <b>22</b> was reacted with different amines in the presence of HOBt/EDCI and triethylamine at room temperature. The final products were purified either by flash column silica gel column chromatography or by preparative HPLC. All analogues <b>8</b>−<b>30</b> obtained by the above-mentioned route were analyzed for purity by analytical HPLC on a prodigy ODS3 column (150 mm × 4.6 mm) using acetonitrile/water mixture. The purity of the newly synthesized compounds was analyzed at 210−370 nm.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/medium/jm-2009-01830p_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/large/jm-2009-01830p_0008.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Methods To Prepare <b>8</b>−<b>30</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/large/jm-2009-01830p_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901830p&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26821" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26821" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Final compounds <b>8</b>−<b>30</b> were tested in vitro against PI3Kα, PI3Kγ, and mTOR. The IC<sub>50</sub> values against PI3Kα and PI3Kγ enzymes were determined using a fluorescence polarization format assay.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The corresponding mTOR inhibition for the newly synthesized compounds was determined using a DELFIA format ELISA.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> PI3Kα, PI3Kγ, and mTOR as well as the cell proliferation (3 days growth inhibition) assay<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> IC<sub>50</sub> values in MDA-361 (breast, PI3K mutant [E545K]/Her2+) and PC3MM2 (prostate, PTEN deletion) human tumor cell lines are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. The solubility (at pH 7.4), PAMPA permeability, and clogP data for analogues <b>8</b>−<b>30</b> are also listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro, Microsomal Stability, Solubility, and clogP Data for Analogues <b>8</b>−<b>30</b><a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="" /></col><col align="char" char="" /></col><col align="char" char="" /></col><col align="char" char="" /></col><col align="char" char="" /></col><col align="char" char="" /></col><col align="char" char="" /></col><col align="char" char="" /></col></colgroup><thead><tr valign="top"><th align="center"> </th><th colspan="5" align="center">IC<sub>50</sub> (nM)</th><th align="center"> </th><th align="center"> </th><th align="center"> </th></tr><tr valign="top"><th align="center">compd</th><th align="center">PI3K-α</th><th align="center">PI3K-γ</th><th align="center">mTOR</th><th align="center">MDA-361</th><th align="center">PC3-MM2</th><th align="center">clogP</th><th align="center">sol.<a class="ref internalNav" href="#t1fn1" aria-label="b">b</a> at pH 7.4</th><th align="center">PAMPA at pH 7.4</th></tr></thead><tbody><tr valign="top"><td align="center"><b>8</b></td><td align="char">3.0</td><td align="char">27.0</td><td align="char">3.9</td><td align="char">56</td><td align="char">107</td><td align="char">2.5</td><td align="char">0.0</td><td align="char">0.2</td></tr><tr valign="top"><td align="center"><b>9</b></td><td align="char">247.5</td><td align="char">814.5</td><td align="char">10.0</td><td align="char">NT</td><td align="char">NT</td><td align="char">1.2</td><td align="char">1.0</td><td align="char">0.7</td></tr><tr valign="top"><td align="center"><b>10</b></td><td align="char">350.0</td><td align="char">789.0</td><td align="char">11.3</td><td align="char">NT</td><td align="char">NT</td><td align="char">NA</td><td align="char">NT</td><td align="char">NT</td></tr><tr valign="top"><td align="center"><b>11</b></td><td align="char">6.5</td><td align="char">52.5</td><td align="char">3.9</td><td align="char">118.0</td><td align="char">193.0</td><td align="char">2.8</td><td align="char">0.0</td><td align="char">1.0</td></tr><tr valign="top"><td align="center"><b>12</b></td><td align="char">16.5</td><td align="char">438.0</td><td align="char">6.3</td><td align="char">200.0</td><td align="char">364.0</td><td align="char">3.0</td><td align="char">0.0</td><td align="char">5.6</td></tr><tr valign="top"><td align="center"><b>13</b></td><td align="char">19.5</td><td align="char">219.5</td><td align="char">6.7</td><td align="char">407.0</td><td align="char">293.0</td><td align="char">3.4</td><td align="char">1.0</td><td align="char">0.0</td></tr><tr valign="top"><td align="center"><b>14</b></td><td align="char">60.5</td><td align="char">528.0</td><td align="char">9.3</td><td align="char">794.0</td><td align="char">5630.5</td><td align="char">2.5</td><td align="char">1.0</td><td align="char">0.0</td></tr><tr valign="top"><td align="center"><b>15</b></td><td align="char">1.0</td><td align="char">14.5</td><td align="char">1.9</td><td align="char">30.0</td><td align="char">30.0</td><td align="char">1.5</td><td align="char">0.0</td><td align="char">0.2</td></tr><tr valign="top"><td align="center"><b>16</b></td><td align="char">1.5</td><td align="char">21.5</td><td align="char">1.8</td><td align="char">36.0</td><td align="char">39.0</td><td align="char">1.7</td><td align="char">0.0</td><td align="char">0.0</td></tr><tr valign="top"><td align="center"><b>17</b></td><td align="char">2.0</td><td align="char">23.0</td><td align="char">1.7</td><td align="char">NT</td><td align="char">218</td><td align="char">2.2</td><td align="char">2.0</td><td align="char">2.4</td></tr><tr valign="top"><td align="center"><b>18</b></td><td align="char">1.7</td><td align="char">34.0</td><td align="char">1.2</td><td align="char">NT</td><td align="char">92</td><td align="char">1.8</td><td align="char">0.0</td><td align="char">0.5</td></tr><tr valign="top"><td align="center"><b>19</b></td><td align="char">3.0</td><td align="char">28.5</td><td align="char">1.2</td><td align="char">45.0</td><td align="char">43.0</td><td align="char">1.8</td><td align="char">0.0</td><td align="char">1.4</td></tr><tr valign="top"><td align="center"><b>20</b></td><td align="char">11.0</td><td align="char">65.0</td><td align="char">2.3</td><td align="char">38.0</td><td align="char">21.0</td><td align="char">1.0</td><td align="char">1.0</td><td align="char">NT</td></tr><tr valign="top"><td align="center"><b>21</b></td><td align="char">12.5</td><td align="char">85.0</td><td align="char">2.5</td><td align="char">115.0</td><td align="char">45.0</td><td align="char">2.9</td><td align="char">1.0</td><td align="char">0.6</td></tr><tr valign="top"><td align="center"><b>22</b></td><td align="char">6.0</td><td align="char">48.5</td><td align="char">1.5</td><td align="char">816.0</td><td align="char">28.0</td><td align="char">2.4</td><td align="char">52.0</td><td align="char">0.0</td></tr><tr valign="top"><td align="center"><b>23</b></td><td align="char">1.5</td><td align="char">20.0</td><td align="char">0.7</td><td align="char">19.0</td><td align="char">24.0</td><td align="char">1.4</td><td align="char">1.0</td><td align="char">NT</td></tr><tr valign="top"><td align="center"><b>24</b></td><td align="char">0.4</td><td align="char">8.0</td><td align="char">0.5</td><td align="char">3.0</td><td align="char">11.0</td><td align="char">1.8</td><td align="char">7.0</td><td align="char">0.1</td></tr><tr valign="top"><td align="center"><b>25</b></td><td align="char">0.5</td><td align="char">9.0</td><td align="char">1.4</td><td align="char">10.0</td><td align="char">13.0</td><td align="char">2.1</td><td align="char">0.0</td><td align="char">0.0</td></tr><tr valign="top"><td align="center"><b>26</b></td><td align="char">0.4</td><td align="char">5.4</td><td align="char">1.6</td><td align="char">4.0</td><td align="char">13.1</td><td align="char">1.2</td><td align="char">14.0</td><td align="char">0.1</td></tr><tr valign="top"><td align="center"><b>27</b></td><td align="char">0.7</td><td align="char">10.0</td><td align="char">0.8</td><td align="char">3.0</td><td align="char">8.3</td><td align="char">2.0</td><td align="char">33.5</td><td align="char">NT</td></tr><tr valign="top"><td align="center"><b>28</b></td><td align="char">0.6</td><td align="char">10.0</td><td align="char">0.7</td><td align="char">3.0</td><td align="char">7.0</td><td align="char">2.5</td><td align="char">31.0</td><td align="char">NT</td></tr><tr valign="top"><td align="center"><b>29</b></td><td align="char">1521.0</td><td align="char">7470.0</td><td align="char">460.0</td><td align="char">NT</td><td align="char">NT</td><td align="char">1.0</td><td align="char">100.0</td><td align="char">0.010</td></tr><tr valign="top"><td align="center"><b>30</b></td><td align="char">0.4</td><td align="char">9.0</td><td align="char">0.6</td><td align="char">9.8</td><td align="char">18.3</td><td align="char">2.0</td><td align="char">9.0</td><td align="char">0.030</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">NT = not tested. PAMPA = permeability Pe × 10<sup>−6</sup> cm/s.</p></div><div class="footnote" id="t1fn1"><sup>b</sup><p class="last">Solubility is in μg/mL.</p></div></div></div><div class="NLM_p">Several morpholine bearing fused pyrimidines such as imidazolopyrimidines,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> pyrrolopyrimidines,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and triazolopyrimidines<a onclick="showRef(event, 'cit21c'); return false;" href="javascript:void(0);" class="ref cit21c">(21c)</a> have been reported by us previously as PI3K/mTOR dual inhibitors. In all these scaffolds, the morpholine oxygen formed a pivotal hinge region hydrogen bond interaction with Val851 of the PI3Kα catalytic domain<a onclick="showRef(event, 'ref18 cit21a cit21b cit21c'); return false;" href="javascript:void(0);" class="ref ref18 cit21a cit21b cit21c">(18, 21a-21c)</a> but also presented a metabolic liability via oxidation α to the morpholine ring oxygen, causing loss of potency. Many potent PI3K enzyme inhibitors based on the above-mentioned scaffolds failed to show antitumor efficacy in in vivo models. The most advanced compound <b>3</b> showed good efficacy in MDA-361 xenograft model. However, advanced studies with <b>3</b> were halted because of its poor solubility.</div><div class="NLM_p">Bearing these facts in mind, we decided to probe the other scaffolds that resemble a pyrimidine core but have lower clogP values than the triazolopyrimidine core in PKI-402. Among the various heterocycles we synthesized, the 1,3,5-triazine scaffold<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> was very attractive for the following reasons:</div><div class="NLM_p">(1) 1,3,5-Triazine is a monocyclic, symmetrical molecule similar to the pyrimidine core with two nitrogens in the 1,3-positions, and it has been used as a kinase inhibitor scaffold.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Hence, we envisaged that 1,3,5-triazine could mimic the pyrimidine scaffold and allow us to position the critical substituents observed in our earlier series for optimum interaction with the binding site of PI3Kα.</div><div class="NLM_p">(2) The presence of three nitrogens in the 1,3,5-triazine core can inherently impart polarity to the whole molecule, and the clogP values of the designed compounds can be about 2 or lower.</div><div class="NLM_p">(3) We also envisioned also that a bismorpholino-1,3,5-triazine scaffold would have an advantage under conditions where one morpholine gets metabolically oxidized, still leaving another morpholine to make the vital hinge region H bond interaction in the PI3K catalytic domain.</div><div class="NLM_p">However, we were aware that these modifications can solve the clogP problem, and to an extent, the morpholine metabolic liability might not address permeability and the microsomal stability problems. In order to explore the above-mentioned points, compound <b>8</b> was designed and modeled in the PI3Kγ homology model (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). The structural similarity of the ATP-binding sites of PI3Kα and PI3Kγ isoforms enabled a homology model to be built based on an in-house X-ray crystal structure of PI3Kγ in complex with a related compound (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3IBE">3IBE</a>.pdb).<a onclick="showRef(event, 'cit21a'); return false;" href="javascript:void(0);" class="ref cit21a">(21a)</a> Overall sequence similarity between PI3Kα and PI3Kγ is 43% in the kinase catalytic domain; however, the ATP-binding site is significantly more conserved with 81% of the residues being identical. As indicated in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, compound <b>8</b> docked in the homology model forms the critical hinge region hydrogen-bond to Val851 through a morpholine oxygen. The urea forms two hydrogen-bonding interactions to Asp810 through both urea-NH groups and one to the catalytic lysine (Lys802) through the urea carbonyl group. Hence, compound <b>8</b> was prepared as depicted in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. As can be seen from Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, compound <b>8</b> was found to have potent PI3Kα, PI3Kγ, and mTOR inhibitory activity but only moderate potency in MDA-361 and PC3MM2 cell proliferation assays. This was attributed to the poor solubility and permeability of compound <b>8</b>.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/medium/jm-2009-01830p_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/large/jm-2009-01830p_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Docking of compound <b>8</b> in PI3Kγ homology model. Hydrogen bonds are shown by blue dashes. The morpholine forms a hydrogen bond to the hinge region Val851. The urea forms three hydrogen bonds to Asp810 and Lys802. The critical salt bridge between the catalytic Lys802 and Asp805 is shown in purple.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/large/jm-2009-01830p_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901830p&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">However, this initial enzyme potency result encouraged us to probe the structure−activity relationship more systematically to further optimize the cellular potency. There was an observed drop in the potency against PI3Kα and PI3Kγ when the phenyl group in compound <b>8</b> was replaced with alkyl groups such as methyl <b>10</b>, ethyl <b>9</b>, or saturated heterocyclyl <b>29</b>. However, the corresponding mTOR activity was not affected. The structural basis for the observed difference in PI3Kα/γ and mTOR activity for compounds <b>9</b>, <b>10</b>, and <b>29</b> is not entirely clear because of a lack of detailed structural information on the mTOR enzyme (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). However, three residue differences are observed in the loop that forms the top of the binding site around the urea substituents. Asp805 in PI3Kα is a glutamic acid in mTOR, and this residue plays a critical role in stabilizing the catalytic lysine (Lys802 in PI3Kα, Lys2187 in mTOR) through the formation of a salt bridge. Substituted ureas of this type result in a concerted motion of the catalytic lysine and the aspartic/glutamic acid,<a onclick="showRef(event, 'cit21a cit21b'); return false;" href="javascript:void(0);" class="ref cit21a cit21b">(21a, 21b)</a> and it is possible that mTOR with the longer side chain in the glutamic acid, compared to the aspartic acid in PI3Kα, undergoes this motion more easily. The second noted residue difference in this area is the different positioning of glycine. In PI3Kα, a glycine (Gly804) is directly adjacent to the aspartic acid involved in the salt bridge, whereas in mTOR, a histidine (His2189) separates the glutamic acid from the glycine (Gly2188). Again, it is possible that the different position of the glycine allows the mTOR loop to accommodate the hydrophobic groups coming off the urea more easily. Substitution of the phenyl group in compound <b>8</b> with 4-fluoro <b>11</b>, 4-methyl <b>12</b>, 4-chloro <b>13</b>, and 2,4-difluorophenyl <b>14</b> led to compounds with moderate PI3Kα, PI3Kγ, and mTOR potency. It can also be noted from Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> that substitution of the phenyl group with a lipophilic group (examples <b>11</b>, <b>12</b>, <b>13</b>, and <b>14</b>) led to a decrease in the potency against PI3Kα. However, all these compounds, with the exception of <b>29</b>, had excellent potency against mTOR. It appears from the different examples that PI3Kα potency is favored if the R group is an aryl substituent. Molecular modeling using the PI3Kγ homology model revealed that the substituents on the R groups are solvent exposed (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). Hence, compounds <b>15</b> and <b>16</b>, bearing polar entities such as −CH<sub>2</sub>OH and −CH<sub>2</sub>CH<sub>2</sub>OH were prepared. This modification led to improvement in both enzyme and cellular potencies. This could be due to their marginally improved permeability. The PAMPA permeability for compound <b>15</b> is 0.18 × 10<sup>−6</sup> cm/s, and the Caco2 data for compound <b>16</b> is 2.9 (A > B) and 7.2 (B > A). Compounds <b>15</b> and <b>16</b> had poor human and nude mouse microsomal stabilities, which precluded them from further investigation. Heterocycles <b>18</b>, <b>19</b>, and <b>20</b> containing polar nitrogen also gave potent compounds with slightly increased human and nude mouse microsomal stabilities. However, these analogues did not have a good solubility profile at pH 7.4. Hence, compounds such as <b>24</b>−<b>30</b> bearing a basic amine moiety were prepared. As can be seen from Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, except for compound <b>29</b>, compounds bearing a basic amine moiety with an amide linkage exhibited excellent enzyme and cell potencies. These analogues also had good microsomal stability in all three species and exhibited good to moderate solubility. This dramatic boost in the PI3Kα enzyme potency by the amide substituent is not very well understood and may be due to an increased hydrogen bond accepting ability of the overall molecule. On the basis of enhanced potency, solubility, microsomal stability, and lack of Cyp inhibition, compound <b>26</b> was chosen for further in vitro and in vivo evaluations. Compound <b>26</b> was evaluated for its potency against class I PI3Ks (i.e., the β, γ, and δ isoforms) and the most frequently occurring mutant forms of PI3Kα, notably the H1047R and E545K. The IC<sub>50</sub> values are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. These results show that compound <b>26</b> is a pan-PI3K/mTOR inhibitor, with equivalent potency against mTOR (IC<sub>50</sub> = 1.4 nM, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). This compound was also evaluated against a panel of 236 other human protein kinases at 10 μM, and it was found to be highly selective for PI3K and mTOR.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/medium/jm-2009-01830p_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/large/jm-2009-01830p_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Detailed of interactions of compound <b>9</b> with PI3K-α and mTOR: overlay of the homology models of PI3Kα (green ribbons and carbons) and mTOR (magenta ribbons and carbons) with the predicted binding mode of compound <b>9</b>. Conserved residues are Val851 (Val2240 in mTOR) and Lys802 (Lys2187) and are therefore only labeled. Several residue differences near the urea-R groups (in this case R = CH<sub>3</sub>) are Asp805-Glu2190, Gly804-His2189, and Asn803-Gly2188.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/large/jm-2009-01830p_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901830p&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/medium/jm-2009-01830p_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/large/jm-2009-01830p_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Surface representation of the ATP binding site around <b>26</b>, illustrating that substitutions coming off the urea extend into the solvent.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/large/jm-2009-01830p_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901830p&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. IC<sub>50</sub> Values against Various PI3K Isoforms and Mutants</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="" /></col><col align="char" char="" /></col><col align="char" char="" /></col><col align="char" char="" /></col><col align="char" char="" /></col></colgroup><thead><tr valign="top"><th align="center"> </th><th colspan="5" align="center">isoforms</th></tr><tr valign="top"><th align="center"> </th><th align="center">PI3Kβ</th><th align="center">PI3Kγ</th><th align="center">PI3Kδ</th><th align="center">H1047R</th><th align="center">E545K</th></tr></thead><tbody><tr valign="top"><td align="left">IC<sub>50</sub> (nM)</td><td align="char">6</td><td align="char">8</td><td align="char">6</td><td align="char">0.6</td><td align="char">0.6</td></tr></tbody></table></div></div><div class="NLM_p">In vitro, compound <b>26</b> showed good potency in cell growth inhibition assays using MDA-361 and PC3-MM2 cell lines. Tumor cell growth inhibition by <b>26</b> correlated with suppression of phosphorylation of PI3K/mTOR signaling pathway proteins in MDA-361 tumor cells (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). Compound <b>26</b> prevented the phosphorylation of Akt (pAkt) at threonine 308 (T308; IC<sub>50</sub> = 8 nM) (phosphoblot IC<sub>50</sub> values were determined by densitometric scans of Western blots) and induced cleaved PARP at 30 nM. Cleaved PARP is a marker for cells undergoing apoptosis. Full activation of Akt kinase occurs when the mTOR containing mammalian target of rapamycin 2 (TORC2) protein complex phosphorylates Akt at serine 473 (S473). Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a> also shows potent (IC<sub>50</sub> < 10 nM) suppression of Akt phosphorylation at S473 by <b>26</b>. Phophorylation of Akt kinase effector proteins GSK3 kinase, endothelial nitric oxide synthase (ENOS), and prolinerich Akt substrate (PRAS 40) was also suppressed by <b>26</b> at concentrations less than 30 nM. The inhibition of mTOR containing TORC1 kinase activity by <b>26</b> was demonstrated by suppression of p70S6K and 4EBP1 phosphorylation at concentrations less than 30 nM by <b>26</b>. Compound <b>26</b> did not affect the overall Akt content in MDA-361 cells at concentrations tested (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>), indicating pAkt suppression was not an artifact of compound cytotoxicity.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/medium/jm-2009-01830p_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/large/jm-2009-01830p_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. In vitro phosphoblot studies. MDA-361 tumor line was exposed to <b>26</b> for 4 h.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/large/jm-2009-01830p_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901830p&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Initial blood level studies in female nude mice were done with compounds <b>24</b>, <b>25</b>, and <b>26</b> via both oral (po) and iv routes of administration. None of these three analogues had oral exposure in nude mice. However, when <b>26</b> was administered to nude mice at 25 mg/kg iv (in 5% dextrose [D5/W], 0.3% lactic acid, pH 3.5), low plasma clearance (7 (mL/min)/kg) compared to liver blood flow (90 (mL/min)/kg), high volume of distribution (7.2 L/kg) compared to plasma volume (0.7 L/kg), and long half-life, (14.4 h) were observed (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Low clearance indicated minimal metabolism, and high volume of distribution was suggestive of extensive tissue distribution in nude mice. When compound <b>26</b> was administered iv (single dose) at 25 mg/kg, it suppressed pAkt (T308 and S473) for up to 36 h and induced cleaved PARP up to 18 h in MDA-361 tumors staged in nude mice (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Pharmacokinetic Parameters of Compound <b>26</b> after a Single 25 mg/kg iv Dose in Female Nude Mice<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top"><th align="center"><i>C</i><sub>0</sub> (ng/mL)</th><th align="center"><i>T</i><sub>1/2</sub> (h)</th><th align="center">AUC<sub>last</sub> (h·ng/mL)</th><th align="center">AUC<sub>0−inf</sub> (h·ng/mL)</th><th align="center">Cl<sub>p</sub> ((mL/min)/kg)</th><th align="center"><i>V</i><sub>ss</sub> (L/kg)</th><th align="center">MRT (h)</th></tr></thead><tbody><tr valign="top"><td align="center">48523</td><td align="center">14.4</td><td align="center">42593</td><td align="center">57927</td><td align="center">7</td><td align="center">7.2</td><td align="center">16.7</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">C<sub>0</sub> = concentration at 0 min. <i>T</i><sub>1/2</sub> = half-life. AUC = area under the plasma concentration time curve. <i>V</i><sub>ss</sub> = volume of distribution at steady state. Cl<sub>p</sub> = clearance;. MRT = mean resonance time.</p></div></div></div><div class="NLM_p">Compound <b>26</b> exhibiting potent antitumor efficacy against MDA-361 tumors is also demonstrated in Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>. Compound <b>26</b> administered iv at 20 mg/kg on an intermittent regimen (days 1, 5, 9) caused regression of large staged (∼900 mm<sup>3</sup>) tumors. This effect was more pronounced than that observed for paclitaxel (Taxol) given at 60 mg/kg (single dose, ip). In subsequent in vivo studies the minimum efficacious dose (MED) of <b>26</b> was determined to be 3 mg/kg against MDA-361 tumors and maximum tolerated single dose (MTD) was determined to be 30 mg/kg.</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/medium/jm-2009-01830p_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/large/jm-2009-01830p_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Compound <b>26</b> in vivo biomarker profile at 25 mg/kg, iv, single dose. Tumor tissue from the MDA-361 xenograft model was examined for p-Akt suppression and induction of cleaved PARP at different time points. The p70 pS6K and pS6 panels show suppression of phosphorylation of these mTOR effector proteins.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/large/jm-2009-01830p_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901830p&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/medium/jm-2009-01830p_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/large/jm-2009-01830p_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Efficacy profile of compound <b>26</b> in MDA-361 xenograft model. Shown is the tumor regression caused by <b>26</b> at 20 mg/kg, iv, on days 1, 5, 9 and by paclitaxel (Taxol) at 60 mg/kg, ip (single dose). <i>Y</i> axis represents tumor volume in mm<sup>3</sup>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/large/jm-2009-01830p_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901830p&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Potent antitumor activity of compound <b>26</b> was also demonstrated in an orthotopic version of the H1975 (non-small-cell lung carcinoma, mutant EGFR [L858R, T790M]) xenograft model (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>). H1975 cells were injected into the pleural cavity of nude mice, and the animals were treated with <b>26</b> once weekly at 25 mg/kg for 7 weeks. As can be seen from Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>, all of the untreated control animals were dead by day 50, compared to 90% survival in the group treated with <b>26</b>.</div><figure id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/medium/jm-2009-01830p_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/large/jm-2009-01830p_0007.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Orthotopic model for compound <b>26</b> in H1975 (non-small-cell lung carcinoma). Compound <b>26</b> was given once weekly for 7 weeks at 25 mg/kg. The <i>Y</i> axis represents % survival (Kaplan−Meier plot).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/large/jm-2009-01830p_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901830p&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65100" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65100" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We have shown that bis(morpholinotriazine) compounds bearing bisarylureas are potent dual PI3K/mTOR inhibitors. We have also discovered that the presence of an amide functionality bearing water solubilizing groups boosted potency, both in enzyme and in cell proliferation assays. During our course of optimization, we identified compound <b>26</b>, which has shown excellent efficacy especially in in vivo xenograft models. Compound <b>26</b> is currently entering phase I clinical trials as a single agent for iv administration.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45755" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45755" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> General Methods</h3><div class="NLM_p last">Melting points were determined in open capillary tubes on a Mel-Temp melting point apparatus and are uncorrected. <sup>1</sup>H NMR spectra were determined with a Bruker DPX-400 spectrometer at 400 MHz. Chemical shifts are reported in parts per million (δ) relative to residual chloroform (7.26 ppm), TMS (0 ppm), or dimethyl sulfoxide (2.49 ppm) as an internal reference with coupling constants (<i>J</i>) reported in hertz (Hz). The peak shapes are denoted as follows: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; br, broad. Electrospray (ES) mass spectra were recorded in positive or negative mode on a Micromass Platform spectrometer. Electron impact (EI) and high-resolution mass spectra were obtained on a Finnigen MAT-90 spectrometer. Combustion analyses were obtained using Perkin-Elmer series II 2400 CHNS/O analyzer. The purity of compounds <b>8</b>−<b>32</b> was determined by analytical LC/MS using an Agilent 1100 LC equipped with an Agilent MSD mass spectrometer and by analytical LC using an X-Bridge BEH column, MeOH/H<sub>2</sub>O eluent at 1 mL/min flow (containing 0.05% NH<sub>4</sub>OAc), 20 min gradient from 10% MeOH to 90% ACN, monitored by UV absorption at 215 nm. The purity of all the above-mentioned compounds was found to be >95%. Reverse phase HPLC purifications were performed on a Gilson preparative HPLC system controlled by Unipoint software, using a Phenomenex Gemini 100 mm × 30.0 mm column. Thin-layer chromatography (TLC) was performed on Merck PLC prescored plates <sub>60</sub>F<sub>254</sub>.The terms “concentrated” and “evaporated” refer to removal of solvents using a rotary evaporator at water aspirator pressure with a bath temperature equal to or less than 40 °C. Unless otherwise noted, reagents were obtained from commercial sources and were used without further purification.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Modeling</h3><div class="NLM_p last">The homology model was built with Prime 1.6 with <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3IBE">3IBE</a><a onclick="showRef(event, 'cit21a'); return false;" href="javascript:void(0);" class="ref cit21a">(21a)</a> as the template. Docking studies were performed using Glide, version 4.5 initially and version 5.5 more recently. Docking studies were performed either without constraints or with a hydrogen bonding constraint to the backbone-NH of Val851. Figures <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> were made using PyMOL: Prime, version 1.6 (2007) (Schrodinger, LLC, New York, NY); Glide, version 5.5 (2009) (Schrodinger, LLC, New York, NY); and PyMOL Molecular Graphics System (2008) (W. L. DeLano; DeLano Scientific LLC, Palo Alto, CA).</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Preparation of 1-[4-(4,6-Dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]-3-phenylurea (<b>8</b>)</h3><div id="sec5_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> Step 1: Preparation of 2-Chloro-4,6-dimorpholin-4-yl[1,3,5]triazine (<b>6</b>)</h4><div class="NLM_p last">To a stirred solution of cyanuric chloride (18.4 g, 10 mmol) in acetone (100 mL) and crushed ice (500 g), a mixture of triethylamine (30.0 g, excess) and morpholine (17.4 g, 20 mmol) was added at −10 °C. After the addition, the reaction mixture was stirred at room temperature for 1 h and diluted with 50 mL of water. Separated white solid was filtered and washed with water. The white solid was dried and filtered. The crude product was found to be pure and taken to the next step without purification (25 g, 87% yield). (M + H) 286.7</div></div><div id="sec5_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> Step 2: Preparation of 4-(4,6-Dimorpholin-4-yl-1,3,5-triazin-2-yl)aniline (<b>7</b>)</h4><div class="NLM_p last">A mixture of 2-chloro-4,6-dimorpholin-4-yl[1,3,5]triazine (1.4 g, 4.9 mmol), a catalytic amount of tetrakis(triphenylphosphine)palladium(0) (70 mg, 0.061 mmol), sodium carbonate solution 2 M (3 mL), 4-aminophneylboronic acid pinacol ester (1.6 g, 7.3 mmol), and DME (100 mL) was refluxed for 24 h. The solvent was evaporated, and the residue was dissolved in methylene chloride and filtered through Celite. The filtrate was washed with water (200 mL), and the organic layer was dried with magnesium sulfate. This was filtered, and the solvent was evaporated. The residue was purified by SiO<sub>2</sub> column chromatography and eluted with ethyl acetate/hexanes (1:1) to give of 4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)aniline (1.40 g, 83% yield) as an amorphous solid. (M + H) 343.</div></div><div id="sec5_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> Step 3: Preparation of 1-[4-(4,6-Dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]-3-phenylurea (<b>8</b>)</h4><div class="NLM_p last">To a stirred mixture of 4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)aniline (140 mg, 0.40 mmol) and a catalytic amount of dimethylaminopyridine (DMAP) in methylene chloride (100 mL) was added a small excess of phenyl isocyanate (59.5 mg, 0.50 mmol). The mixture was stirred at room temperature for 48 h. The reaction mixture was concentrated to half of its original volume, and the separated precipitate was collected by filtration and washed with methanol (15 mL) and then with diethyl ether. In some cases the crude product obtained was purified by SiO<sub>2</sub> column chromatography by eluting it with 10% ethyl acetate/hexane (128 mg, 68% yield). White solid. 462.3 (M + H). Purity by analytical HPLC 99.3%. (Prodigy ODS3, 0.46 cm × 15 cm, 20 min gradient acetonitrile in water, trifluoroacetic acid, detector wavelengths, 215 and 254 nM.) <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 3.6 (m, 8H), 3.7 (m, 8H), 7.0 (t, <i>J</i> = 7.0 Hz, 1H), 7.3 (t, <i>J</i> = 7.3 Hz, 2H), 7.5 (d, <i>J</i> = 8.1 Hz, 2H), 7.6 (d, <i>J</i> = 8.8 Hz, 2H), 8.3 (d, <i>J</i> = 8.6 Hz, 2H), 8.7 (s, 1H), 9.0 (s, 1H) ppm.</div></div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Preparation of 1-[4-(4,6-Dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]-3-ethylurea (<b>9</b>)</h3><div class="NLM_p last">Starting from 4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)aniline (0.130 g 0.38 mmol) and ethyl isocyanate (260 mg, 10-fold excess) and following the procedure outlined for compound <b>8</b>, the title compound was isolated as a white solid (38 mg, 25% yield). (M + H) 414.3. Purity by analytical HPLC 97.8%. (Prodigy ODS3, 0.46 cm × 15 cm, 20 min gradient acetonitrile in water, trifluoroacetic acid, detector wavelengths, 215 and 254 nM.) <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 3.6 (m, 8H), 3.7 (m, 8H), 3.75 (t, <i>J</i> = 6.8 Hz, 3H), 3.8 (q, <i>J</i> = 6.8 Hz, 2H), 7.6 (d, 2H, <i>J</i> = 8.3 Hz), 8.2 (d, 2H, <i>J</i> = 8.3 Hz), 8.9 (broad s, 2H) ppm.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Preparation of 1-[4-(4,6-Dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]-3-(4-fluorophenyl)urea (<b>11</b>)</h3><div class="NLM_p last">Starting from 4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)aniline (0.140 g 0.40 mmol) and 4-fluorophenyl isocyanate (83 mg, 0.61 mmol) and following the procedure outlined in example <b>8</b>, 65 mg (33% yield) of the title product was isolated as white solid. (M + H) 480.3. Purity by analytical HPLC 97.9%. (Prodigy ODS3, 0.46 cm × 15 cm, 20 min gradient acetonitrile in water, trifluoroacetic acid, detector wavelengths, 215 and 254 nM.) <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 3.6 (m, 8H), 3.7 (m 8H), 7.2 (t, <i>J</i> = 8.3 Hz, 2H), 7.4 (m, 2H), 7.5 (d, <i>J</i> = 9.3 Hz, 2H), 8.3 (d, <i>J</i> = 9.1 Hz, 2H), 8.8 (s, 1H), 9.0 (s, 1H) ppm.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Preparation of 1-[4-(4,6-Dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]-3-(4-methylphenyl)urea (<b>12</b>)</h3><div class="NLM_p last">Starting from 4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)aniline (0.140 g 0.40 mmol) and 4-methylphenyl isocyanate (74 mg, 0.56 mmol) and following the procedure outlined for the preparation of compound <b>8</b>, the title compound was isolated as a white solid (65 mg, 33% yield). (M + H) 476.4. Purity by analytical HPLC 98.2%. (Prodigy ODS3, 0.46 cm × 15 cm, 20 min gradient acetonitrile in water, trifluoroacetic acid, detector wavelengths, 215 and 254 nM.) <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 3.6 (m, 8H), 3.7 (m, 8H), 2.5 (s, 3H), 7.1 (d, <i>J</i> = 9.6 Hz, 2H), 7.3 (d, <i>J</i> = 8.3 Hz, 2H), 7.6 (d, <i>J</i> = 8.6 Hz, 2H), 8.2 (d, <i>J</i> = 9.6 Hz, 2H), 8.6 (s, 1H), 8.9 (s, 1H) ppm.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Preparation of 1-(4-Chlorophenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea (<b>13</b>)</h3><div class="NLM_p last">Starting from 4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)aniline (0.140 g 0.40 mmol) and 4-chlorophenyl isocyanate (94 mg, 0.61 mmol) and following the procedure outlined for the preparation of <b>8</b>, the title compound was isolated as a white solid (60 mg, 30% yield). (M + H) 496.3. Purity by analytical HPLC 96.8%. (Prodigy ODS3, 0.46 cm × 15 cm, 20 min gradient acetonitrile in water, trifluoroacetic acid, detector wavelengths, 215 and 254 nM.) <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 3.6 (m, 8H), 3.7 (m, 8H), 7.1 (m, 2H), 7.4 (m, <i>J</i> = 8.1 Hz, 2H), 7.6 (d, <i>J</i> = 8.8 Hz, 2H), 8.2 (d, <i>J</i> = 8.3 Hz, 2H), 8.8 (s, 1H), 9.0 (s, 1H) ppm.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Preparation of (2,4-Difluorophenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea (<b>14</b>)</h3><div class="NLM_p last">Starting from 4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)aniline (0.105 g 0.30 mmol) and 2,4-difluorophenyl isocyanate (71 mg, 0.45 mmol) and following the procedure outlined in example <b>8</b>, the title compound was isolated as a white solid (40 mg, 27% yield). (M + H) 498.4. Purity by analytical HPLC 97.5%. (Prodigy ODS3, 0.46 cm × 15 cm, 20 min gradient acetonitrile in water, trifluoroacetic acid, detector wavelengths, 215 and 254 nm.) <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 3.65 (m, 8H), 3.8 (b, 8H), 7.04 (m, 1H), 7.32 (m, 1H), 7.54 (d, <i>J</i> = 8.6 Hz, 2H), 8.07 (m, 1H), 8.1 (d, <i>J</i> = 8.2 Hz, 2H), 8.57 (s, 1H), 9.32 (s, 1H) ppm.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Preparation of 1-[4-(4,6-Dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]-3-[4-(1-hydroxyethyl)phenyl]urea (<b>16</b>)</h3><div class="NLM_p last">To a stirred mixture of 4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)aniline (0.140, 0.40 mmol) in methylene chloride at 0 °C was added triphosgene (0.25, 0.84 mmol) and Et<sub>3</sub>N (3 mL). The reaction mixture was stirred for 20 min at 0 °C. Then 1-(4-aminophenyl)ethanol (0.10 g, 0.73 mmol) was added to the mixture. The reaction mixture was stirred for about 16 h at room temperature. The solvent was removed. The residue was dissolved in DMSO and placed in an HPLC instrument, with acetonitrile buffer TFA to give [4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]-3-[4-(1- hydroxyethyl)phenyl]urea (48 mg, 24% yield). (M + H) 506.4. Purity by analytical HPLC 95.5%. (Prodigy ODS3, 0.46 cm × 15 cm, 20 min gradient acetonitrile in water, trifluoroacetic acid, detector wavelengths, 215 and 254 nm.) <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 2.66 (t, <i>J</i> = 7.1 Hz, 2H), 3.43 (b, 1H), 3.57 (t, <i>J</i> = 7.6, 2H), 3.66 (m, 8H), 3.81 (b, 8H), 7.13 (d, <i>J</i> = 8.1 Hz, 2H), 7.36 (d, <i>J</i> = 8.3 Hz, 2H), 7.54 (d, <i>J</i> = 8.8 Hz 2H), 8.27 (d, <i>J</i> = 8.26 Hz 2H), 8.63 (s, 1H), 8.95 (s, 1H) ppm.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Preparation of 1-[4-(4,6-Dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]-3-[4-(hydroxymethyl)phenyl]urea (<b>15</b>)</h3><div class="NLM_p last">Starting from 4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)aniline (0.140, 0.40 mmol) and 4-aminophenylmethanol (100 mg, 0.81 mmol) and following the procedure described in example <b>16</b>, 1-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]-3-[4-(hydroxymethyl)phenyl]urea was isolated by HPLC purification (58 mg, 26% yield). (M + H) (ESI) <i>m</i>/<i>z</i> = 492.3. Purity by analytical HPLC 95.8%. (Prodigy ODS3, 0.46 cm × 15 cm, 20 min gradient acetonitrile in water, trifluoroacetic acid, detector wavelengths, 215 and 254 nm.) <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 3.43 (b, 1H), 3.66 (m, 8H), 3.81 (b, 8H), 4.43 (s, 2H), 7.23 (d, <i>J</i> = 8.8 2H), 7.41 (d, <i>J</i> = 8.3 Hz, 2H), 7.55 (d, <i>J</i> = 8.6 Hz, 2H), 8.27 (d, <i>J</i> = 8.8 Hz, 2H), 8.7 (s, 1H), 8.98 (s, 1H) ppm.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Preparation of 1-[4-(4,6-Dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]-3-thiophen-2-ylurea (<b>17</b>)</h3><div class="NLM_p last">Starting from 4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)aniline (60 mg, 0.17 mmol) and 2-thienyl isocyanate (18 mg, 0.14 mmol) and following the procedure as outlined in example <b>8</b>, the title compound was isolated as a gray solid after SiO<sub>2</sub> column chromatography by eluting with 5% ethyl acetate/methanol. (12 mg, 14% yield). (M + H) = 468.3. Purity by analytical HPLC 96.9%. (Prodigy ODS3, 0.46 cm × 15 cm, 20 min gradient acetonitrile in water, trifluoroacetic acid, detector wavelengths, 215 and 254 nm.) <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 3.66 (m, 8H), 3.81 (b, 8H), 6.58 (dd, <i>J</i> = 1.3 Hz, <i>J</i> = 3.8 Hz, 1H), 6.82 (dd, <i>J</i> = 3.8 Hz, <i>J</i> = 5.8 Hz, 1H), 6.9 (dd, <i>J</i> = 1.3 Hz, <i>J</i> = 5.8 Hz, 1H), 7.55 (d, <i>J</i> = 8.6 Hz, 2H), 8.28 (d, <i>J</i> = 8.6 Hz 2H), 9.05 (s, 1H), 9.68 (s, 1H), ppm.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Preparation of 1-[4-(4,6-Dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]-3-pyridin-3-ylurea (<b>18</b>)</h3><div class="NLM_p last">Starting from 4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)aniline (0.08 g 0.23 mmol) and 3-pyridyl isocyanate (30 mg, 0.25 mmol) and following the procedure as outlined in example <b>8</b>, the title compound was isolated as a white solid. The product was purified by SiO<sub>2</sub> column chromatography by eluting it with 10% methanol/ethyl acetate. (60 mg, 56% yield). (M + H) 463.2. Purity by analytical HPLC 98.2%. (Prodigy ODS3, 0.46 cm × 15 cm, 20 min gradient acetonitrile in water, trifluoroacetic acid, detector wavelengths, 215 and 254 nm.) <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 3.66 (m, 8H), 3.82 (b, 8H), 7.33 (m, 1H), 7.56 (d, <i>J</i> = 8.6 Hz, 2H), 7.96 (d, <i>J</i> = 8.8 Hz, 1H), 8.21 (d, <i>J</i> = 5.3 Hz, 1H), 8.58 (d, <i>J</i> = 8.3 Hz, 2H), 8.61 (d, <i>J</i> = 2.5 Hz 1H), 8.91 (s, 1H), 9.13 (s, 1H), ppm.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Preparation of 1-[4-(4,6-Dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]-4-pyridin-4-ylurea (<b>19</b>)</h3><div class="NLM_p last">To a mixture of 4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)aniline (0.20 g 0.40 mmol) in methylene chloride (80 mL) at 0 °C was added triphosgene (0.25 mg, 0.84 mmol) and triethylamine (3 mL). The mixture was stirred for 20 min at 0 °C, and 4-aminopyridine (0.10 g 0.83 mmol) was added to the reaction mixture. The mixture was stirred for another 2 h at room temperature. The solvent was evaporated and the residue was submitted to HPLC using acetonitrile/TFA as mobile phase to give 1-[4-(4,6-dimophorlin-4-yl-1,3,5-triazin-2-yl)phenyl]-3-pyridin-4-ylurea (98.2 mg 36% yield). (M + H) 463.4. Purity by analytical HPLC 97.9%. (Prodigy ODS3, 0.46 cm × 15 cm, 20 min gradient acetonitrile in water, trifluoroacetic acid, detector wavelengths, 215 and 254 nm.) <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 3.51 (b, 8H), 3.64 (b, 8H), 7.60 (d, <i>J</i> = 8.6 Hz, 2H), 7.92 (d, <i>J</i> = 7.3 Hz, 2H), 8.32 (d, <i>J</i> = 8.8 Hz, 2H), 8.58 (d, <i>J</i> = 7.6 Hz, 2H), 9.79 (s,1H), 10.54 (s, 1H) ppm.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Preparation of 1-[4-(4,6-Dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]-3-pyridazin-4-ylurea (<b>20</b>)</h3><div class="NLM_p last">To a mixture of 4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)aniline (50 mg 0.15 mmol) in methylene chloride (80 mL) at 0 °C was added triphosgene (26 mg, 0.088 mmol) and triethylamine (0.2 mL). The mixture was stirred for 20 min at 0 °C. Pyridazine-4-amine (42 mg 0.48 mmol) was added to the reaction mixture, and the mixture was stirred for another 2 h at room temperature. The solvent was evaporated and the residue was submitted to the HPLC using acetonitrile/NH<sub>3</sub> as mobile phase to give 17 mg (25% yield) of 1-[4-(4,6-dimophorlin-4-yl-1,3,5-triazin-2-yl)phenyl]-3-pyridazin-4-ylurea. (M + H) 464.2. Purity by analytical HPLC 95.6%. (Prodigy ODS3, 0.46 cm × 15 cm, 20 min gradient acetonitrile in water, trifluoroacetic acid, detector wavelengths, 215 and 254 nm.) <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 3.6 (m, 8H), 3.7 (m, 8H), 7.5 (d, <i>J</i> = 9.4 Hz 1H), 7.81−7.84 (m, 2H), 8.3 (d, <i>J</i> = 8.3 Hz, 2H), 8.9 (d, <i>J</i> = 6.4 Hz, 2H), 9.1 (m, 1H), 9.4 (s, 1H) ppm.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Preparation of Methyl 4-(3-(4-(4,6-Dimorpholino-1,3,5-triazin-2-yl)phenyl)ureido)benzoate (<b>21</b>)</h3><div class="NLM_p last">Starting from 4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)aniline (342 mg, 1.0 mmol) and methyl 4-isocyanatobenzoate (177 mg, 1 mmol) and following the procedure as outlined in example <b>8</b>, the title compound was isolated as a gray solid (480 mg, 92%) after SiO<sub>2</sub> column chromatography by eluting with 50% ethyl acetate/hexane. (M + H) 520.3. Purity by analytical HPLC 95.3%. (Prodigy ODS3, 0.46 cm × 15 cm, 20 min gradient acetonitrile in water, trifluoroacetic acid, detector wavelengths, 215 and 254 nm.) <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 3.6 (m, 8H), 3.7 (m, 8H), 3.8 (s, 3H), 7.57−7.62 (m, 2H), 7.8 (d, <i>J</i> = 7.6 Hz, 4H), 8.3 (d, <i>J</i> = 9.1 Hz, 2H), 9.11−9.15 (d, <i>J</i> = 12.6 Hz, 2H) ppm.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Preparation of 4-[3-{4-(4,6-Dimorpholino-1,3,5-triazin-2yl)phenyl}ureido]benzoic Acid (<b>22</b>)</h3><div class="NLM_p last">To a stirred mixture of methyl 4-(3-(4-(4,6-dimorpholino-1,3,5-triazin-2-yl)phenyl)ureido)benzoate (1.4 g, 2.69 mmol), THF (10 mL), MeOH (5 mL), and H<sub>2</sub>O (2.5 mL) was added LiOH·H<sub>2</sub>O (339 mg, 8.07 mmol). The mixture was then heated under reflux for 8 h and concentrated. H<sub>2</sub>O (5 mL) was added, and the mixture was then acidified with 2 N HCl. The solid was filtered, washed with H<sub>2</sub>O, and dried to give the product as a tan solid, which was taken to next step without purification (1.3 g, 96% yield). MS (ESI) <i>m</i>/<i>z</i> = 506.2. Purity by analytical HPLC 98.4%. (Prodigy ODS3, 0.46 cm × 15 cm, 20 min gradient acetonitrile in water, trifluoroacetic acid, detector wavelengths, 215 and 254 nm.) <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 3.6 (m, 8H), 3.7 (m, 8H), 7.56−7.59 (m, 4H), 7.9 (d, <i>J</i> = 8.6 Hz, 2H), 8.3 (d, <i>J</i> = 7.6 Hz, 2H), 9.31−9.34 (d, <i>J</i> = 10.8 Hz, 2H) ppm.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Preparation of of <i>N</i>-[2-(Dimethylamino)ethyl]-4-({[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]carbamoyl}amino)benzamide (<b>24</b>)</h3><div class="NLM_p last">A solution of 4-[3-{4-(4,6-dimorpholino-1,3,5-triazin-2yl)phenyl}ureido]benzoic acid (150 mg, 0.297 mmol), Hunig’s base (303 μL, 1.782 mmol), and HBTU (563 mg, 1.485 mmol) in 2 mL of NMP was stirred for 1 h at room temperature. <i>N</i>′,<i>N</i>′-Dimethylethane-1,2-diamine (130 uL, 1.188 mmol) was added, and then the mixture was stirred overnight. At the end, CH<sub>2</sub>Cl<sub>2</sub> (40 mL) was added and washing was done with saturated NaHCO<sub>3</sub> and H<sub>2</sub>O. The mixture was concentrated and purified by silica gel chromatography, with CH<sub>2</sub>Cl<sub>2</sub>/methanol/7N NH<sub>3</sub> in MeOH (10:1:0.22) to give the product as a white solid (98 mg, 57% yield). MS (ESI) <i>m</i>/<i>z</i> = 576.4, MS (ESI) <i>m</i>/<i>z</i> 288.7. HRMS: calcd for C<sub>29</sub>H<sub>37</sub>N<sub>9</sub>O<sub>4</sub> + H<sup>+</sup>, 576.3041; found 576.3036. Purity by analytical HPLC 98.4%. (Prodigy ODS3, 0.46 cm × 15 cm, 20 min gradient acetonitrile in water, trifluoroacetic acid, detector wavelengths, 215 and 254 nm.) <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 3.6 (m, 8H), 3.7 (m, 8H), 2.5 (s, 6H), 2.8 (d, <i>J</i> = 5.3 Hz, 2H), 3.2 (q, <i>J</i> = 5.3 Hz, 2H), 7.55−7.58 (m, 4H), 7.8 (d, <i>J</i> = 9.1 Hz, 2H), 8.2 (d, <i>J</i> = 8.8 Hz, 2H), 8.6 (m, 1H), 9.6 (s, 1H), 9.7 (broad s,1H) ppm.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Preparation of 4-(3-(4-(4,6-Dimorpholino-1,3,5-triazin-2-yl)phenyl)ureido)-<i>N</i>-methylbenzamide (<b>23</b>)</h3><div class="NLM_p last">A solution of 4-(3-(4-(4,6-dimorpholino-1,3,5-triazin-2yl)phenyl)ureido)benzoic acid (150 mg, 0.297 mmol), Hunig’s base (303 μL, 1.782 mmol), and HBTU (563 mg, 1.485 mmol) in 2 mL of NMP was reacted according to example <b>24</b> with methylamine (594 μL, 2 M solution in THF) to give the product as a white solid (118 mg, 77% yield). MS (ESI) <i>m</i>/<i>z</i> = 519.3. HRMS: calcd for C<sub>26</sub>H<sub>30</sub>N<sub>8</sub>O<sub>4</sub> + H<sup>+</sup>, 519.2463; found 519.2456. Purity by analytical HPLC 95.7%. (Prodigy ODS3, 0.46 cm × 15 cm, 20 min gradient acetonitrile in water, trifluoroacetic acid, detector wavelengths, 215 and 254 nm.) <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 3.6 (m, 8H), 3.7 (m, 8H), 2.81 (d, <i>J = </i>3.8 Hz, 3H), 7.51−7.57 (m, 4H), 7.8 (d, <i>J =</i> 7.3 Hz, 2H), 8.3 (d, <i>J</i> = 7.6 Hz, 2H), 8.9 (s, 1H), 9.9 (s, 1H) ppm.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Preparation of 1-[4-(4,6-Dimorpholino-1,3,5-triazin-2-yl)phenyl]-3-{4-[(4-methylpiperazine-1-yl)carbonyl]phenyl}urea Hydrochloride (<b>25</b>)</h3><div class="NLM_p last">A stirred solution of 4-(3-(4-(4,6-dimorpholino-1,3,5-triazin-2yl)phenyl)ureido)benzoic acid (150 mg, 0.297 mmol), Hunig’s base (303 μL, 1.782 mmol), and HBTU (563 mg, 1.485 mmol) in 2 mL of NMP was reacted according to example <b>24</b> with 1-methylpiperazine (132 μL, 1.188 mmol) to give 1-(4-(4,6-dimorpholino-1,3,5-triazin-2-yl)phenyl)-3-(4-(4-methylpiperazine-1-carbonyl)phenyl)urea as a white solid (95 mg, 54% yield). MS (ESI) <i>m</i>/<i>z</i> = 588.4 and 294.7. HRMS: calcd for C<sub>30</sub>H<sub>37</sub>N<sub>9</sub>O<sub>4</sub> + H<sup>+</sup>, 588.3041; found (ESI, [M + H]<sup>+</sup> obsd), 588.3033. Purity by analytical HPLC 98.2%. (Prodigy ODS3, 0.46 cm × 15 cm, 20 min gradient acetonitrile in water, trifluoroacetic acid, detector wavelengths, 215 and 254 nm.) <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 2.2 (s, 3H), 2.5 (m, 4H), 3.3 (m, 4H), 3.6 (m, 8H), 3.7 (m, 8H), 7.3 (d, <i>J</i> = 8.3 Hz, 2H), 7.51−7.58 (m, 4H), 8.3 (d, <i>J</i> = 9.0 Hz, 2H), 8.9 (s, 1H), 9.1 (s, 1H) ppm. To 1-(4-(4,6-dimorpholino-1,3,5-triazin-2-yl)phenyl)-3-(4-(4-methylpiperazine-1-carbonyl)phenyl)urea (70 mg, 0.119 mmol) and MeOH (1 mL) was added 4 N HCl in dioxane (1 mL), and the mixture was stirred for 3 h. The solid was filtered and washed with ether to give the product as a white solid (74 mg, 100% yield).</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Preparation of 1-(4-{[4-(Dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4- yl-1,3,5-triazin-2-yl)phenyl]urea (<b>26</b>)</h3><div class="NLM_p last">A solution of 4-(3-(4-(4,6-dimorpholino-1,3,5-triazin-2yl)phenyl)ureido)benzoic acid (50 mg, 0.099 mmol), Hunig’s base (103 μL, 0.594 mmol), and HBTU (188 mg, 0.495 mmol) in 2 mL of NMP was reacted according to example <b>24</b> with <i>N</i>,<i>N</i>-dimethylpiperidin-4-amine (51 mg, 0.396 mmol). The solvent was evaporated and purified by HPLC to give the product (30.6 mg, 52% yield). MS (ESI) <i>m</i>/<i>z</i> = 616.7. HRMS: calcd for C<sub>32</sub>H<sub>41</sub>N<sub>9</sub>O<sub>4</sub> + H<sup>+</sup>, 616.335 43; found (ESI-FTMS, [M + H]<sup>+</sup>), 616.334 24. Purity by analytical HPLC 99.3%. (Prodigy ODS3, 0.46 cm × 15 cm, 20 min gradient acetonitrile in water, trifluoroacetic acid, detector wavelengths, 215 and 254 nm.) <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.29−1.36 (m, 6H), 2.6 (m, 4H), 2.9 (m,1H), 3.3 (m, 4H), 3.6 (m, 8H), 3.7 (m, 8H), 7.3 (d, <i>J</i> = 8.3 Hz, 2H), 7.51−7.57 (m, 4H), 8.3 (d, <i>J</i> = 8.3 Hz 2H), 8.9 (s, 1H), 9.0 (s, 1H) ppm. Anal. Calcd for C<sub>32</sub>H<sub>41</sub>N<sub>9</sub>O<sub>4</sub>: C 62.42%, H 6.71%, N 20.47%. Found: C 62.34%, H 6.67%, N 20.39%.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Preparation of 1-[4-(4,6-Dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]-3-{4-[(4-pyrrolidin-1-ylpiperidin-1-yl)carbonyl]phenyl}urea (<b>27</b>)</h3><div class="NLM_p last">Compound <b>27</b> was prepared by reacting 4-(3-(4-(4,6-dimorpholino-1,3,5-triazin-2yl)phenyl)ureido)benzoic acid and 4-pyrrolidi-1-ylpiperidine. (M + H) <i>m</i>/<i>z</i> = 642.3. HRMS: calcd for C<sub>34</sub>H<sub>43</sub>N<sub>9</sub>O<sub>4</sub> + H<sup>+</sup>, 642.3510; found (ESI-FTMS, [M + H]<sup>+</sup>), 642.3491. Purity by analytical HPLC 97.2%. (Prodigy ODS3, 0.46 cm × 15 cm, 20 min gradient acetonitrile in water, trifluoroacetic acid, detector wavelengths, 215 and 254 nm.) <sup>1</sup>H NMR (DMSO) δ 1.62 (m, 2H), 1.86 (m, 2H), 1.98 (m, 2H), 2.08 (m, 2H), 2.94 (brs, 2H), 3.07 ((m, 2H), 3.38 (m, 1H), 3.48 (m, 2H), 3.72−4.01 (m, 17H), 7.35 (d, <i>J</i> = 8.8 Hz, 2H), 7.55 (d, <i>J</i> = 8.8 Hz, 2H), 7.57 (d, <i>J</i> = 8.8 Hz, 2H), 8.28 (d, <i>J</i> = 8.8 Hz, 2H), 9.33 (s, 1H), 9.37 (s, 1H), 10.43 (m,1H) ppm.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Preparation of 1-(4-(1,4′-Bipiperidine-1′-carbonyl)phenyl)-3-(4-(4,6-dimorpholino-1,3,5-triazin-2-yl)phenyl)urea (<b>28</b>)</h3><div class="NLM_p last">A solution of 4-(3-(4-(4,6-dimorpholino-1,3,5-triazin-2yl)phenyl)ureido)benzoic acid (50 mg, 0.099 mmol), Hunig’s base (103 μL, 0.594 mmol), and HBTU (188 mg, 0.495 mmol) in 2 mL of NMP was reacted according to example <b>24</b> with 1,4′-bipiperidine (67 mg, 0.396 mmol). The solvent was evaporated and purified by HPLC to give the product as a white solid (39 mg, 60% yield). MS (ESI) <i>m</i>/<i>z</i> = 656.8.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Preparation of <i>N</i>-(2-(Dimethylamino)ethyl)-4-(3-(4-(4,6-dimorpholino-1,3,5-triazin-2-yl)phenyl)ureido)-<i>N</i>-methylbenzamide Hydrochloride (<b>30</b>)</h3><div class="NLM_p">A stirred solution of 4-(3-(4-(4,6-dimorpholino-1,3,5-triazin-2yl)phenyl)ureido)benzoic acid (150 mg, 0.297 mmol), Hunig’s base (303 uL, 1.782 mmol), and HBTU (563 mg, 1.485 mmol) in 2 mL of NMP was reacted according to example <b>24</b> with <i>N</i><sup>1</sup><i>,N</i><sup>1</sup><i>,N</i><sup>2</sup>-trimethylethane-1,2-diamine (154 μL, 1.188 mmol) to give <i>N</i>-(2-(dimethylamino)ethyl)-4-(3-(4-(4,6-dimorpholino-1,3,5-triazin-2-yl)phenyl)ureido)-<i>N</i>-methylbenzamide as a white solid (88 mg, 50% yield). MS (ESI) <i>m</i>/<i>z</i> = 590.2.</div><div class="NLM_p last">To <i>N</i>-(2-(dimethylamino)ethyl)-4-(3-(4-(4,6-dimorpholino-1,3,5-triazin-2-yl)phenyl)ureido)-<i>N</i>-methylbenzamide (55 mg, 0.127 mmol) and MeOH (1 mL) was added 4 N HCl in dioxane (1 mL), and the mixture was stirred for 3 h. The solid was filtered and washed with ether to give the product as a white solid (70 mg, yield = 88%). HRMS: calcd for C<sub>30</sub>H<sub>39</sub>N<sub>9</sub>O<sub>4</sub> + H<sup>+</sup>, 590.3198; found (ESI-FTMS, [M + H]<sup>+</sup>), 590.3194. Purity by analytical HPLC 99.8%. (Prodigy ODS3, 0.46 cm × 15 cm, 20 min gradient acetonitrile in water, trifluoroacetic acid, detector wavelengths, 215 and 254 nm.)</div></div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46105" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46105" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aranapakam M. Venkatesan</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e395868d88829782a3949a86978bcd808c8ec395868d88829782d5dadaa3848e828a8fcd808c8e"><span class="__cf_email__" data-cfemail="9ceaf9f2f7fde8fddcebe5f9e8f4b2fff3f1">[email protected]</span> <span class="__cf_email__" data-cfemail="0c7a6962676d786d3a35354c6b616d6560226f6361">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christoph M. Dehnhardt</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Efren Delos Santos</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zecheng Chen</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Osvaldo Dos Santos</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Semiramis Ayral-Kaloustian</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gulnaz Khafizova</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Natasja Brooijmans</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert Mallon</span> - <span class="hlFld-Affiliation affiliation">Oncology</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Irwin Hollander</span> - <span class="hlFld-Affiliation affiliation">Oncology</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Larry Feldberg</span> - <span class="hlFld-Affiliation affiliation">Oncology</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Judy Lucas</span> - <span class="hlFld-Affiliation affiliation">Oncology</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ker Yu</span> - <span class="hlFld-Affiliation affiliation">Oncology</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James Gibbons</span> - <span class="hlFld-Affiliation affiliation">Oncology</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert T. Abraham</span> - <span class="hlFld-Affiliation affiliation">Oncology</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Inder Chaudhary</span> - <span class="hlFld-Affiliation affiliation">Drug Metabolism</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tarek S. Mansour</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm901830p" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i36">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30273" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30273" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank members of the Wyeth Chemical Technologies Group for analytical and spectral determinations, Dr. Joseph Marini and Angela Bretz for nude mouse microsome assays, and Dr. Li Di and Susan Li for human microsome assays.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i37">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26163" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26163" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 27 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Vivanco, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyers, C. L.</span><span> </span><span class="NLM_article-title">The phosphatidylinositol-3-kinase Akt pathway in human cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">489</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm901830p&amp;key=10.1038%2Fnrc839" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm901830p&amp;key=12094235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm901830p&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvFKltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=489-501&author=I.+Vivancoauthor=C.+L.+Sawyers&title=The+phosphatidylinositol-3-kinase+Akt+pathway+in+human+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">The phosphatidylinositol 3-Kinase-AKT pathway in human cancer</span></div><div class="casAuthors">Vivanco, Igor; Sawyers, Charles L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">489-501</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  One signal that is overactivated in a wide range of tumor types is the prodn. of a phospholipid, phosphatidylinositol (3,4,5) trisphosphate, by phosphatidylinositol 3-kinase (PI3K).  This lipid and the protein kinase that is activated by it, AKT, trigger a cascade of responses, from cell growth and proliferation to survival and motility, that drive tumor progression.  Small-mol. therapeutics that block PI3K signaling might deal a severe blow to cancer cells by blocking many aspects of the tumor-cell phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzAQ-0qeD7pLVg90H21EOLACvtfcHk0liLVNIOKeAIOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkvFKltLs%253D&md5=c6762d32f9f1281632f4ccdbcd29268c</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1038%2Fnrc839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc839%26sid%3Dliteratum%253Aachs%26aulast%3DVivanco%26aufirst%3DI.%26aulast%3DSawyers%26aufirst%3DC.%2BL.%26atitle%3DThe%2520phosphatidylinositol-3-kinase%2520Akt%2520pathway%2520in%2520human%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D489%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J. J.</span><span> </span><span class="NLM_article-title">Targeting the phosphoinositide 3-kinase pathway in cancer</span> <span class="citation_source-journal">Nat. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">627</span><span class="NLM_x">–</span> <span class="NLM_lpage">644</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm901830p&amp;key=10.1038%2Fnrd2926" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm901830p&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1Wgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=627-644&author=P.+Liuauthor=H.+Chengauthor=T.+M.+Robertsauthor=J.+J.+Zhao&title=Targeting+the+phosphoinositide+3-kinase+pathway+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the phosphoinositide 3-kinase pathway in cancer</span></div><div class="casAuthors">Liu, Pixu; Cheng, Hailing; Roberts, Thomas M.; Zhao, Jean J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">627-644</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The phosphoinositide 3-kinase (PI3K) pathway is a key signal transduction system that links oncogenes and multiple receptor classes to many essential cellular functions, and is perhaps the most commonly activated signalling pathway in human cancer.  This pathway therefore presents both an opportunity and a challenge for cancer therapy.  Even as inhibitors that target PI3K isoforms and other major nodes in the pathway, including AKT and mammalian target of rapamycin (mTOR), reach clin. trials, major issues remain.  Here, we highlight recent progress that has been made in our understanding of the PI3K pathway and discuss the potential of and challenges for the development of therapeutic agents that target this pathway in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUk9T-ZoNDtLVg90H21EOLACvtfcHk0liLVNIOKeAIOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1Wgtb4%253D&md5=fdc94abd15178a9dbe7c56dafbfb7787</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1038%2Fnrd2926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2926%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DRoberts%26aufirst%3DT.%2BM.%26aulast%3DZhao%26aufirst%3DJ.%2BJ.%26atitle%3DTargeting%2520the%2520phosphoinositide%25203-kinase%2520pathway%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%26date%3D2009%26volume%3D8%26spage%3D627%26epage%3D644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Lempiainen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halazonetis, T. D.</span><span> </span><span class="NLM_article-title">Emerging common themes in regulation of PIKKS and PI3Ks</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">3067</span><span class="NLM_x">–</span> <span class="NLM_lpage">3073</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2009&pages=3067-3073&author=H.+Lempiainenauthor=T.+D.+Halazonetis&title=Emerging+common+themes+in+regulation+of+PIKKS+and+PI3Ks"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLempiainen%26aufirst%3DH.%26aulast%3DHalazonetis%26aufirst%3DT.%2BD.%26atitle%3DEmerging%2520common%2520themes%2520in%2520regulation%2520of%2520PIKKS%2520and%2520PI3Ks%26jtitle%3DEMBO%2520J.%26date%3D2009%26volume%3D28%26spage%3D3067%26epage%3D3073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Yap, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walton, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynand, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">deBono, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Targeting the PI3K-Akt-mTor pathway, progress, pitfalls and promises</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">393</span><span class="NLM_x">–</span> <span class="NLM_lpage">414</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm901830p&amp;key=10.1016%2Fj.coph.2008.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm901830p&amp;key=18721898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm901830p&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFCktL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=393-414&author=T.+A.+Yapauthor=M.+D.+Garrettauthor=M.+I.+Waltonauthor=F.+Raynandauthor=J.+S.+deBonoauthor=P.+Workman&title=Targeting+the+PI3K-Akt-mTor+pathway%2C+progress%2C+pitfalls+and+promises"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promises</span></div><div class="casAuthors">Yap, Timothy A.; Garrett, Michelle D.; Walton, Mike I.; Raynaud, Florence; de Bono, Johann S.; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">393-412</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The strategy of drugging the cancer kinome' has led to the successful development and regulatory approval of several novel mol. targeted agents.  The spotlight is now shifting to the phosphatidylinositide 3-kinase (PI3K)-AKT-mammalian target of rapamycin (mTOR) pathway as a key potential target.  This review details the role of the pathway in oncogenesis and the rationale for inhibiting its vital components.  The focus will be on the progress made in the development of novel therapies for cancer treatment, with emphasis placed on agents that have entered clin. development.  Strategies involving horizontal and vertical blockade of the pathway, as well as the use of biomarkers to select appropriate patients and to provide proof of target modulation will also be highlighted.  Finally, we discuss the issues and limitations involved with targeting the PI3K-AKT-mTOR pathway, and predict what the future may hold for these novel anticancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnmwezNSKUfbVg90H21EOLACvtfcHk0lim3jRPFJVzwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCktL7E&md5=b6a4f3c01a6776977d61cde8222d7201</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2008.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2008.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DYap%26aufirst%3DT.%2BA.%26aulast%3DGarrett%26aufirst%3DM.%2BD.%26aulast%3DWalton%26aufirst%3DM.%2BI.%26aulast%3DRaynand%26aufirst%3DF.%26aulast%3DdeBono%26aufirst%3DJ.%2BS.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DTargeting%2520the%2520PI3K-Akt-mTor%2520pathway%252C%2520progress%252C%2520pitfalls%2520and%2520promises%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2008%26volume%3D8%26spage%3D393%26epage%3D414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Bellacosa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dicristofano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, J. R.</span><span> </span><span class="NLM_article-title">Activation of Akt kinases in cancer: implications for therapeutic targetting</span> <span class="citation_source-journal">Adv. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">86</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2005&pages=29-86&author=A.+Bellacosaauthor=C.+C.+Kumarauthor=A.+Dicristofanoauthor=J.+R.+Testa&title=Activation+of+Akt+kinases+in+cancer%3A+implications+for+therapeutic+targetting"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBellacosa%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DC.%2BC.%26aulast%3DDicristofano%26aufirst%3DA.%26aulast%3DTesta%26aufirst%3DJ.%2BR.%26atitle%3DActivation%2520of%2520Akt%2520kinases%2520in%2520cancer%253A%2520implications%2520for%2520therapeutic%2520targetting%26jtitle%3DAdv.%2520Cancer%2520Res.%26date%3D2005%26volume%3D94%26spage%3D29%26epage%3D86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Manning, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span> </span><span class="NLM_article-title">Akt/PKB signaling: navigating down stream</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">1261</span><span class="NLM_x">–</span> <span class="NLM_lpage">1274</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=1261-1274&author=B.+D.+Manningauthor=L.+C.+Cantley&title=Akt%2FPKB+signaling%3A+navigating+down+stream"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DB.%2BD.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DAkt%252FPKB%2520signaling%253A%2520navigating%2520down%2520stream%26jtitle%3DCell%26date%3D2007%26volume%3D129%26spage%3D1261%26epage%3D1274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Engelman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span> </span><span class="NLM_article-title">The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism</span> <span class="citation_source-journal">Nat. Rev. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">606</span><span class="NLM_x">–</span> <span class="NLM_lpage">619</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm901830p&amp;key=10.1038%2Fnrg1879" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm901830p&amp;key=16847462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm901830p&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvFCnu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=606-619&author=J.+A.+Engelmanauthor=J.+Luoauthor=L.+C.+Cantley&title=The+evolution+of+phosphatidylinositol+3-kinases+as+regulators+of+growth+and+metabolism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism</span></div><div class="casAuthors">Engelman, Jeffrey A.; Luo, Ji; Cantley, Lewis C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Genetics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">606-619</span>CODEN:
                <span class="NLM_cas:coden">NRGAAM</span>;
        ISSN:<span class="NLM_cas:issn">1471-0056</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Phosphatidylinositol 3-kinases (PI3Ks) evolved from a single enzyme that regulates vesicle trafficking in unicellular eukaryotes into a family of enzymes that regulate cellular metab. and growth in multicellular organisms.  In this review, we examine how the PI3K pathway has evolved to control these fundamental processes, and how this pathway is in turn regulated by intricate feedback and crosstalk mechanisms.  In light of the recent advances in our understanding of the function of PI3Ks in the pathogenesis of diabetes and cancer, we discuss the exciting therapeutic opportunities for targeting this pathway to treat these diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphucxYJIwcQLVg90H21EOLACvtfcHk0lim3jRPFJVzwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvFCnu7Y%253D&md5=cd9eb85158710db6b33336af4e0a8cfe</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrg1879&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrg1879%26sid%3Dliteratum%253Aachs%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DThe%2520evolution%2520of%2520phosphatidylinositol%25203-kinases%2520as%2520regulators%2520of%2520growth%2520and%2520metabolism%26jtitle%3DNat.%2520Rev.%2520Genet.%26date%3D2006%26volume%3D7%26spage%3D606%26epage%3D619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Hennessy, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ram, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span> </span><span class="NLM_article-title">Exploiting the PI3K/Akt pathway for cancer drug discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">988</span><span class="NLM_x">–</span> <span class="NLM_lpage">1004</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm901830p&amp;key=10.1038%2Fnrd1902" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm901830p&amp;key=16341064" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm901830p&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1yktbjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=988-1004&author=B.+T.+Hennessyauthor=D.+L.+Smithauthor=P.+T.+Ramauthor=Y.+Luauthor=G.+B.+Mills&title=Exploiting+the+PI3K%2FAkt+pathway+for+cancer+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery</span></div><div class="casAuthors">Hennessy, Bryan T.; Smith, Debra L.; Ram, Prahlad T.; Lu, Yiling; Mills, Gordon B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">988-1004</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Evolving studies with several different targeted therapeutic agents are demonstrating that patients with genomic alterations of the target, including amplification, translocation and mutation, are more likely to respond to the therapy.  Recent studies indicate that numerous components of the phosphatidylinositol-3-kinase (PI3K)/AKT pathway are targeted by amplification, mutation and translocation more frequently than any other pathway in cancer patients, with resultant activation of the pathway.  This warrants exploiting the PI3K/AKT pathway for cancer drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq40Fg-hLrrMbVg90H21EOLACvtfcHk0lim3jRPFJVzwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1yktbjI&md5=faecabc3a6799137d133afb37d139ceb</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrd1902&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1902%26sid%3Dliteratum%253Aachs%26aulast%3DHennessy%26aufirst%3DB.%2BT.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DRam%26aufirst%3DP.%2BT.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DMills%26aufirst%3DG.%2BB.%26atitle%3DExploiting%2520the%2520PI3K%252FAkt%2520pathway%2520for%2520cancer%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D988%26epage%3D1004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Maehama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, J. E.</span><span> </span><span class="NLM_article-title">The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-triphosphate</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">13375</span><span class="NLM_x">–</span> <span class="NLM_lpage">13378</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=13375-13378&author=T.+Maehamaauthor=J.+E.+Dixon&title=The+tumor+suppressor%2C+PTEN%2FMMAC1%2C+dephosphorylates+the+lipid+second+messenger%2C+phosphatidylinositol+3%2C4%2C5-triphosphate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaehama%26aufirst%3DT.%26aulast%3DDixon%26aufirst%3DJ.%2BE.%26atitle%3DThe%2520tumor%2520suppressor%252C%2520PTEN%252FMMAC1%252C%2520dephosphorylates%2520the%2520lipid%2520second%2520messenger%252C%2520phosphatidylinositol%25203%252C4%252C5-triphosphate%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D13375%26epage%3D13378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Ali, I. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schriml, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, M.</span><span> </span><span class="NLM_article-title">Mutational spectra of PTEN/MMACI gene: a tumor suppressor with lipid phosphatase activity</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">1922</span><span class="NLM_x">–</span> <span class="NLM_lpage">1932</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm901830p&amp;key=10.1093%2Fjnci%2F91.22.1922" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm901830p&amp;key=10564676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm901830p&amp;key=1%3ACAS%3A528%3ADyaK1MXotVaitr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1999&pages=1922-1932&author=I.+U.+Aliauthor=L.+M.+Schrimlauthor=M.+Dean&title=Mutational+spectra+of+PTEN%2FMMACI+gene%3A+a+tumor+suppressor+with+lipid+phosphatase+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity</span></div><div class="casAuthors">Ali, Iqbal Unnisa; Schriml, Lynn M.; Dean, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">1922-1932</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review with 120 refs.  PTEN/MMAC1 (phosphatase, tensin homolog/mutated in multiple advanced cancers) is a tumor suppressor protein that has sequence homol. with dual-specificity phosphatases, which are capable of dephosphorylating both tyrosine phosphate and serine/threonine phosphate residues on proteins.  The in vivo function of PTEN/MMAC1 appears to be dephosphorylation of phosphotidylinositol 3,4,5-triphosphate.  The PTEN/MMAC1 gene is mutated in the germline of patients with rare autosomal dominant cancer syndromes and in subsets of specific cancers.  Here we review the mutational spectra of the PTEN/MMAC1 gene in tumors from various tissues, esp. endometrium, brain, prostate, and ovary, in which the gene is inactivated very frequently.  Germline and somatic mutations in the PTEN/MMAC1 gene occur mostly in the protein coding region and involve the phosphatase domain and poly(A)6 stretches.  Compared with germline alterations found in the PTEN/MMAC1 gene, there is a substantially increased frequency of frameshift mutations in tumors.  Glioblastomas and endometrial carcinomas appear to have distinct mutational spectra, probably reflecting differences in the underlying mechanisms of inactivation of the PTEN/MMAC1 gene in the two tissue types.  Also, depending on the tissue type, the gene appears to be involved in the initiation or the progression of cancers.  Further understanding of PTEN/MMAC1 gene mutations in different tumors and the physiol. consequences of these mutations is likely to open up new therapeutic opportunities for targeting this crit. gene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox1hhrBuiMKrVg90H21EOLACvtfcHk0ligMUE2xUFsBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXotVaitr4%253D&md5=2b00e89439f512e96d9089d0f7312c28</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F91.22.1922&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F91.22.1922%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DI.%2BU.%26aulast%3DSchriml%26aufirst%3DL.%2BM.%26aulast%3DDean%26aufirst%3DM.%26atitle%3DMutational%2520spectra%2520of%2520PTEN%252FMMACI%2520gene%253A%2520a%2520tumor%2520suppressor%2520with%2520lipid%2520phosphatase%2520activity%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1999%26volume%3D91%26spage%3D1922%26epage%3D1932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Shayesteh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldocchi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godfrey, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinkel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, J. W.</span><span> </span><span class="NLM_article-title">PIK3CA is implicated as an oncogene in ovarian cancer</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">102</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm901830p&amp;key=10.1038%2F5042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm901830p&amp;key=9916799" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm901830p&amp;key=1%3ACAS%3A528%3ADyaK1MXltlWjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1999&pages=99-102&author=L.+Shayestehauthor=W.+Kuoauthor=R.+Baldocchiauthor=T.+Godfreyauthor=C.+Collinsauthor=D.+Pinkelauthor=B.+Powellauthor=G.+B.+Millsauthor=J.+W.+Gray&title=PIK3CA+is+implicated+as+an+oncogene+in+ovarian+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">PIK3CA is implicated as an oncogene in ovarian cancer</span></div><div class="casAuthors">Shayesteh, Laleh; Lu, Yiling; Kuo, Wen-Lin; Baldocchi, Russell; Godfrey, Tony; Collins, Colin; Pinkel, Daniel; Powell, Bethan; Mills, Gordon B.; Gray, Joe W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">99-102</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">Ovarian cancer is the leading cause of death from gynecol. malignancy and the 4th leading cause of cancer death among American women, yet little is known about its mol. etiol.  Studies using comparative genomic hybridization (CGH) have revealed several regions of recurrent, abnormal, DNA sequence copy no. that may encode genes involved in the genesis or progression of the disease.  A region at 3q26 was increased in copy no. in 40% of ovarian and other cancers contains PIK3CA, which encodes the p110α catalytic subunit of phosphatidylinositol 3-kinase (PI3-kinase).  The assocn. between PIK3CA copy no. and PI3-kinase activity makes PIK3CA a candidate oncogene because a broad range of cancer-related functions were assocd. with PI3-kinase mediated signalling.  These include proliferation, glucose transport and catabolism, cell adhesion, apoptosis, RAS signalling6 and oncogenic transformation.  Downstream effectors of PI3-kinase, AKT1 and AKT2, were amplified or activated in human tumors, including ovarian cancer.  We show that PIK3CA is frequently increased in copy no. in ovarian cancers, that the increased copy no. is assocd. with increased PIK3CA transcription, p110α protein expression, and PI3-kinase activity and that treatment with the PI3-kinase inhibitor LY294002 decreases proliferation and increases apoptosis.  These observations suggest PIK3CA is an oncogene that has an important role in ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYnLbYYzMTtrVg90H21EOLACvtfcHk0ligMUE2xUFsBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltlWjtw%253D%253D&md5=e46ad55fb14c5465bf7ce86fb5a9cca0</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2F5042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F5042%26sid%3Dliteratum%253Aachs%26aulast%3DShayesteh%26aufirst%3DL.%26aulast%3DKuo%26aufirst%3DW.%26aulast%3DBaldocchi%26aufirst%3DR.%26aulast%3DGodfrey%26aufirst%3DT.%26aulast%3DCollins%26aufirst%3DC.%26aulast%3DPinkel%26aufirst%3DD.%26aulast%3DPowell%26aufirst%3DB.%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DGray%26aufirst%3DJ.%2BW.%26atitle%3DPIK3CA%2520is%2520implicated%2520as%2520an%2520oncogene%2520in%2520ovarian%2520cancer%26jtitle%3DNat.%2520Genet.%26date%3D1999%26volume%3D21%26spage%3D99%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Samuels, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silliman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ptak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szabo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazdar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riggins, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markowitz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velculescu, V. E.</span><span> </span><span class="NLM_article-title">High frequency mutations of the PIK3CA gene in human cancers</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">554</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2004&pages=554&author=Y.+Samuelsauthor=Z.+Wangauthor=A.+Bardelliauthor=N.+Sillimanauthor=J.+Ptakauthor=S.+Szaboauthor=H.+Yanauthor=A.+Gazdarauthor=S.+M.+Powellauthor=G.+J.+Rigginsauthor=J.+K.+Wilsonauthor=S.+Markowitzauthor=K.+W.+Kinzlerauthor=B.+Vogelsteinauthor=V.+E.+Velculescu&title=High+frequency+mutations+of+the+PIK3CA+gene+in+human+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSamuels%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DBardelli%26aufirst%3DA.%26aulast%3DSilliman%26aufirst%3DN.%26aulast%3DPtak%26aufirst%3DJ.%26aulast%3DSzabo%26aufirst%3DS.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DGazdar%26aufirst%3DA.%26aulast%3DPowell%26aufirst%3DS.%2BM.%26aulast%3DRiggins%26aufirst%3DG.%2BJ.%26aulast%3DWilson%26aufirst%3DJ.%2BK.%26aulast%3DMarkowitz%26aufirst%3DS.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26atitle%3DHigh%2520frequency%2520mutations%2520of%2520the%2520PIK3CA%2520gene%2520in%2520human%2520cancers%26jtitle%3DScience%26date%3D2004%26volume%3D30%26spage%3D554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Parsons, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuels, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummins, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Long, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silliman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ptak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szabo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markowitz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lengauer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velculescu, V. E.</span><span> </span><span class="NLM_article-title">Colorectal cancer: mutations in a signaling pathway</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">436</span><span class="NLM_x">, </span> <span class="NLM_fpage">792</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436&publication_year=2005&pages=792&author=D.+W.+Parsonsauthor=T.+L.+Wangauthor=Y.+Samuelsauthor=A.+Bardelliauthor=J.+M.+Cumminsauthor=L.+De+Longauthor=N.+Sillimanauthor=J.+Ptakauthor=S.+Szaboauthor=J.+K.+Wilsonauthor=S.+Markowitzauthor=K.+W.+Kinzlerauthor=B.+Vogelsteinauthor=C.+Lengauerauthor=V.+E.+Velculescu&title=Colorectal+cancer%3A+mutations+in+a+signaling+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParsons%26aufirst%3DD.%2BW.%26aulast%3DWang%26aufirst%3DT.%2BL.%26aulast%3DSamuels%26aufirst%3DY.%26aulast%3DBardelli%26aufirst%3DA.%26aulast%3DCummins%26aufirst%3DJ.%2BM.%26aulast%3DDe%2BLong%26aufirst%3DL.%26aulast%3DSilliman%26aufirst%3DN.%26aulast%3DPtak%26aufirst%3DJ.%26aulast%3DSzabo%26aufirst%3DS.%26aulast%3DWilson%26aufirst%3DJ.%2BK.%26aulast%3DMarkowitz%26aufirst%3DS.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DLengauer%26aufirst%3DC.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26atitle%3DColorectal%2520cancer%253A%2520mutations%2520in%2520a%2520signaling%2520pathway%26jtitle%3DNature%26date%3D2005%26volume%3D436%26spage%3D792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Vogt, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bader, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S.</span><span> </span><span class="NLM_article-title">PI3-kinase hidden potential revealed</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">946</span><span class="NLM_x">–</span> <span class="NLM_lpage">949</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=946-949&author=P.+K.+Vogtauthor=A.+G.+Baderauthor=S.+Kang&title=PI3-kinase+hidden+potential+revealed"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVogt%26aufirst%3DP.%2BK.%26aulast%3DBader%26aufirst%3DA.%2BG.%26aulast%3DKang%26aufirst%3DS.%26atitle%3DPI3-kinase%2520hidden%2520potential%2520revealed%26jtitle%3DCell%2520Cycle%26date%3D2006%26volume%3D5%26spage%3D946%26epage%3D949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F.</span><span> </span><span class="NLM_article-title">l. Drugging the PI3 kinome</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">794</span><span class="NLM_x">–</span> <span class="NLM_lpage">796</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=794-796&author=P.+Workmanauthor=P.+A.+Clarkeauthor=S.+Guillardauthor=F.+Raynaud&title=l.+Drugging+the+PI3+kinome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DGuillard%26aufirst%3DS.%26aulast%3DRaynaud%26aufirst%3DF.%26atitle%3Dl.%2520Drugging%2520the%2520PI3%2520kinome%26jtitle%3DNat.%2520Biotechnol.%26date%3D2006%26volume%3D24%26spage%3D794%26epage%3D796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Fan, Q. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldenberg, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mostov, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokoe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, W. A.</span><span> </span><span class="NLM_article-title">A dual PI3 kinase/mTor inhibitor reveals emergent efficacy in glioma</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=341-349&author=Q.+W.+Fanauthor=Z.+A.+Knightauthor=D.+D.+Goldenbergauthor=W.+Yuauthor=K.+E.+Mostovauthor=D.+Stokoeauthor=K.+M.+Shokatauthor=W.+A.+Weiss&title=A+dual+PI3+kinase%2FmTor+inhibitor+reveals+emergent+efficacy+in+glioma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DQ.%2BW.%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DGoldenberg%26aufirst%3DD.%2BD.%26aulast%3DYu%26aufirst%3DW.%26aulast%3DMostov%26aufirst%3DK.%2BE.%26aulast%3DStokoe%26aufirst%3DD.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DWeiss%26aufirst%3DW.%2BA.%26atitle%3DA%2520dual%2520PI3%2520kinase%252FmTor%2520inhibitor%2520reveals%2520emergent%2520efficacy%2520in%2520glioma%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D9%26spage%3D341%26epage%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Vlahos, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matter, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, R. F.</span><span> </span><span class="NLM_article-title">A specific inhibitor of phosphatidylinositol-3-kinase, 2-(4-morpholinyl)-8-phenyl-4<i>H</i>-1-benzopyran-4-one (LY294002)</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">269</span><span class="NLM_x">, </span> <span class="NLM_fpage">5241</span><span class="NLM_x">–</span> <span class="NLM_lpage">5248</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=5241-5248&author=C.+J.+Vlahosauthor=W.+F.+Matterauthor=K.+Y.+Huiauthor=R.+F.+Brown&title=A+specific+inhibitor+of+phosphatidylinositol-3-kinase%2C+2-%284-morpholinyl%29-8-phenyl-4H-1-benzopyran-4-one+%28LY294002%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVlahos%26aufirst%3DC.%2BJ.%26aulast%3DMatter%26aufirst%3DW.%2BF.%26aulast%3DHui%26aufirst%3DK.%2BY.%26aulast%3DBrown%26aufirst%3DR.%2BF.%26atitle%3DA%2520specific%2520inhibitor%2520of%2520phosphatidylinositol-3-kinase%252C%25202-%25284-morpholinyl%2529-8-phenyl-4H-1-benzopyran-4-one%2520%2528LY294002%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1994%26volume%3D269%26spage%3D5241%26epage%3D5248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Yaguchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koshimizu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirono, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamori, T.</span><span> </span><span class="NLM_article-title">Antitumor activity of ZSTK474, a new phosphatidylinositol-3-kinase inhibitor</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">545</span><span class="NLM_x">–</span> <span class="NLM_lpage">556</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm901830p&amp;key=10.1093%2Fjnci%2Fdjj133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm901830p&amp;key=16622124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm901830p&amp;key=1%3ACAS%3A528%3ADC%252BD28XjslOjsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2006&pages=545-556&author=S.+Yaguchiauthor=Y.+Fukuiauthor=I.+Koshimizuauthor=H.+Yoshimiauthor=T.+Matsunoauthor=H.+Goudaauthor=S.+Hironoauthor=K.+Yamazakiauthor=T.+Yamori&title=Antitumor+activity+of+ZSTK474%2C+a+new+phosphatidylinositol-3-kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor Activity of ZSTK474, a New Phosphatidylinositol 3-Kinase Inhibitor</span></div><div class="casAuthors">Yaguchi, Shin-ichi; Fukui, Yasuhisa; Koshimizu, Ichiro; Yoshimi, Hisashi; Matsuno, Toshiyuki; Gouda, Hiroaki; Hirono, Shuichi; Yamazaki, Kanami; Yamori, Takao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">545-556</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background: We previously synthesized a novel s-triazine deriv., ZSTK474 [2-(2-difluoromethylbenzimidazol-1-yl)-4,6-dimorpholino-1,3,5-triazine], that strongly inhibited the growth of tumor cells.  We identified its mol. target, investigated its effects on cellular signaling pathways, and examd. its antitumor efficacy and toxicity in vivo.  Methods: We used COMPARE anal. of chemosensitivity measurements from 39 human cancer cell lines and identified phosphatidylinositol 3-kinase (PI3K) as a mol. target for ZSTK474.  PI3K was immunopptd. from A549 cell lysates, and its activity was measured by assessing the incorporation of 32P into phosphatidylinositol.  We used the crystal structure of the PI3K-LY294002 complex to model the binding of ZSTK474 to PI3K (where LY294002 is a known PI3K inhibitor).  PI3K downstream activity was analyzed by immunoblotting.  Antitumor activity of ZSTK474 was examd. against A549, PC-3, and WiDr xenografts in nude mice.  Phosphorylation of Akt, a serine/threonine protein kinase and a major signaling component downstream of PI3K, was assessed in vivo by immunohistochem.  Results: PI3K was identified as a mol. target for ZSTK474 by COMPARE anal.  We confirmed that ZSTK474 directly inhibited PI3K activity more efficiently than the PI3K inhibitor LY294002.  At concns. of 1 μM, ZSTK474 and LY2194002 reduced PI3K activity to 4.7% (95% confidence interval [CI] = 3.2% to 6.1%) and 44.6% (95% CI = 38.9% to 50.3%), resp., of the untreated control level.  Mol. modeling of the PI3K-ZSTK474 complex indicated that ZSTK474 could bind to the ATP-binding pocket of PI3K.  ZSTK474 inhibited phosphorylation of signaling components downstream from PI3K, such as Akt and glycogen synthase kinase 3β, and mediated a decrease in cyclin D1 levels.  ZSTK474 administered orally to mice had strong antitumor activity against human cancer xenografts without toxic effects in crit. organs.  Akt phosphorylation was reduced in xenograft tumors after oral administration of ZSTK474.  Conclusion: ZSTK474 is a new PI3K inhibitor with strong antitumor activity against human cancer xenografts without toxic effects in crit. organs.  ZSTK474 merits further investigation as an anticancer drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG0v8LFKdruLVg90H21EOLACvtfcHk0li-cDoCpBk1zA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjslOjsLw%253D&md5=a2593024975536089ab2ee7e53234ebc</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjj133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjj133%26sid%3Dliteratum%253Aachs%26aulast%3DYaguchi%26aufirst%3DS.%26aulast%3DFukui%26aufirst%3DY.%26aulast%3DKoshimizu%26aufirst%3DI.%26aulast%3DYoshimi%26aufirst%3DH.%26aulast%3DMatsuno%26aufirst%3DT.%26aulast%3DGouda%26aufirst%3DH.%26aulast%3DHirono%26aufirst%3DS.%26aulast%3DYamazaki%26aufirst%3DK.%26aulast%3DYamori%26aufirst%3DT.%26atitle%3DAntitumor%2520activity%2520of%2520ZSTK474%252C%2520a%2520new%2520phosphatidylinositol-3-kinase%2520inhibitor%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2006%26volume%3D98%26spage%3D545%26epage%3D556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Kong, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamori, T.</span><span> </span><span class="NLM_article-title">ZSTK474 is an ATP-competitive inhibitor of class I phosphatidylinositol-3-kinase isoform</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">1638</span><span class="NLM_x">–</span> <span class="NLM_lpage">1642</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm901830p&amp;key=10.1111%2Fj.1349-7006.2007.00580.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm901830p&amp;key=17711503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm901830p&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtF2qtbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2007&pages=1638-1642&author=D.+Kongauthor=T.+Yamori&title=ZSTK474+is+an+ATP-competitive+inhibitor+of+class+I+phosphatidylinositol-3-kinase+isoform"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">ZSTK474 is an ATP-competitive inhibitor of class I phosphatidylinositol 3 kinase isoforms</span></div><div class="casAuthors">Kong, Dexin; Yamori, Takao</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1638-1642</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1347-9032</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Asia Pty Ltd.</span>)
        </div><div class="casAbstract">Class I phosphatidylinositol 3 kinases (PI3K) phosphorylate phosphatidylinositol 4,5-bisphosphate to generate phosphatidylinositol 3,4,5-trisphosphate.  These mols. play an important role in fundamental cellular responses.  Four isoforms of class I PI3K are known to have different functions, and abnormalities in their activities have been related to various diseases such as cancer and inflammation.  We previously identified a novel PI3K inhibitor, ZSTK474, which showed potent antitumor activity in vivo against a human cancer xenograft without observable toxicity.  However, the mode of its mol. action was not investigated in detail.  Our previous study only suggested that ZSTK474 possibly competes with ATP for the ATP-binding pocket of PI3Kγ.  In the present study, we have used an in vitro homogeneous time-resolved fluorescence kinase assay to examine whether ZSTK474 is indeed an ATP-competing inhibitor of PI3K, and also to det. whether the inhibitory activity of ZSTK474 was isoform-specific.  Lineweaver-Burk plot anal. revealed that ZSTK474 inhibits all four PI3K isoforms in an ATP-competitive manner.  Among all of the PI3K isoforms, PI3Kδ was inhibited most potently by ZSTK474 with a Ki of 1.8 nM, and the other isoforms were inhibited at higher doses.  We have also used a kinase activity ELISA to det. whether ZSTK474 inhibits mammalian target of rapamycin, a key kinase acting downstream of PI3K to promote protein synthesis and cell proliferation.  Even at a concn. of 100 μM, ZSTK474 inhibited mammalian target of rapamycin activity rather weakly.  These results indicate that ZSTK474 is an ATP-competitive pan-class I PI3K inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpN82wpwPzvvLVg90H21EOLACvtfcHk0lhVSYGj7w-ZJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtF2qtbzI&md5=02f89fcfcdda97438724700eb3a3499a</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2007.00580.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2007.00580.x%26sid%3Dliteratum%253Aachs%26aulast%3DKong%26aufirst%3DD.%26aulast%3DYamori%26aufirst%3DT.%26atitle%3DZSTK474%2520is%2520an%2520ATP-competitive%2520inhibitor%2520of%2520class%2520I%2520phosphatidylinositol-3-kinase%2520isoform%26jtitle%3DCancer%2520Sci.%26date%3D2007%26volume%3D98%26spage%3D1638%26epage%3D1642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Folkes, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmadi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alderto, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alix, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Box, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuckowree, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depledge, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancox, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kugendradas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lensun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivero, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pergl-Wilson, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saghir, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salphati, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ultsch, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallweber, H. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weismann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhyvoloup, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zvelebil, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuttleworth, S. J.</span><span> </span><span class="NLM_article-title">The identification of 2-(1<i>H</i>-indazol-4-yl)-6-(4-methane sulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-<i>d</i>]pyrimidine (GDC-0941) as a potent, selective, orally bio-available inhibitor of class I PI3 kinase for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5522</span><span class="NLM_x">–</span> <span class="NLM_lpage">5532</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800295d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5522-5532&author=A.+J.+Folkesauthor=K.+Ahmadiauthor=W.+K.+Aldertoauthor=S.+Alixauthor=S.+J.+Bakerauthor=G.+Boxauthor=I.+S.+Chuckowreeauthor=P.+A.+Clarkeauthor=P.+Depledgeauthor=S.+A.+Ecclesauthor=L.+S.+Friedmanauthor=A.+Hayesauthor=T.+C.+Hancoxauthor=A.+Kugendradasauthor=L.+Lensunauthor=P.+Mooreauthor=A.+G.+Oliveroauthor=J.+Pangauthor=S.+Patelauthor=G.+H.+Pergl-Wilsonauthor=F.+I.+Raynaudauthor=A.+Robsonauthor=N.+Saghirauthor=L.+Salphatiauthor=S.+Sohalauthor=M.+H.+Ultschauthor=M.+Valentiauthor=H.+J.+A.+Wallweberauthor=N.+C.+Wanauthor=C.+Weismannauthor=P.+Workmanauthor=A.+Zhyvoloupauthor=M.+J.+Zvelebilauthor=S.+J.+Shuttleworth&title=The+identification+of+2-%281H-indazol-4-yl%29-6-%284-methane+sulfonyl-piperazin-1-ylmethyl%29-4-morpholin-4-yl-thieno%5B3%2C2-d%5Dpyrimidine+%28GDC-0941%29+as+a+potent%2C+selective%2C+orally+bio-available+inhibitor+of+class+I+PI3+kinase+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm800295d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800295d%26sid%3Dliteratum%253Aachs%26aulast%3DFolkes%26aufirst%3DA.%2BJ.%26aulast%3DAhmadi%26aufirst%3DK.%26aulast%3DAlderto%26aufirst%3DW.%2BK.%26aulast%3DAlix%26aufirst%3DS.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DChuckowree%26aufirst%3DI.%2BS.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DDepledge%26aufirst%3DP.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DFriedman%26aufirst%3DL.%2BS.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DHancox%26aufirst%3DT.%2BC.%26aulast%3DKugendradas%26aufirst%3DA.%26aulast%3DLensun%26aufirst%3DL.%26aulast%3DMoore%26aufirst%3DP.%26aulast%3DOlivero%26aufirst%3DA.%2BG.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DPergl-Wilson%26aufirst%3DG.%2BH.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DRobson%26aufirst%3DA.%26aulast%3DSaghir%26aufirst%3DN.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSohal%26aufirst%3DS.%26aulast%3DUltsch%26aufirst%3DM.%2BH.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%2BA.%26aulast%3DWan%26aufirst%3DN.%2BC.%26aulast%3DWeismann%26aufirst%3DC.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DZhyvoloup%26aufirst%3DA.%26aulast%3DZvelebil%26aufirst%3DM.%2BJ.%26aulast%3DShuttleworth%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520identification%2520of%25202-%25281H-indazol-4-yl%2529-6-%25284-methane%2520sulfonyl-piperazin-1-ylmethyl%2529-4-morpholin-4-yl-thieno%255B3%252C2-d%255Dpyrimidine%2520%2528GDC-0941%2529%2520as%2520a%2520potent%252C%2520selective%252C%2520orally%2520bio-available%2520inhibitor%2520of%2520class%2520I%2520PI3%2520kinase%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5522%26epage%3D5532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Stauffer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maira, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Echeverria, C.</span><span> </span><span class="NLM_article-title">Imidazo[4,5-<i>c</i>]quinolines as inhibitors of the PI3K/PKB-pathway</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1027</span><span class="NLM_x">–</span> <span class="NLM_lpage">1030</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1027-1030&author=F.+Staufferauthor=S.+M.+Mairaauthor=P.+Furetauthor=C.+Garcia-Echeverria&title=Imidazo%5B4%2C5-c%5Dquinolines+as+inhibitors+of+the+PI3K%2FPKB-pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStauffer%26aufirst%3DF.%26aulast%3DMaira%26aufirst%3DS.%2BM.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26atitle%3DImidazo%255B4%252C5-c%255Dquinolines%2520as%2520inhibitors%2520of%2520the%2520PI3K%252FPKB-pathway%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1027%26epage%3D1030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Maira, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brueggen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritsch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brachmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chene, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Pover, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schemaker, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Echeverria, C.</span><span> </span><span class="NLM_article-title">Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1851</span><span class="NLM_x">–</span> <span class="NLM_lpage">1863</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=16&amp;doi=10.1021%2Fjm901830p&amp;key=10.1158%2F1535-7163.MCT-08-0017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=8&amp;doi=10.1021%2Fjm901830p&amp;key=18606717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Fjm901830p&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslCgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=1851-1863&author=S.+M.+Mairaauthor=F.+Staufferauthor=J.+Brueggenauthor=P.+Furetauthor=C.+Schnellauthor=C.+Fritschauthor=S.+Brachmannauthor=P.+Cheneauthor=A.+De+Poverauthor=K.+Schemakerauthor=D.+Fabbroauthor=D.+Gabrielauthor=M.+Simonenauthor=L.+Murphyauthor=P.+Finanauthor=W.+Sellersauthor=C.+Garcia-Echeverria&title=Identification+and+characterization+of+NVP-BEZ235%2C+a+new+orally+available+dual+phosphatidylinositol+3-kinase%2Fmammalian+target+of+rapamycin+inhibitor+with+potent+in+vivo+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19b</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity</span></div><div class="casAuthors">Maira, Sauveur-Michel; Stauffer, Frederic; Brueggen, Josef; Furet, Pascal; Schnell, Christian; Fritsch, Christine; Brachmann, Saskia; Chene, Patrick; De Pover, Alain; Schoemaker, Kevin; Fabbro, Doriano; Gabriel, Daniela; Simonen, Marjo; Murphy, Leon; Finan, Peter; Sellers, William; Garcia-Echeverria, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1851-1863</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin inhibitor (mTOR) pathway is often constitutively activated in human tumor cells, providing unique opportunities for anticancer therapeutic intervention.  NVP-BEZ235 is an imidazo[4,5-c]quinoline deriv. that inhibits PI3K and mTOR kinase activity by binding to the ATP-binding cleft of these enzymes.  In cellular settings using human tumor cell lines, this mol. is able to effectively and specifically block the dysfunctional activation of the PI3K pathway, inducing G1 arrest.  The cellular activity of NVP-BEZ235 translates well in in vivo models of human cancer.  Thus, the compd. was well tolerated, displayed disease stasis when administered orally, and enhanced the efficacy of other anticancer agents when used in in vivo combination studies.  Ex vivo pharmacokinetic/pharmacodynamic analyses of tumor tissues showed a time-dependent correlation between compd. concn. and PI3K/Akt pathway inhibition.  Collectively, the preclin. data show that NVP-BEZ235 is a potent dual PI3K/mTOR modulator with favorable pharmaceutical properties.  NVP-BEZ235 is currently in phase I clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyO784qv52vrVg90H21EOLACvtfcHk0lj_tbPqcfaS2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslCgtb4%253D&md5=5b1979e134dd12065198d86dbc11ce15</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0017%26sid%3Dliteratum%253Aachs%26aulast%3DMaira%26aufirst%3DS.%2BM.%26aulast%3DStauffer%26aufirst%3DF.%26aulast%3DBrueggen%26aufirst%3DJ.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DSchnell%26aufirst%3DC.%26aulast%3DFritsch%26aufirst%3DC.%26aulast%3DBrachmann%26aufirst%3DS.%26aulast%3DChene%26aufirst%3DP.%26aulast%3DDe%2BPover%26aufirst%3DA.%26aulast%3DSchemaker%26aufirst%3DK.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DGabriel%26aufirst%3DD.%26aulast%3DSimonen%26aufirst%3DM.%26aulast%3DMurphy%26aufirst%3DL.%26aulast%3DFinan%26aufirst%3DP.%26aulast%3DSellers%26aufirst%3DW.%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520NVP-BEZ235%252C%2520a%2520new%2520orally%2520available%2520dual%2520phosphatidylinositol%25203-kinase%252Fmammalian%2520target%2520of%2520rapamycin%2520inhibitor%2520with%2520potent%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D1851%26epage%3D1863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Garlich, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dey, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murali, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kundra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, H.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durden, D. L.</span><span> </span><span class="NLM_article-title">A vascular targeted pan phosphoinositide 3-kinase inhibitor prodrug, SF1126, with antitumor and antiangiogenic activity</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">206</span><span class="NLM_x">–</span> <span class="NLM_lpage">215</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=206-215&author=J.+R.+Garlichauthor=P.+Deauthor=N.+Deyauthor=J.+D.+Suauthor=X.+Pengauthor=A.+Millerauthor=R.+Muraliauthor=Y.+Luauthor=G.+B.+Millsauthor=V.+Kundraauthor=H.-K.+Shuauthor=Q.+Pengauthor=D.+L.+Durden&title=A+vascular+targeted+pan+phosphoinositide+3-kinase+inhibitor+prodrug%2C+SF1126%2C+with+antitumor+and+antiangiogenic+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarlich%26aufirst%3DJ.%2BR.%26aulast%3DDe%26aufirst%3DP.%26aulast%3DDey%26aufirst%3DN.%26aulast%3DSu%26aufirst%3DJ.%2BD.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DMiller%26aufirst%3DA.%26aulast%3DMurali%26aufirst%3DR.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DKundra%26aufirst%3DV.%26aulast%3DShu%26aufirst%3DH.-K.%26aulast%3DPeng%26aufirst%3DQ.%26aulast%3DDurden%26aufirst%3DD.%2BL.%26atitle%3DA%2520vascular%2520targeted%2520pan%2520phosphoinositide%25203-kinase%2520inhibitor%2520prodrug%252C%2520SF1126%252C%2520with%2520antitumor%2520and%2520antiangiogenic%2520activity%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D206%26epage%3D215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zask, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheijen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malwitz, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooijmans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svenson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span> </span><span class="NLM_article-title">ATP-competitive inhibitors of the mammalian target of rapamycin: design and synthesis of highly potent and selective pyrazolopyrimidines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5013</span><span class="NLM_x">–</span> <span class="NLM_lpage">5016</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900851f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5013-5016&author=A.+Zaskauthor=J.+C.+Verheijenauthor=K.+Curranauthor=J.+Kaplanauthor=D.+J.+Richardauthor=P.+Nowakauthor=D.+J.+Malwitzauthor=N.+Brooijmansauthor=J.+Bardauthor=K.+Svensonauthor=J.+Lucasauthor=L.+Toral-Barzaauthor=W.+G.+Zhangauthor=I.+Hollanderauthor=J.+J.+Gibbonsauthor=R.+T.+Abrahamauthor=S.+Ayral-Kaloustianauthor=T.+S.+Mansourauthor=K.+Yu&title=ATP-competitive+inhibitors+of+the+mammalian+target+of+rapamycin%3A+design+and+synthesis+of+highly+potent+and+selective+pyrazolopyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1021%2Fjm900851f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900851f%26sid%3Dliteratum%253Aachs%26aulast%3DZask%26aufirst%3DA.%26aulast%3DVerheijen%26aufirst%3DJ.%2BC.%26aulast%3DCurran%26aufirst%3DK.%26aulast%3DKaplan%26aufirst%3DJ.%26aulast%3DRichard%26aufirst%3DD.%2BJ.%26aulast%3DNowak%26aufirst%3DP.%26aulast%3DMalwitz%26aufirst%3DD.%2BJ.%26aulast%3DBrooijmans%26aufirst%3DN.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DSvenson%26aufirst%3DK.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DW.%2BG.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DGibbons%26aufirst%3DJ.%2BJ.%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26aulast%3DYu%26aufirst%3DK.%26atitle%3DATP-competitive%2520inhibitors%2520of%2520the%2520mammalian%2520target%2520of%2520rapamycin%253A%2520design%2520and%2520synthesis%2520of%2520highly%2520potent%2520and%2520selective%2520pyrazolopyrimidines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5013%26epage%3D5016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zask, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheijen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooijmans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu., K.</span><span> </span><span class="NLM_article-title">Morpholine derivatives greatly enhance the selectivity of mammalian target of rapamycin (mTOR) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7942</span><span class="NLM_x">–</span> <span class="NLM_lpage">7945</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901415x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=32&amp;doi=10.1021%2Fjm901830p&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVWrtb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7942-7945&author=A.+Zaskauthor=J.+Kaplanauthor=J.+C.+Verheijenauthor=D.+J.+Richardauthor=K.+Curranauthor=N.+Brooijmansauthor=E.+M.+Bennettauthor=L.+Toral-Barzaauthor=I.+Hollanderauthor=S.+Ayral-Kaloustianauthor=K.+Yu.&title=Morpholine+derivatives+greatly+enhance+the+selectivity+of+mammalian+target+of+rapamycin+%28mTOR%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21bR"><div class="casContent"><span class="casTitleNuber">21b</span><div class="casTitle"><span class="NLM_cas:atitle">Morpholine Derivatives Greatly Enhance the Selectivity of Mammalian Target of Rapamycin (mTOR) Inhibitors</span></div><div class="casAuthors">Zask, Arie; Kaplan, Joshua; Verheijen, Jeroen C.; Richard, David J.; Curran, Kevin; Brooijmans, Natasja; Bennett, Eric M.; Toral-Barza, Lourdes; Hollander, Irwin; Ayral-Kaloustian, Semiramis; Yu, Ker</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7942-7945</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dramatic improvements in mTOR-targeting selectivity were achieved by replacing morpholine in pyrazolopyrimidine inhibitors with bridged morpholines.  Analogs I [R1 = (R)- or (S)-3-methyl-4-morpholinyl, 2-methyl-4-morpholinyl, 8-oxa-3-azabicyclo[3.2.1]octan-3-yl, etc.; R2 = Me, Et, cyclopropyl, FCH2CH2, 3-pyridyl, 4-pyridyl; R3 = F3CCH2, 1-methoxycarbonyl-4-piperidinyl, 1-ethoxycarbonyl-4-piperidinyl, 3-pyridylmethyl] with subnanomolar mTOR IC50 values and up to 26000-fold selectivity vs. PI3Kα were prepd.  Chiral morpholines gave inhibitors whose enantiomers had different selectivity and potency profiles.  Mol. modeling suggests that a single amino acid difference between PI3K and mTOR (Phe961Leu) accounts for the profound selectivity seen by creating a deeper pocket in mTOR that can accommodate bridged morpholines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK2HnMHqTHqbVg90H21EOLACvtfcHk0lj_tbPqcfaS2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVWrtb3J&md5=5ef1eee5aa79531970049d3d26b46eb2</span></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1021%2Fjm901415x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901415x%26sid%3Dliteratum%253Aachs%26aulast%3DZask%26aufirst%3DA.%26aulast%3DKaplan%26aufirst%3DJ.%26aulast%3DVerheijen%26aufirst%3DJ.%2BC.%26aulast%3DRichard%26aufirst%3DD.%2BJ.%26aulast%3DCurran%26aufirst%3DK.%26aulast%3DBrooijmans%26aufirst%3DN.%26aulast%3DBennett%26aufirst%3DE.%2BM.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DYu.%26aufirst%3DK.%26atitle%3DMorpholine%2520derivatives%2520greatly%2520enhance%2520the%2520selectivity%2520of%2520mammalian%2520target%2520of%2520rapamycin%2520%2528mTOR%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7942%26epage%3D7945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Dehnhardt, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatesan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delos Santos, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dos Santos, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bursavich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellingboe, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khafizova, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooijmans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldberg, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhary, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span> </span><span class="NLM_article-title">Lead optimization of N3 substituted-7-morpholino-triazolopyrimidines as dual phosphoinositide 3-kinase and mammalian target of rapamycin inhibitors: discovery of PKI-402</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">798</span><span class="NLM_x">–</span> <span class="NLM_lpage">810</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9014982" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=798-810&author=C.+M.+Dehnhardtauthor=A.+M.+Venkatesanauthor=Z.+Chenauthor=E.+Delos+Santosauthor=O.+Dos+Santosauthor=M.+Bursavichauthor=A.+M.+Gilbertauthor=J.+W.+Ellingboeauthor=S.+Ayral-Kaloustianauthor=G.+Khafizovaauthor=N.+Brooijmansauthor=R.+Mallonauthor=I.+Hollanderauthor=L.+Feldbergauthor=J.+Lucasauthor=I.+Chaudharyauthor=K.+Yuauthor=J.+Gibbonsauthor=R.+Abrahamauthor=T.+S.+Mansour&title=Lead+optimization+of+N3+substituted-7-morpholino-triazolopyrimidines+as+dual+phosphoinositide+3-kinase+and+mammalian+target+of+rapamycin+inhibitors%3A+discovery+of+PKI-402"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21c&amp;dbid=16384&amp;doi=10.1021%2Fjm9014982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9014982%26sid%3Dliteratum%253Aachs%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26aulast%3DVenkatesan%26aufirst%3DA.%2BM.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DDelos%2BSantos%26aufirst%3DE.%26aulast%3DDos%2BSantos%26aufirst%3DO.%26aulast%3DBursavich%26aufirst%3DM.%26aulast%3DGilbert%26aufirst%3DA.%2BM.%26aulast%3DEllingboe%26aufirst%3DJ.%2BW.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DKhafizova%26aufirst%3DG.%26aulast%3DBrooijmans%26aufirst%3DN.%26aulast%3DMallon%26aufirst%3DR.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DFeldberg%26aufirst%3DL.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DChaudhary%26aufirst%3DI.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DGibbons%26aufirst%3DJ.%26aulast%3DAbraham%26aufirst%3DR.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26atitle%3DLead%2520optimization%2520of%2520N3%2520substituted-7-morpholino-triazolopyrimidines%2520as%2520dual%2520phosphoinositide%25203-kinase%2520and%2520mammalian%2520target%2520of%2520rapamycin%2520inhibitors%253A%2520discovery%2520of%2520PKI-402%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D798%26epage%3D810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldberg, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, S. F.</span><span> </span><span class="NLM_article-title">A directly labelled TR-FRET assay for monitoring phosphoinositide-3-kinase activity</span> <span class="citation_source-journal">Comb. Chem. High Throughput Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">565</span><span class="NLM_x">–</span> <span class="NLM_lpage">570</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm901830p&amp;key=10.2174%2F138620706777935360" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm901830p&amp;key=16925516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm901830p&amp;key=1%3ACAS%3A528%3ADC%252BD28XosVKrtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=565-570&author=X.+Yangauthor=P.+Liauthor=L.+Feldbergauthor=S.+C.+Kimauthor=M.+Bowmanauthor=I.+Hollanderauthor=R.+Mallonauthor=S.+F.+Wolf&title=A+directly+labelled+TR-FRET+assay+for+monitoring+phosphoinositide-3-kinase+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">A directly labeled TR-FRET assay for monitoring phosphoinositide-3-kinase activity</span></div><div class="casAuthors">Yang, Xiaoke; Li, Puyao; Feldberg, Larry; Kim, Steven C.; Bowman, Michael; Hollander, Irwin; Mallon, Robert; Wolf, Stanley F.</div><div class="citationInfo"><span class="NLM_cas:title">Combinatorial Chemistry & High Throughput Screening</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">565-570</span>CODEN:
                <span class="NLM_cas:coden">CCHSFU</span>;
        ISSN:<span class="NLM_cas:issn">1386-2073</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Phosphoinositide 3-kinases (PI3Ks) comprise a family of kinases that transfer the terminal phosphate of ATP to phosphoinositides at the 3-hydroxyl of the inositol ring to form phosphoinositide (3,4,5)-triphosphate (PIP3).  The PI3Ks have been shown to play key roles in cell growth, motility, morphol., and survival and thus are of interest as targets in anti-inflammatory and anti-oncogenic drug development.  To facilitate identification of novel and selective inhibitors of PI3Ks, we have developed a TR-FRET assay that uses directly labeled reagents.  The assay makes use of the high affinity binding of phosphoinositides to a pleckstrin homol. (PH) domain in the general receptor for phosphoinositides 1 (Grp1) protein.  It monitors PIP3 produced from the enzymic reaction by measuring its competition with Bodipy-FL-labeled PIP3 for binding to terbium chelate-labeled Grp1.  By using directly labeled reagents, this assay configuration offers higher sensitivity and faster binding/dissocn. kinetics than existing non-radioactive assays, which are crit. for competitive assay formats.  The assay is homogeneous, robust (Z' = 0.88), and simple and, thus, compatible with high throughput screening (HTS) processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3gMlKxLJcJLVg90H21EOLACvtfcHk0liBXwFy3WiBkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XosVKrtb0%253D&md5=def2c27a291077edddd2047918779826</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.2174%2F138620706777935360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138620706777935360%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DFeldberg%26aufirst%3DL.%26aulast%3DKim%26aufirst%3DS.%2BC.%26aulast%3DBowman%26aufirst%3DM.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DMallon%26aufirst%3DR.%26aulast%3DWolf%26aufirst%3DS.%2BF.%26atitle%3DA%2520directly%2520labelled%2520TR-FRET%2520assay%2520for%2520monitoring%2520phosphoinositide-3-kinase%2520activity%26jtitle%3DComb.%2520Chem.%2520High%2520Throughput%2520Screening%26date%3D2006%26volume%3D9%26spage%3D565%26epage%3D570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamison, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larocque, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">332</span><span class="NLM_x">, </span> <span class="NLM_fpage">304</span><span class="NLM_x">–</span> <span class="NLM_lpage">310</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Toral-Barza%2C+L.%3B+Zhang%2C+W.+G.%3B+Lamison%2C+C.%3B+Larocque%2C+J.%3B+Gibbons%2C+J.%3B+Yu%2C+K.Biochem.+Biophys.+Res.+Commun.+2005%2C+332%2C+304%E2%80%93310"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DW.%2BG.%26aulast%3DLamison%26aufirst%3DC.%26aulast%3DLarocque%26aufirst%3DJ.%26aulast%3DGibbons%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DK.%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2005%26volume%3D332%26spage%3D304%26epage%3D310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Yu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Discafani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skotnicki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frost, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J.</span> <span class="citation_source-journal">Endocr-Relat. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">258</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm901830p&amp;key=10.1677%2Ferc.0.0080249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm901830p&amp;key=11566616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm901830p&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotlCqsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Yu%2C+K.%3B+Toral-Barza%2C+L.%3B+Discafani%2C+C.%3B+Zhang%2C+W.+G.%3B+Skotnicki%2C+J.%3B+Frost%2C+P.%3B+Gibbons%2C+J.Endocr-Relat.+Cancer+2001%2C+8%2C+249%E2%80%93258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer</span></div><div class="casAuthors">Yu, K.; Toral-Barza, L.; Discafani, C.; Zhang, W-G.; Skotnicki, J.; Frost, P.; Gibbons, J. J.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine-Related Cancer</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">249-258</span>CODEN:
                <span class="NLM_cas:coden">ERCAE9</span>;
        ISSN:<span class="NLM_cas:issn">1351-0088</span>.
    
            (<span class="NLM_cas:orgname">Society for Endocrinology</span>)
        </div><div class="casAbstract">The mammalian target of rapamycin (mTOR) is a central regulator of G1 cell cycle protein synthesis that precedes commitment to normal cellular replication.  We have studied the effect of cell cycle inhibitor-779 (CCI-779), a rapamycin ester that inhibits mTOR function, on the proliferation of a panel of breast cancer cell lines.  Six of eight lines studied were sensitive (IC50≤50 nM) and two lines were resistant (IC50>1.0 μM) to CCI-779.  Sensitive lines were estrogen dependent (MCF-7, BT-474, T-47D), or lacked expression of the tumor suppressor PTEN (MDA-MB-468, BT-549), and/or overexpressed the Her-2/neu oncogene (SKBR-3, BT-474).  Resistant lines (MDA-MB-435, MDA-MB-231) shared none of these properties.  CCI-779 (50 nM) inhibited mTOR function in both a sensitive and a resistant line.  In nu/nu mouse xenografts, CCI-779 inhibited growth of MDA-MB-468 (sensitive) but not MDA-MB-435 resistant tumors.  Treatment of sensitive lines with CCI-779 resulted in a decrease in D-type cyclin and c-myc levels and an increase in p27kip-1 levels.  There was good correlation between activation of the Akt pathway and sensitivity to CCI-779.  Amplification of mTOR-regulated p70S6 kinase, which is downstream of Akt, may also have conferred CCI-779 sensitivity to MCF-7 cells.  Taken together, the data suggest that mTOR may be a good target for breast cancer therapy, esp. in tumors with Akt activation resulting from either growth factor dependency or loss of PTEN function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3hbuBzWiqyLVg90H21EOLACvtfcHk0liBXwFy3WiBkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotlCqsbw%253D&md5=2ed58571e559ee799da2e9a2e9fd3600</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1677%2Ferc.0.0080249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1677%252Ferc.0.0080249%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DK.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DDiscafani%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.%2BG.%26aulast%3DSkotnicki%26aufirst%3DJ.%26aulast%3DFrost%26aufirst%3DP.%26aulast%3DGibbons%26aufirst%3DJ.%26jtitle%3DEndocr-Relat.%2520Cancer%26date%3D2001%26volume%3D8%26spage%3D249%26epage%3D258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Venkatesan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehnhardt, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delos Santos, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dos Santos, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bursavich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellingboe, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khafizova, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooijmans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldberg, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span> </span><span class="NLM_article-title">Novel Imidazolopyrimidines as dual PI3-kinase, mTOR inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">653</span><span class="NLM_x">–</span> <span class="NLM_lpage">657</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=653-657&author=A.+M.+Venkatesanauthor=C.+M.+Dehnhardtauthor=Z.+Chenauthor=E.+Delos+Santosauthor=O.+Dos+Santosauthor=M.+Bursavichauthor=A.+M.+Gilbertauthor=J.+W.+Ellingboeauthor=S.+Ayral-Kaloustianauthor=G.+Khafizovaauthor=N.+Brooijmansauthor=R.+Mallonauthor=I.+Hollanderauthor=L.+Feldbergauthor=J.+Lucasauthor=K.+Yuauthor=J.+Gibbonsauthor=R.+Abrahamauthor=T.+S.+Mansour&title=Novel+Imidazolopyrimidines+as+dual+PI3-kinase%2C+mTOR+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatesan%26aufirst%3DA.%2BM.%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DDelos%2BSantos%26aufirst%3DE.%26aulast%3DDos%2BSantos%26aufirst%3DO.%26aulast%3DBursavich%26aufirst%3DM.%26aulast%3DGilbert%26aufirst%3DA.%2BM.%26aulast%3DEllingboe%26aufirst%3DJ.%2BW.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DKhafizova%26aufirst%3DG.%26aulast%3DBrooijmans%26aufirst%3DN.%26aulast%3DMallon%26aufirst%3DR.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DFeldberg%26aufirst%3DL.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DGibbons%26aufirst%3DJ.%26aulast%3DAbraham%26aufirst%3DR.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26atitle%3DNovel%2520Imidazolopyrimidines%2520as%2520dual%2520PI3-kinase%252C%2520mTOR%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D653%26epage%3D657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Chen, Z.; Venkatesan, A. M.; Dehnhardt, C. M.; Ayral-Kaloustian, S.; Mansour, T. S.; Brooijmans, N.; Mallon, R.; Hollander, I.; Yu, K.</span><span> </span><span class="NLM_article-title">Discovery of Novel Pyrrolo[3,2-<i>d</i>]pyrimidine Derivatives as PI#-Kinase Inhibitors</span>. Presented at the 238th National Meeting of the American Chemical Society, Washington, D.C., August 16−20,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=Z.+Chen&author=A.+M.+Venkatesan&author=C.+M.+Dehnhardt&author=S.+Ayral-Kaloustian&author=T.+S.+Mansour&author=N.+Brooijmans&author=R.+Mallon&author=I.+Hollander&author=K.+Yu&title=Discovery+of+Novel+Pyrrolo%5B3%2C2-d%5Dpyrimidine+Derivatives+as+PI%23-Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26atitle%3DDiscovery%2520of%2520Novel%2520Pyrrolo%255B3%252C2-d%255Dpyrimidine%2520Derivatives%2520as%2520PI%2523-Kinase%2520Inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Kaplan, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, P.</span><span> </span><span class="NLM_article-title">Nonparametric estimation from incomplete observations</span> <span class="citation_source-journal">J. Am. Stat. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1958</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">481</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm901830p&amp;key=10.2307%2F2281868" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1958&pages=457-481&author=E.+L.+Kaplanauthor=P.+Meier&title=Nonparametric+estimation+from+incomplete+observations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.2307%2F2281868&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2307%252F2281868%26sid%3Dliteratum%253Aachs%26aulast%3DKaplan%26aufirst%3DE.%2BL.%26aulast%3DMeier%26aufirst%3DP.%26atitle%3DNonparametric%2520estimation%2520from%2520incomplete%2520observations%26jtitle%3DJ.%2520Am.%2520Stat.%2520Assoc.%26date%3D1958%26volume%3D53%26spage%3D457%26epage%3D481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19a','cit19b'],'ref20':['cit20'],'ref21':['cit21a','cit21b','cit21c'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 121 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Aisha A. K. Al-Ashmawy, Khaled M. Elokely, Oscar Perez-Leal, Mario Rico, John Gordon, George Mateo, Abdelsattar M. Omar, Magid Abou-Gharbia, <span class="NLM_string-name hlFld-ContribAuthor">Wayne E. Childers, Jr.</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and SAR of Novel Disubstituted Quinazolines as Dual PI3Kalpha/mTOR Inhibitors Targeting Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (11)
                                     , 2156-2164. <a href="https://doi.org/10.1021/acsmedchemlett.0c00289" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00289</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00289%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Band%252BSAR%252Bof%252BNovel%252BDisubstituted%252BQuinazolines%252Bas%252BDual%252BPI3Kalpha%25252FmTOR%252BInhibitors%252BTargeting%252BBreast%252BCancer%26aulast%3DAl-Ashmawy%26aufirst%3DAisha%2BA.%2BK.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D28052020%26date%3D06102020%26date%3D12102020%26volume%3D11%26issue%3D11%26spage%3D2156%26epage%3D2164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dinesh Mahajan, Somdutta Sen, Bilash Kuila, Amit Sharma, Reena Arora, Milind Sagar, Amal Ray Mahapatra, Lalita Babasaheb Gawade, <span class="NLM_string-name hlFld-ContribAuthor">Sundeep Dugar</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Development of SPR519 as a Potent, Selective, and Orally Bioavailable Inhibitor of PI3Kα and mTOR Kinases for the Treatment of Solid Tumors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (19)
                                     , 11121-11130. <a href="https://doi.org/10.1021/acs.jmedchem.0c01061" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01061</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01061%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BDevelopment%252Bof%252BSPR519%252Bas%252Ba%252BPotent%25252C%252BSelective%25252C%252Band%252BOrally%252BBioavailable%252BInhibitor%252Bof%252BPI3K%2525CE%2525B1%252Band%252BmTOR%252BKinases%252Bfor%252Bthe%252BTreatment%252Bof%252BSolid%252BTumors%26aulast%3DMahajan%26aufirst%3DDinesh%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D19062020%26date%3D23092020%26date%3D08092020%26volume%3D63%26issue%3D19%26spage%3D11121%26epage%3D11130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Aimie
E. Garces, <span class="NLM_string-name hlFld-ContribAuthor">Michael J. Stocks</span>. </span><span class="cited-content_cbyCitation_article-title">Class 1 PI3K Clinical Candidates and Recent Inhibitor Design Strategies: A Medicinal Chemistry Perspective. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (10)
                                     , 4815-4850. <a href="https://doi.org/10.1021/acs.jmedchem.8b01492" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01492</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01492%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DClass%252B1%252BPI3K%252BClinical%252BCandidates%252Band%252BRecent%252BInhibitor%252BDesign%252BStrategies%25253A%252BA%252BMedicinal%252BChemistry%252BPerspective%26aulast%3DGarces%26aufirst%3DAimie%2BE.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D25092018%26date%3D24122018%26volume%3D62%26issue%3D10%26spage%3D4815%26epage%3D4850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Tao Yu, Ning Li, Chengde Wu, Amy Guan, Yi Li, Zhengang Peng, Miao He, Jie Li, Zhen Gong, Lei Huang, Bo Gao, Dongling Hao, Jikui Sun, Yan Pan, Liang Shen, Chichung Chan, Xiulian Lu, Hongyu Yuan, Yongguo Li, Jian Li, <span class="NLM_string-name hlFld-ContribAuthor">Shuhui Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Pyridopyrimidinones as Potent and Orally Active Dual Inhibitors of PI3K/mTOR. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (3)
                                     , 256-261. <a href="https://doi.org/10.1021/acsmedchemlett.8b00002" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00002%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BPyridopyrimidinones%252Bas%252BPotent%252Band%252BOrally%252BActive%252BDual%252BInhibitors%252Bof%252BPI3K%25252FmTOR%26aulast%3DYu%26aufirst%3DTao%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D03012018%26date%3D27022018%26date%3D28022018%26date%3D27022018%26volume%3D9%26issue%3D3%26spage%3D256%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiangyu  Liu</span>, <span class="hlFld-ContribAuthor ">Guoqing  Zhu</span>, <span class="hlFld-ContribAuthor ">Lingai  Li</span>, <span class="hlFld-ContribAuthor ">Yaowei  Liu</span>, <span class="hlFld-ContribAuthor ">Feng  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaoping  Song</span>, and <span class="hlFld-ContribAuthor ">Yongjun  Mao</span>  . </span><span class="cited-content_cbyCitation_article-title">New and Practical Synthesis of Gedatolisib. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2018,</strong> <em>22 </em>
                                    (1)
                                     , 62-66. <a href="https://doi.org/10.1021/acs.oprd.7b00298" title="DOI URL">https://doi.org/10.1021/acs.oprd.7b00298</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.7b00298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.7b00298%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DNew%252Band%252BPractical%252BSynthesis%252Bof%252BGedatolisib%26aulast%3DLiu%26aufirst%3DXiangyu%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D18092017%26date%3D11122017%26date%3D19012018%26date%3D30112017%26volume%3D22%26issue%3D1%26spage%3D62%26epage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Florent  Beaufils</span>, <span class="hlFld-ContribAuthor ">Natasa  Cmiljanovic</span>, <span class="hlFld-ContribAuthor ">Vladimir  Cmiljanovic</span>, <span class="hlFld-ContribAuthor ">Thomas  Bohnacker</span>, <span class="hlFld-ContribAuthor ">Anna  Melone</span>, <span class="hlFld-ContribAuthor ">Romina  Marone</span>, <span class="hlFld-ContribAuthor ">Eileen  Jackson</span>, <span class="hlFld-ContribAuthor ">Xuxiao  Zhang</span>, <span class="hlFld-ContribAuthor ">Alexander  Sele</span>, <span class="hlFld-ContribAuthor ">Chiara  Borsari</span>, <span class="hlFld-ContribAuthor ">Jürgen  Mestan</span>, <span class="hlFld-ContribAuthor ">Paul  Hebeisen</span>, <span class="hlFld-ContribAuthor ">Petra  Hillmann</span>, <span class="hlFld-ContribAuthor ">Bernd  Giese</span>, <span class="hlFld-ContribAuthor ">Marketa  Zvelebil</span>, <span class="hlFld-ContribAuthor ">Doriano  Fabbro</span>, <span class="hlFld-ContribAuthor ">Roger L.  Williams</span>, <span class="hlFld-ContribAuthor ">Denise  Rageot</span>, and <span class="hlFld-ContribAuthor ">Matthias P.  Wymann</span>  . </span><span class="cited-content_cbyCitation_article-title">5-(4,6-Dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine (PQR309), a Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/mTOR Inhibitor as Clinical Candidate in Oncology. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (17)
                                     , 7524-7538. <a href="https://doi.org/10.1021/acs.jmedchem.7b00930" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00930</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00930%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D5-%2525284%25252C6-Dimorpholino-1%25252C3%25252C5-triazin-2-yl%252529-4-%252528trifluoromethyl%252529pyridin-2-amine%252B%252528PQR309%252529%25252C%252Ba%252BPotent%25252C%252BBrain-Penetrant%25252C%252BOrally%252BBioavailable%25252C%252BPan-Class%252BI%252BPI3K%25252FmTOR%252BInhibitor%252Bas%252BClinical%252BCandidate%252Bin%252BOncology%26aulast%3DBeaufils%26aufirst%3DFlorent%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D23062017%26date%3D01092017%26date%3D14092017%26date%3D22082017%26volume%3D60%26issue%3D17%26spage%3D7524%26epage%3D7538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chengbin  Yang</span>, <span class="hlFld-ContribAuthor ">Xi  Zhang</span>, <span class="hlFld-ContribAuthor ">Yi  Wang</span>, <span class="hlFld-ContribAuthor ">Yongtai  Yang</span>, <span class="hlFld-ContribAuthor ">Xiaofeng  Liu</span>, <span class="hlFld-ContribAuthor ">Mingli  Deng</span>, <span class="hlFld-ContribAuthor ">Yu  Jia</span>, <span class="hlFld-ContribAuthor ">Yun  Ling</span>, <span class="hlFld-ContribAuthor ">Ling-hua  Meng</span>, and <span class="hlFld-ContribAuthor ">Yaming  Zhou</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Novel Series of 7-Azaindole Scaffold Derivatives as PI3K Inhibitors with Potent Activity. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (8)
                                     , 875-880. <a href="https://doi.org/10.1021/acsmedchemlett.7b00222" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00222</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00222%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252BNovel%252BSeries%252Bof%252B7-Azaindole%252BScaffold%252BDerivatives%252Bas%252BPI3K%252BInhibitors%252Bwith%252BPotent%252BActivity%26aulast%3DYang%26aufirst%3DChengbin%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D28052017%26date%3D26072017%26date%3D31072017%26date%3D10082017%26date%3D26072017%26volume%3D8%26issue%3D8%26spage%3D875%26epage%3D880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Miao  Zhan</span>, <span class="hlFld-ContribAuthor ">Yufang  Deng</span>, <span class="hlFld-ContribAuthor ">Lifeng  Zhao</span>, <span class="hlFld-ContribAuthor ">Guoyi  Yan</span>, <span class="hlFld-ContribAuthor ">Fangying  Wang</span>, <span class="hlFld-ContribAuthor ">Ye  Tian</span>, <span class="hlFld-ContribAuthor ">Lanxi  Zhang</span>, <span class="hlFld-ContribAuthor ">Hongxia  Jiang</span>, and <span class="hlFld-ContribAuthor ">Yuanwei  Chen</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of Dimorpholine Substituted Thienopyrimidines as Potential Class I PI3K/mTOR Dual Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (9)
                                     , 4023-4035. <a href="https://doi.org/10.1021/acs.jmedchem.7b00357" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00357</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00357%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BDimorpholine%252BSubstituted%252BThienopyrimidines%252Bas%252BPotential%252BClass%252BI%252BPI3K%25252FmTOR%252BDual%252BInhibitors%26aulast%3DZhan%26aufirst%3DMiao%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D08032017%26date%3D24042017%26date%3D11052017%26date%3D14042017%26volume%3D60%26issue%3D9%26spage%3D4023%26epage%3D4035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marco  Falasca</span>, <span class="hlFld-ContribAuthor ">Justin R.  Hamilton</span>, <span class="hlFld-ContribAuthor ">Maria  Selvadurai</span>, <span class="hlFld-ContribAuthor ">Krithika  Sundaram</span>, <span class="hlFld-ContribAuthor ">Aleksandra  Adamska</span>, and <span class="hlFld-ContribAuthor ">Philip E.  Thompson</span>  . </span><span class="cited-content_cbyCitation_article-title">Class II Phosphoinositide 3-Kinases as Novel Drug Targets. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (1)
                                     , 47-65. <a href="https://doi.org/10.1021/acs.jmedchem.6b00963" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00963</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00963%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DClass%252BII%252BPhosphoinositide%252B3-Kinases%252Bas%252BNovel%252BDrug%252BTargets%26aulast%3DFalasca%26aufirst%3DMarco%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D30062016%26date%3D21102016%26date%3D12012017%26date%3D20092016%26volume%3D60%26issue%3D1%26spage%3D47%26epage%3D65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fangbin  Han</span>, <span class="hlFld-ContribAuthor ">Songwen  Lin</span>, <span class="hlFld-ContribAuthor ">Peng  Liu</span>, <span class="hlFld-ContribAuthor ">Xiujie  Liu</span>, <span class="hlFld-ContribAuthor ">Jing  Tao</span>, <span class="hlFld-ContribAuthor ">Xiaobing  Deng</span>, <span class="hlFld-ContribAuthor ">Chongqin  Yi</span>, and <span class="hlFld-ContribAuthor ">Heng  Xu</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Novel Series of Thienopyrimidine as Highly Potent and Selective PI3K Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>6 </em>
                                    (4)
                                     , 434-438. <a href="https://doi.org/10.1021/ml5005014" title="DOI URL">https://doi.org/10.1021/ml5005014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml5005014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml5005014%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252BNovel%252BSeries%252Bof%252BThienopyrimidine%252Bas%252BHighly%252BPotent%252Band%252BSelective%252BPI3K%252BInhibitors%26aulast%3DHan%26aufirst%3DFangbin%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D05122014%26date%3D11032015%26date%3D13032015%26date%3D09042015%26date%3D11032015%26volume%3D6%26issue%3D4%26spage%3D434%26epage%3D438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin  Andrs</span>, <span class="hlFld-ContribAuthor ">Jan  Korabecny</span>, <span class="hlFld-ContribAuthor ">Daniel  Jun</span>, <span class="hlFld-ContribAuthor ">Zdenek  Hodny</span>, <span class="hlFld-ContribAuthor ">Jiri  Bartek</span>, and <span class="hlFld-ContribAuthor ">Kamil  Kuca</span>  . </span><span class="cited-content_cbyCitation_article-title">Phosphatidylinositol 3-Kinase (PI3K) and Phosphatidylinositol 3-Kinase-Related Kinase (PIKK) Inhibitors: Importance of the Morpholine Ring. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (1)
                                     , 41-71. <a href="https://doi.org/10.1021/jm501026z" title="DOI URL">https://doi.org/10.1021/jm501026z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501026z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501026z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPhosphatidylinositol%252B3-Kinase%252B%252528PI3K%252529%252Band%252BPhosphatidylinositol%252B3-Kinase-Related%252BKinase%252B%252528PIKK%252529%252BInhibitors%25253A%252BImportance%252Bof%252Bthe%252BMorpholine%252BRing%26aulast%3DAndrs%26aufirst%3DMartin%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D08072014%26date%3D05122014%26date%3D08012015%26date%3D11112014%26volume%3D58%26issue%3D1%26spage%3D41%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hengmiao  Cheng</span>, <span class="hlFld-ContribAuthor ">Chunze  Li</span>, <span class="hlFld-ContribAuthor ">Simon  Bailey</span>, <span class="hlFld-ContribAuthor ">Sangita M.  Baxi</span>, <span class="hlFld-ContribAuthor ">Lance  Goulet</span>, <span class="hlFld-ContribAuthor ">Lisa  Guo</span>, <span class="hlFld-ContribAuthor ">Jacqui  Hoffman</span>, <span class="hlFld-ContribAuthor ">Ying  Jiang</span>, <span class="hlFld-ContribAuthor ">Theodore Otto  Johnson</span>, <span class="hlFld-ContribAuthor ">Ted W.  Johnson</span>, <span class="hlFld-ContribAuthor ">Daniel R.  Knighton</span>, <span class="hlFld-ContribAuthor ">John  Li</span>, <span class="hlFld-ContribAuthor ">Kevin K.-C.  Liu</span>, <span class="hlFld-ContribAuthor ">Zhengyu  Liu</span>, <span class="hlFld-ContribAuthor ">Matthew A.  Marx</span>, <span class="hlFld-ContribAuthor ">Marlena  Walls</span>, <span class="hlFld-ContribAuthor ">Peter A.  Wells</span>, <span class="hlFld-ContribAuthor ">Min-Jean  Yin</span>, <span class="hlFld-ContribAuthor ">Jinjiang  Zhu</span>, and <span class="hlFld-ContribAuthor ">Michael  Zientek</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of the Highly Potent PI3K/mTOR Dual Inhibitor PF-04979064 through Structure-Based Drug Design. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>4 </em>
                                    (1)
                                     , 91-97. <a href="https://doi.org/10.1021/ml300309h" title="DOI URL">https://doi.org/10.1021/ml300309h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml300309h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml300309h%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bthe%252BHighly%252BPotent%252BPI3K%25252FmTOR%252BDual%252BInhibitor%252BPF-04979064%252Bthrough%252BStructure-Based%252BDrug%252BDesign%26aulast%3DCheng%26aufirst%3DHengmiao%26date%3D2013%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D02102012%26date%3D07112012%26date%3D19112012%26date%3D10012013%26date%3D07112012%26volume%3D4%26issue%3D1%26spage%3D91%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel P.  Sutherlin</span>, <span class="hlFld-ContribAuthor ">Linda  Bao</span>, <span class="hlFld-ContribAuthor ">Megan  Berry</span>, <span class="hlFld-ContribAuthor ">Georgette  Castanedo</span>, <span class="hlFld-ContribAuthor ">Irina  Chuckowree</span>, <span class="hlFld-ContribAuthor ">Jenna  Dotson</span>, <span class="hlFld-ContribAuthor ">Adrian  Folks</span>, <span class="hlFld-ContribAuthor ">Lori  Friedman</span>, <span class="hlFld-ContribAuthor ">Richard  Goldsmith</span>, <span class="hlFld-ContribAuthor ">Janet  Gunzner</span>, <span class="hlFld-ContribAuthor ">Timothy  Heffron</span>, <span class="hlFld-ContribAuthor ">John  Lesnick</span>, <span class="hlFld-ContribAuthor ">Cristina  Lewis</span>, <span class="hlFld-ContribAuthor ">Simon  Mathieu</span>, <span class="hlFld-ContribAuthor ">Jeremy  Murray</span>, <span class="hlFld-ContribAuthor ">Jim  Nonomiya</span>, <span class="hlFld-ContribAuthor ">Jodie  Pang</span>, <span class="hlFld-ContribAuthor ">Niel  Pegg</span>, <span class="hlFld-ContribAuthor ">Wei Wei  Prior</span>, <span class="hlFld-ContribAuthor ">Lionel  Rouge</span>, <span class="hlFld-ContribAuthor ">Laurent  Salphati</span>, <span class="hlFld-ContribAuthor ">Deepak  Sampath</span>, <span class="hlFld-ContribAuthor ">Qingping  Tian</span>, <span class="hlFld-ContribAuthor ">Vickie  Tsui</span>, <span class="hlFld-ContribAuthor ">Nan Chi  Wan</span>, <span class="hlFld-ContribAuthor ">Shumei  Wang</span>, <span class="hlFld-ContribAuthor ">BinQing  Wei</span>, <span class="hlFld-ContribAuthor ">Christian  Wiesmann</span>, <span class="hlFld-ContribAuthor ">Ping  Wu</span>, <span class="hlFld-ContribAuthor ">Bing-Yan  Zhu</span>, and <span class="hlFld-ContribAuthor ">Alan  Olivero</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potent, Selective, and Orally Available Class I Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Kinase Inhibitor (GDC-0980) for the Treatment of Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (21)
                                     , 7579-7587. <a href="https://doi.org/10.1021/jm2009327" title="DOI URL">https://doi.org/10.1021/jm2009327</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm2009327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm2009327%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BPotent%25252C%252BSelective%25252C%252Band%252BOrally%252BAvailable%252BClass%252BI%252BPhosphatidylinositol%252B3-Kinase%252B%252528PI3K%252529%25252FMammalian%252BTarget%252Bof%252BRapamycin%252B%252528mTOR%252529%252BKinase%252BInhibitor%252B%252528GDC-0980%252529%252Bfor%252Bthe%252BTreatment%252Bof%252BCancer%26aulast%3DSutherlin%26aufirst%3DDaniel%2BP.%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D13072011%26date%3D07102011%26date%3D10112011%26volume%3D54%26issue%3D21%26spage%3D7579%26epage%3D7587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alban R.  Pereira</span>, <span class="hlFld-ContribAuthor ">Wendy K.  Strangman</span>, <span class="hlFld-ContribAuthor ">Frederic  Marion</span>, <span class="hlFld-ContribAuthor ">Larry  Feldberg</span>, <span class="hlFld-ContribAuthor ">Deborah  Roll</span>, <span class="hlFld-ContribAuthor ">Robert  Mallon</span>, <span class="hlFld-ContribAuthor ">Irwin  Hollander</span>, and <span class="hlFld-ContribAuthor ">Raymond J.  Andersen</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of Phosphatidylinositol 3-Kinase (PI3K) Inhibitory Analogues of the Sponge Meroterpenoid Liphagal. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (24)
                                     , 8523-8533. <a href="https://doi.org/10.1021/jm100531u" title="DOI URL">https://doi.org/10.1021/jm100531u</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100531u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100531u%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Bof%252BPhosphatidylinositol%252B3-Kinase%252B%252528PI3K%252529%252BInhibitory%252BAnalogues%252Bof%252Bthe%252BSponge%252BMeroterpenoid%252BLiphagal%26aulast%3DPereira%26aufirst%3DAlban%2BR.%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D07062010%26date%3D01122010%26date%3D23122010%26volume%3D53%26issue%3D24%26spage%3D8523%26epage%3D8533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chiara  Borsari</span>, <span class="hlFld-ContribAuthor ">Martina  De Pascale</span>, <span class="hlFld-ContribAuthor ">Matthias P.  Wymann</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical and Structural Strategies to Selectively Target mTOR Kinase. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>9 </em><a href="https://doi.org/10.1002/cmdc.202100332" title="DOI URL">https://doi.org/10.1002/cmdc.202100332</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202100332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202100332%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DChemical%252Band%252BStructural%252BStrategies%252Bto%252BSelectively%252BTarget%252BmTOR%252BKinase%26aulast%3DBorsari%26aufirst%3DChiara%26date%3D2021%26date%3D2021%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Iksen</span>, <span class="hlFld-ContribAuthor ">Sutthaorn  Pothongsrisit</span>, <span class="hlFld-ContribAuthor ">Varisa  Pongrakhananon</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the PI3K/AKT/mTOR Signaling Pathway in Lung Cancer: An Update Regarding Potential Drugs and Natural Products. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (13)
                                     , 4100. <a href="https://doi.org/10.3390/molecules26134100" title="DOI URL">https://doi.org/10.3390/molecules26134100</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26134100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26134100%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DTargeting%252Bthe%252BPI3K%25252FAKT%25252FmTOR%252BSignaling%252BPathway%252Bin%252BLung%252BCancer%25253A%252BAn%252BUpdate%252BRegarding%252BPotential%252BDrugs%252Band%252BNatural%252BProducts%26aulast%3DIksen%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D13%26spage%3D4100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rosalin  Mishra</span>, <span class="hlFld-ContribAuthor ">Hima  Patel</span>, <span class="hlFld-ContribAuthor ">Samar  Alanazi</span>, <span class="hlFld-ContribAuthor ">Mary Kate  Kilroy</span>, <span class="hlFld-ContribAuthor ">Joan T.  Garrett</span>. </span><span class="cited-content_cbyCitation_article-title">PI3K Inhibitors in Cancer: Clinical Implications and Adverse Effects. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (7)
                                     , 3464. <a href="https://doi.org/10.3390/ijms22073464" title="DOI URL">https://doi.org/10.3390/ijms22073464</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22073464&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22073464%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DPI3K%252BInhibitors%252Bin%252BCancer%25253A%252BClinical%252BImplications%252Band%252BAdverse%252BEffects%26aulast%3DMishra%26aufirst%3DRosalin%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D7%26spage%3D3464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manoj K  Rathinaswamy</span>, <span class="hlFld-ContribAuthor ">Zied  Gaieb</span>, <span class="hlFld-ContribAuthor ">Kaelin D  Fleming</span>, <span class="hlFld-ContribAuthor ">Chiara  Borsari</span>, <span class="hlFld-ContribAuthor ">Noah J  Harris</span>, <span class="hlFld-ContribAuthor ">Brandon E  Moeller</span>, <span class="hlFld-ContribAuthor ">Matthias P  Wymann</span>, <span class="hlFld-ContribAuthor ">Rommie E  Amaro</span>, <span class="hlFld-ContribAuthor ">John E  Burke</span>. </span><span class="cited-content_cbyCitation_article-title">Disease-related mutations in PI3Kγ disrupt regulatory C-terminal dynamics and reveal a path to selective inhibitors. </span><span class="cited-content_cbyCitation_journal-name">eLife</span><span> <strong>2021,</strong> <em>10 </em><a href="https://doi.org/10.7554/eLife.64691" title="DOI URL">https://doi.org/10.7554/eLife.64691</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.7554/eLife.64691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.7554%2FeLife.64691%26sid%3Dliteratum%253Aachs%26jtitle%3DeLife%26atitle%3DDisease-related%252Bmutations%252Bin%252BPI3K%2525CE%2525B3%252Bdisrupt%252Bregulatory%252BC-terminal%252Bdynamics%252Band%252Breveal%252Ba%252Bpath%252Bto%252Bselective%252Binhibitors%26aulast%3DRathinaswamy%26aufirst%3DManoj%2BK%26date%3D2021%26date%3D2021%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Junbo  Hu</span>, <span class="hlFld-ContribAuthor ">Yanli  Zhang</span>, <span class="hlFld-ContribAuthor ">Na  Tang</span>, <span class="hlFld-ContribAuthor ">Yanju  Lu</span>, <span class="hlFld-ContribAuthor ">Peng  Guo</span>, <span class="hlFld-ContribAuthor ">Ziming  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel 1,3,5-triazine derivatives as potent inhibitor of cervical cancer via dual inhibition of PI3K/mTOR. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>32 </em>, 115997. <a href="https://doi.org/10.1016/j.bmc.2021.115997" title="DOI URL">https://doi.org/10.1016/j.bmc.2021.115997</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2021.115997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2021.115997%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252B1%25252C3%25252C5-triazine%252Bderivatives%252Bas%252Bpotent%252Binhibitor%252Bof%252Bcervical%252Bcancer%252Bvia%252Bdual%252Binhibition%252Bof%252BPI3K%25252FmTOR%26aulast%3DHu%26aufirst%3DJunbo%26date%3D2021%26volume%3D32%26spage%3D115997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yifan  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaoping  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Research progress of mTOR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>208 </em>, 112820. <a href="https://doi.org/10.1016/j.ejmech.2020.112820" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112820</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112820&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112820%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DResearch%252Bprogress%252Bof%252BmTOR%252Binhibitors%26aulast%3DChen%26aufirst%3DYifan%26date%3D2020%26volume%3D208%26spage%3D112820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Deze  Zhao</span>, <span class="hlFld-ContribAuthor ">Man  Jiang</span>, <span class="hlFld-ContribAuthor ">Xiaochun  Zhang</span>, <span class="hlFld-ContribAuthor ">Helei  Hou</span>. </span><span class="cited-content_cbyCitation_article-title">The role of RICTOR amplification in targeted therapy and drug resistance. </span><span class="cited-content_cbyCitation_journal-name">Molecular Medicine</span><span> <strong>2020,</strong> <em>26 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s10020-020-0146-6" title="DOI URL">https://doi.org/10.1186/s10020-020-0146-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s10020-020-0146-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs10020-020-0146-6%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Medicine%26atitle%3DThe%252Brole%252Bof%252BRICTOR%252Bamplification%252Bin%252Btargeted%252Btherapy%252Band%252Bdrug%252Bresistance%26aulast%3DZhao%26aufirst%3DDeze%26date%3D2020%26date%3D2020%26volume%3D26%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ting-Ting  Wu</span>, <span class="hlFld-ContribAuthor ">Qing-Qing  Guo</span>, <span class="hlFld-ContribAuthor ">Zi-Li  Chen</span>, <span class="hlFld-ContribAuthor ">Li-Li  Wang</span>, <span class="hlFld-ContribAuthor ">Yao  Du</span>, <span class="hlFld-ContribAuthor ">Rui  Chen</span>, <span class="hlFld-ContribAuthor ">Yuan-Hu  Mao</span>, <span class="hlFld-ContribAuthor ">Sheng-Gang  Yang</span>, <span class="hlFld-ContribAuthor ">Jing  Huang</span>, <span class="hlFld-ContribAuthor ">Jian-Ta  Wang</span>, <span class="hlFld-ContribAuthor ">Ling  Wang</span>, <span class="hlFld-ContribAuthor ">Lei  Tang</span>, <span class="hlFld-ContribAuthor ">Ji-Quan  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and bioevaluation of novel substituted triazines as potential dual PI3K/mTOR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>204 </em>, 112637. <a href="https://doi.org/10.1016/j.ejmech.2020.112637" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112637</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112637%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbioevaluation%252Bof%252Bnovel%252Bsubstituted%252Btriazines%252Bas%252Bpotential%252Bdual%252BPI3K%25252FmTOR%252Binhibitors%26aulast%3DWu%26aufirst%3DTing-Ting%26date%3D2020%26volume%3D204%26spage%3D112637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Salihanur  Darici</span>, <span class="hlFld-ContribAuthor ">Hazem  Alkhaldi</span>, <span class="hlFld-ContribAuthor ">Gillian  Horne</span>, <span class="hlFld-ContribAuthor ">Heather G.  Jørgensen</span>, <span class="hlFld-ContribAuthor ">Sandra  Marmiroli</span>, <span class="hlFld-ContribAuthor ">Xu  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting PI3K/Akt/mTOR in AML: Rationale and Clinical Evidence. </span><span class="cited-content_cbyCitation_journal-name">Journal of Clinical Medicine</span><span> <strong>2020,</strong> <em>9 </em>
                                    (9)
                                     , 2934. <a href="https://doi.org/10.3390/jcm9092934" title="DOI URL">https://doi.org/10.3390/jcm9092934</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/jcm9092934&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fjcm9092934%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Clinical%2520Medicine%26atitle%3DTargeting%252BPI3K%25252FAkt%25252FmTOR%252Bin%252BAML%25253A%252BRationale%252Band%252BClinical%252BEvidence%26aulast%3DDarici%26aufirst%3DSalihanur%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D9%26spage%3D2934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Azam  Karimian</span>, <span class="hlFld-ContribAuthor ">Zahra  Karimi</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of A Novel Heterocyclic System of 3,8-Disubstituted-5
              H-
              Pyrimido[5’,4’:5,6][1,4]Thiazino[3,2-
              e
              ][1,2,4]Triazine. </span><span class="cited-content_cbyCitation_journal-name">Polycyclic Aromatic Compounds</span><span> <strong>2020,</strong> <em>5 </em>, 1-8. <a href="https://doi.org/10.1080/10406638.2020.1784242" title="DOI URL">https://doi.org/10.1080/10406638.2020.1784242</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10406638.2020.1784242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10406638.2020.1784242%26sid%3Dliteratum%253Aachs%26jtitle%3DPolycyclic%2520Aromatic%2520Compounds%26atitle%3DSynthesis%252Bof%252BA%252BNovel%252BHeterocyclic%252BSystem%252Bof%252B3%25252C8-Disubstituted-5%252BH-%252BPyrimido%25255B5%2525E2%252580%252599%25252C4%2525E2%252580%252599%25253A5%25252C6%25255D%25255B1%25252C4%25255DThiazino%25255B3%25252C2-%252Be%252B%25255D%25255B1%25252C2%25252C4%25255DTriazine%26aulast%3DKarimian%26aufirst%3DAzam%26date%3D2020%26date%3D2020%26volume%3D5%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michelle J.  Lee</span>, <span class="hlFld-ContribAuthor ">Nan  Jin</span>, <span class="hlFld-ContribAuthor ">Jennifer R.  Grandis</span>, <span class="hlFld-ContribAuthor ">Daniel E.  Johnson</span>. </span><span class="cited-content_cbyCitation_article-title">Alterations and molecular targeting of the GSK-3 regulator, PI3K, in head and neck cancer. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Molecular Cell Research</span><span> <strong>2020,</strong> <em>1867 </em>
                                    (6)
                                     , 118679. <a href="https://doi.org/10.1016/j.bbamcr.2020.118679" title="DOI URL">https://doi.org/10.1016/j.bbamcr.2020.118679</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbamcr.2020.118679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbamcr.2020.118679%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Molecular%2520Cell%2520Research%26atitle%3DAlterations%252Band%252Bmolecular%252Btargeting%252Bof%252Bthe%252BGSK-3%252Bregulator%25252C%252BPI3K%25252C%252Bin%252Bhead%252Band%252Bneck%252Bcancer%26aulast%3DLee%26aufirst%3DMichelle%2BJ.%26date%3D2020%26volume%3D1867%26issue%3D6%26spage%3D118679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmad  Junaid</span>, <span class="hlFld-ContribAuthor ">Felicia Phei Lin  Lim</span>, <span class="hlFld-ContribAuthor ">Lay Hong  Chuah</span>, <span class="hlFld-ContribAuthor ">Anton V.  Dolzhenko</span>. </span><span class="cited-content_cbyCitation_article-title">6,
              N
              2
              -Diaryl-1,3,5-triazine-2,4-diamines: synthesis, antiproliferative activity and 3D-QSAR modeling. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2020,</strong> <em>10 </em>
                                    (21)
                                     , 12135-12144. <a href="https://doi.org/10.1039/D0RA00643B" title="DOI URL">https://doi.org/10.1039/D0RA00643B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA00643B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA00643B%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3D6%25252C%252BN%252B2%252B-Diaryl-1%25252C3%25252C5-triazine-2%25252C4-diamines%25253A%252Bsynthesis%25252C%252Bantiproliferative%252Bactivity%252Band%252B3D-QSAR%252Bmodeling%26aulast%3DJunaid%26aufirst%3DAhmad%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D21%26spage%3D12135%26epage%3D12144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Angeliki P.  Kourounakis</span>, <span class="hlFld-ContribAuthor ">Dimitrios  Xanthopoulos</span>, <span class="hlFld-ContribAuthor ">Ariadni  Tzara</span>. </span><span class="cited-content_cbyCitation_article-title">Morpholine as a privileged structure: A review on the medicinal chemistry and pharmacological activity of morpholine containing bioactive molecules. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2020,</strong> <em>40 </em>
                                    (2)
                                     , 709-752. <a href="https://doi.org/10.1002/med.21634" title="DOI URL">https://doi.org/10.1002/med.21634</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21634%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DMorpholine%252Bas%252Ba%252Bprivileged%252Bstructure%25253A%252BA%252Breview%252Bon%252Bthe%252Bmedicinal%252Bchemistry%252Band%252Bpharmacological%252Bactivity%252Bof%252Bmorpholine%252Bcontaining%252Bbioactive%252Bmolecules%26aulast%3DKourounakis%26aufirst%3DAngeliki%2BP.%26date%3D2020%26volume%3D40%26issue%3D2%26spage%3D709%26epage%3D752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chiara  Tarantelli</span>, <span class="hlFld-ContribAuthor ">Antonio  Lupia</span>, <span class="hlFld-ContribAuthor ">Anastasios  Stathis</span>, <span class="hlFld-ContribAuthor ">Francesco  Bertoni</span>. </span><span class="cited-content_cbyCitation_article-title">Is There a Role for Dual PI3K/mTOR Inhibitors for Patients Affected with Lymphoma?. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (3)
                                     , 1060. <a href="https://doi.org/10.3390/ijms21031060" title="DOI URL">https://doi.org/10.3390/ijms21031060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21031060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21031060%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DIs%252BThere%252Ba%252BRole%252Bfor%252BDual%252BPI3K%25252FmTOR%252BInhibitors%252Bfor%252BPatients%252BAffected%252Bwith%252BLymphoma%25253F%26aulast%3DTarantelli%26aufirst%3DChiara%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D3%26spage%3D1060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ravindra P.  Sonawane</span>, <span class="hlFld-ContribAuthor ">Vikas  Sikervar</span>, <span class="hlFld-ContribAuthor ">Swarnendu  Sasmal</span>. </span><span class="cited-content_cbyCitation_article-title">1,3,5-Triazines. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00018-4" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00018-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00018-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00018-4%26sid%3Dliteratum%253Aachs%26atitle%3D1%25252C3%25252C5-Triazines%26aulast%3DSonawane%26aufirst%3DRavindra%2BP.%26date%3D2020%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2020%26volume%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Monica M.  Kangussu-Marcolino</span>, <span class="hlFld-ContribAuthor ">Gretchen M.  Ehrenkaufer</span>, <span class="hlFld-ContribAuthor ">Emily  Chen</span>, <span class="hlFld-ContribAuthor ">Anjan  Debnath</span>, <span class="hlFld-ContribAuthor ">Upinder  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of plicamycin, TG02, panobinostat, lestaurtinib, and GDC-0084 as promising compounds for the treatment of central nervous system infections caused by the free-living amebae Naegleria, Acanthamoeba and Balamuthia. </span><span class="cited-content_cbyCitation_journal-name">International Journal for Parasitology: Drugs and Drug Resistance</span><span> <strong>2019,</strong> <em>11 </em>, 80-94. <a href="https://doi.org/10.1016/j.ijpddr.2019.10.003" title="DOI URL">https://doi.org/10.1016/j.ijpddr.2019.10.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijpddr.2019.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijpddr.2019.10.003%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520for%2520Parasitology%253A%2520Drugs%2520and%2520Drug%2520Resistance%26atitle%3DIdentification%252Bof%252Bplicamycin%25252C%252BTG02%25252C%252Bpanobinostat%25252C%252Blestaurtinib%25252C%252Band%252BGDC-0084%252Bas%252Bpromising%252Bcompounds%252Bfor%252Bthe%252Btreatment%252Bof%252Bcentral%252Bnervous%252Bsystem%252Binfections%252Bcaused%252Bby%252Bthe%252Bfree-living%252Bamebae%252BNaegleria%25252C%252BAcanthamoeba%252Band%252BBalamuthia%26aulast%3DKangussu-Marcolino%26aufirst%3DMonica%2BM.%26date%3D2019%26volume%3D11%26spage%3D80%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui  Hua</span>, <span class="hlFld-ContribAuthor ">Qingbin  Kong</span>, <span class="hlFld-ContribAuthor ">Hongying  Zhang</span>, <span class="hlFld-ContribAuthor ">Jiao  Wang</span>, <span class="hlFld-ContribAuthor ">Ting  Luo</span>, <span class="hlFld-ContribAuthor ">Yangfu  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting mTOR for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Hematology & Oncology</span><span> <strong>2019,</strong> <em>12 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13045-019-0754-1" title="DOI URL">https://doi.org/10.1186/s13045-019-0754-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13045-019-0754-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13045-019-0754-1%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Hematology%2520%2526%2520Oncology%26atitle%3DTargeting%252BmTOR%252Bfor%252Bcancer%252Btherapy%26aulast%3DHua%26aufirst%3DHui%26date%3D2019%26date%3D2019%26volume%3D12%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yoshiyuki  Suehara</span>, <span class="hlFld-ContribAuthor ">Deepu  Alex</span>, <span class="hlFld-ContribAuthor ">Anita  Bowman</span>, <span class="hlFld-ContribAuthor ">Sumit  Middha</span>, <span class="hlFld-ContribAuthor ">Ahmet  Zehir</span>, <span class="hlFld-ContribAuthor ">Debyani  Chakravarty</span>, <span class="hlFld-ContribAuthor ">Lu  Wang</span>, <span class="hlFld-ContribAuthor ">George  Jour</span>, <span class="hlFld-ContribAuthor ">Khedoudja  Nafa</span>, <span class="hlFld-ContribAuthor ">Takuo  Hayashi</span>, <span class="hlFld-ContribAuthor ">Achim A.  Jungbluth</span>, <span class="hlFld-ContribAuthor ">Denise  Frosina</span>, <span class="hlFld-ContribAuthor ">Emily  Slotkin</span>, <span class="hlFld-ContribAuthor ">Neerav  Shukla</span>, <span class="hlFld-ContribAuthor ">Paul  Meyers</span>, <span class="hlFld-ContribAuthor ">John H.  Healey</span>, <span class="hlFld-ContribAuthor ">Meera  Hameed</span>, <span class="hlFld-ContribAuthor ">Marc  Ladanyi</span>. </span><span class="cited-content_cbyCitation_article-title">Clinical Genomic Sequencing of Pediatric and Adult Osteosarcoma Reveals Distinct Molecular Subsets with Potentially Targetable Alterations. </span><span class="cited-content_cbyCitation_journal-name">Clinical Cancer Research</span><span> <strong>2019,</strong> <em>25 </em>
                                    (21)
                                     , 6346-6356. <a href="https://doi.org/10.1158/1078-0432.CCR-18-4032" title="DOI URL">https://doi.org/10.1158/1078-0432.CCR-18-4032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1078-0432.CCR-18-4032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1078-0432.CCR-18-4032%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Cancer%2520Research%26atitle%3DClinical%252BGenomic%252BSequencing%252Bof%252BPediatric%252Band%252BAdult%252BOsteosarcoma%252BReveals%252BDistinct%252BMolecular%252BSubsets%252Bwith%252BPotentially%252BTargetable%252BAlterations%26aulast%3DSuehara%26aufirst%3DYoshiyuki%26date%3D2019%26date%3D2019%26volume%3D25%26issue%3D21%26spage%3D6346%26epage%3D6356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajeev  Kumar</span>, <span class="hlFld-ContribAuthor ">Neeraj  Kumar</span>, <span class="hlFld-ContribAuthor ">Ram Kumar  Roy</span>, <span class="hlFld-ContribAuthor ">Anita  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">1,3,5-Triazine Analogs: A Potent Anticancer Scaffold. </span><span class="cited-content_cbyCitation_journal-name">Current Signal Transduction Therapy</span><span> <strong>2019,</strong> <em>14 </em>
                                    (2)
                                     , 87-106. <a href="https://doi.org/10.2174/1574362413666180221113805" title="DOI URL">https://doi.org/10.2174/1574362413666180221113805</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1574362413666180221113805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1574362413666180221113805%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Signal%2520Transduction%2520Therapy%26atitle%3D1%25252C3%25252C5-Triazine%252BAnalogs%25253A%252BA%252BPotent%252BAnticancer%252BScaffold%26aulast%3DKumar%26aufirst%3DRajeev%26date%3D2019%26volume%3D14%26issue%3D2%26spage%3D87%26epage%3D106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi-Cong  Wu</span>, <span class="hlFld-ContribAuthor ">Xin-Yue  Ren</span>, <span class="hlFld-ContribAuthor ">Guo-Wu  Rao</span>. </span><span class="cited-content_cbyCitation_article-title">Research Progress of Diphenyl Urea Derivatives as Anticancer Agents and Synthetic Methodologies. </span><span class="cited-content_cbyCitation_journal-name">Mini-Reviews in Organic Chemistry</span><span> <strong>2019,</strong> <em>16 </em>
                                    (7)
                                     , 617-630. <a href="https://doi.org/10.2174/1570193X15666181029130418" title="DOI URL">https://doi.org/10.2174/1570193X15666181029130418</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1570193X15666181029130418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1570193X15666181029130418%26sid%3Dliteratum%253Aachs%26jtitle%3DMini-Reviews%2520in%2520Organic%2520Chemistry%26atitle%3DResearch%252BProgress%252Bof%252BDiphenyl%252BUrea%252BDerivatives%252Bas%252BAnticancer%252BAgents%252Band%252BSynthetic%252BMethodologies%26aulast%3DWu%26aufirst%3DYi-Cong%26date%3D2019%26volume%3D16%26issue%3D7%26spage%3D617%26epage%3D630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guoyi  Yan</span>, <span class="hlFld-ContribAuthor ">Chunlan  Pu</span>, <span class="hlFld-ContribAuthor ">Suke  Lan</span>, <span class="hlFld-ContribAuthor ">Xinxin  Zhong</span>, <span class="hlFld-ContribAuthor ">Meng  Zhou</span>, <span class="hlFld-ContribAuthor ">Xueyan  Hou</span>, <span class="hlFld-ContribAuthor ">Jie  Yang</span>, <span class="hlFld-ContribAuthor ">Huifang  Shan</span>, <span class="hlFld-ContribAuthor ">Lifeng  Zhao</span>, <span class="hlFld-ContribAuthor ">Rui  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 4-phenyl-2H-benzo[b][1,4]oxazin-3(4H)-one derivatives as potent and orally active PI3K/mTOR dual inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>178 </em>, 667-686. <a href="https://doi.org/10.1016/j.ejmech.2019.06.021" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.06.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.06.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.06.021%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B4-phenyl-2H-benzo%25255Bb%25255D%25255B1%25252C4%25255Doxazin-3%2525284H%252529-one%252Bderivatives%252Bas%252Bpotent%252Band%252Borally%252Bactive%252BPI3K%25252FmTOR%252Bdual%252Binhibitors%26aulast%3DYan%26aufirst%3DGuoyi%26date%3D2019%26volume%3D178%26spage%3D667%26epage%3D686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dhara M.  Chhatbar</span>, <span class="hlFld-ContribAuthor ">Udit J.  Chaube</span>, <span class="hlFld-ContribAuthor ">Vivek K.  Vyas</span>, <span class="hlFld-ContribAuthor ">Hardik G.  Bhatt</span>. </span><span class="cited-content_cbyCitation_article-title">CoMFA, CoMSIA, Topomer CoMFA, HQSAR, molecular docking and molecular dynamics simulations study of triazine morpholino derivatives as mTOR inhibitors for the treatment of breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Computational Biology and Chemistry</span><span> <strong>2019,</strong> <em>80 </em>, 351-363. <a href="https://doi.org/10.1016/j.compbiolchem.2019.04.017" title="DOI URL">https://doi.org/10.1016/j.compbiolchem.2019.04.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.compbiolchem.2019.04.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.compbiolchem.2019.04.017%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520Biology%2520and%2520Chemistry%26atitle%3DCoMFA%25252C%252BCoMSIA%25252C%252BTopomer%252BCoMFA%25252C%252BHQSAR%25252C%252Bmolecular%252Bdocking%252Band%252Bmolecular%252Bdynamics%252Bsimulations%252Bstudy%252Bof%252Btriazine%252Bmorpholino%252Bderivatives%252Bas%252BmTOR%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Bbreast%252Bcancer%26aulast%3DChhatbar%26aufirst%3DDhara%2BM.%26date%3D2019%26volume%3D80%26spage%3D351%26epage%3D363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajpal S.  Burmi</span>, <span class="hlFld-ContribAuthor ">Elaina N.  Maginn</span>, <span class="hlFld-ContribAuthor ">Hani  Gabra</span>, <span class="hlFld-ContribAuthor ">Euan A.  Stronach</span>, <span class="hlFld-ContribAuthor ">Harpreet S.  Wasan</span>. </span><span class="cited-content_cbyCitation_article-title">Combined inhibition of the PI3K/mTOR/MEK pathway induces Bim/Mcl-1-regulated apoptosis in pancreatic cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Cancer Biology & Therapy</span><span> <strong>2019,</strong> <em>20 </em>
                                    (1)
                                     , 21-30. <a href="https://doi.org/10.1080/15384047.2018.1504718" title="DOI URL">https://doi.org/10.1080/15384047.2018.1504718</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/15384047.2018.1504718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F15384047.2018.1504718%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Biology%2520%2526%2520Therapy%26atitle%3DCombined%252Binhibition%252Bof%252Bthe%252BPI3K%25252FmTOR%25252FMEK%252Bpathway%252Binduces%252BBim%25252FMcl-1-regulated%252Bapoptosis%252Bin%252Bpancreatic%252Bcancer%252Bcells%26aulast%3DBurmi%26aufirst%3DRajpal%2BS.%26date%3D2019%26date%3D2018%26volume%3D20%26issue%3D1%26spage%3D21%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  McKenna</span>, <span class="hlFld-ContribAuthor ">Sarah  McGarrigle</span>, <span class="hlFld-ContribAuthor ">Graham P.  Pidgeon</span>. </span><span class="cited-content_cbyCitation_article-title">The next generation of PI3K-Akt-mTOR pathway inhibitors in breast cancer cohorts. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Reviews on Cancer</span><span> <strong>2018,</strong> <em>1870 </em>
                                    (2)
                                     , 185-197. <a href="https://doi.org/10.1016/j.bbcan.2018.08.001" title="DOI URL">https://doi.org/10.1016/j.bbcan.2018.08.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbcan.2018.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbcan.2018.08.001%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Reviews%2520on%2520Cancer%26atitle%3DThe%252Bnext%252Bgeneration%252Bof%252BPI3K-Akt-mTOR%252Bpathway%252Binhibitors%252Bin%252Bbreast%252Bcancer%252Bcohorts%26aulast%3DMcKenna%26aufirst%3DMichael%26date%3D2018%26volume%3D1870%26issue%3D2%26spage%3D185%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kyungsuk  Jung</span>, <span class="hlFld-ContribAuthor ">Hyunseok  Kang</span>, <span class="hlFld-ContribAuthor ">Ranee  Mehra</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting phosphoinositide 3-kinase (PI3K) in head and neck squamous cell carcinoma (HNSCC). </span><span class="cited-content_cbyCitation_journal-name">Cancers of the Head & Neck</span><span> <strong>2018,</strong> <em>3 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s41199-018-0030-z" title="DOI URL">https://doi.org/10.1186/s41199-018-0030-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s41199-018-0030-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs41199-018-0030-z%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%2520of%2520the%2520Head%2520%2526%2520Neck%26atitle%3DTargeting%252Bphosphoinositide%252B3-kinase%252B%252528PI3K%252529%252Bin%252Bhead%252Band%252Bneck%252Bsquamous%252Bcell%252Bcarcinoma%252B%252528HNSCC%252529%26aulast%3DJung%26aufirst%3DKyungsuk%26date%3D2018%26date%3D2018%26volume%3D3%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Boulos  Zacharie</span>, <span class="hlFld-ContribAuthor ">Shaun D.  Abbott</span>, <span class="hlFld-ContribAuthor ">Jean‐Simon  Duceppe</span>, <span class="hlFld-ContribAuthor ">Lyne  Gagnon</span>, <span class="hlFld-ContribAuthor ">Brigitte  Grouix</span>, <span class="hlFld-ContribAuthor ">Lilianne  Geerts</span>, <span class="hlFld-ContribAuthor ">Liette  Gervais</span>, <span class="hlFld-ContribAuthor ">François  Sarra‐Bournet</span>, <span class="hlFld-ContribAuthor ">Valérie  Perron</span>, <span class="hlFld-ContribAuthor ">Nicole  Wilb</span>, <span class="hlFld-ContribAuthor ">Christopher L.  Penney</span>, <span class="hlFld-ContribAuthor ">Pierre  Laurin</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of New 1,3,5‐Trisubstituted Triazines for the Treatment of Cancer and Inflammation. </span><span class="cited-content_cbyCitation_journal-name">ChemistryOpen</span><span> <strong>2018,</strong> <em>7 </em>
                                    (9)
                                     , 737-749. <a href="https://doi.org/10.1002/open.201800136" title="DOI URL">https://doi.org/10.1002/open.201800136</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/open.201800136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fopen.201800136%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistryOpen%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BNew%252B1%25252C3%25252C5%2525E2%252580%252590Trisubstituted%252BTriazines%252Bfor%252Bthe%252BTreatment%252Bof%252BCancer%252Band%252BInflammation%26aulast%3DZacharie%26aufirst%3DBoulos%26date%3D2018%26date%3D2018%26volume%3D7%26issue%3D9%26spage%3D737%26epage%3D749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bingbing  Zhao</span>, <span class="hlFld-ContribAuthor ">Fei  Lei</span>, <span class="hlFld-ContribAuthor ">Caolin  Wang</span>, <span class="hlFld-ContribAuthor ">Binliang  Zhang</span>, <span class="hlFld-ContribAuthor ">Zunhua  Yang</span>, <span class="hlFld-ContribAuthor ">Wei  Li</span>, <span class="hlFld-ContribAuthor ">Wufu  Zhu</span>, <span class="hlFld-ContribAuthor ">Shan  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Biological Evaluation of Novel Phenylsulfonylurea Derivatives as PI3K/mTOR Dual Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (7)
                                     , 1553. <a href="https://doi.org/10.3390/molecules23071553" title="DOI URL">https://doi.org/10.3390/molecules23071553</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23071553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23071553%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BNovel%252BPhenylsulfonylurea%252BDerivatives%252Bas%252BPI3K%25252FmTOR%252BDual%252BInhibitors%26aulast%3DZhao%26aufirst%3DBingbing%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D7%26spage%3D1553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ronald  Nelson</span>, <span class="hlFld-ContribAuthor ">Taylor  Schronce</span>, <span class="hlFld-ContribAuthor ">Yue  Huang</span>, <span class="hlFld-ContribAuthor ">Alanoud  Albugami</span>, <span class="hlFld-ContribAuthor ">George  Kulik</span>, <span class="hlFld-ContribAuthor ">Mark  Welker</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and PI 3-Kinase Inhibition Activity of Some Novel 2,4,6-Trisubstituted 1,3,5-Triazines. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (7)
                                     , 1628. <a href="https://doi.org/10.3390/molecules23071628" title="DOI URL">https://doi.org/10.3390/molecules23071628</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23071628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23071628%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Band%252BPI%252B3-Kinase%252BInhibition%252BActivity%252Bof%252BSome%252BNovel%252B2%25252C4%25252C6-Trisubstituted%252B1%25252C3%25252C5-Triazines%26aulast%3DNelson%26aufirst%3DRonald%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D7%26spage%3D1628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rebecca  Mitchell</span>, <span class="hlFld-ContribAuthor ">Lisa E M  Hopcroft</span>, <span class="hlFld-ContribAuthor ">Pablo  Baquero</span>, <span class="hlFld-ContribAuthor ">Elaine K  Allan</span>, <span class="hlFld-ContribAuthor ">Kay  Hewit</span>, <span class="hlFld-ContribAuthor ">Daniel  James</span>, <span class="hlFld-ContribAuthor ">Graham  Hamilton</span>, <span class="hlFld-ContribAuthor ">Arunima  Mukhopadhyay</span>, <span class="hlFld-ContribAuthor ">Jim  O’Prey</span>, <span class="hlFld-ContribAuthor ">Alan  Hair</span>, <span class="hlFld-ContribAuthor ">Junia V  Melo</span>, <span class="hlFld-ContribAuthor ">Edmond  Chan</span>, <span class="hlFld-ContribAuthor ">Kevin M  Ryan</span>, <span class="hlFld-ContribAuthor ">Véronique  Maguer-Satta</span>, <span class="hlFld-ContribAuthor ">Brian J  Druker</span>, <span class="hlFld-ContribAuthor ">Richard E  Clark</span>, <span class="hlFld-ContribAuthor ">Subir  Mitra</span>, <span class="hlFld-ContribAuthor ">Pawel  Herzyk</span>, <span class="hlFld-ContribAuthor ">Franck E  Nicolini</span>, <span class="hlFld-ContribAuthor ">Paolo  Salomoni</span>, <span class="hlFld-ContribAuthor ">Emma  Shanks</span>, <span class="hlFld-ContribAuthor ">Bruno  Calabretta</span>, <span class="hlFld-ContribAuthor ">Tessa L  Holyoake</span>, <span class="hlFld-ContribAuthor ">G Vignir  Helgason</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting BCR-ABL-Independent TKI Resistance in Chronic Myeloid Leukemia by mTOR and Autophagy Inhibition. </span><span class="cited-content_cbyCitation_journal-name">JNCI: Journal of the National Cancer Institute</span><span> <strong>2018,</strong> <em>110 </em>
                                    (5)
                                     , 467-478. <a href="https://doi.org/10.1093/jnci/djx236" title="DOI URL">https://doi.org/10.1093/jnci/djx236</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/jnci/djx236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fjnci%2Fdjx236%26sid%3Dliteratum%253Aachs%26jtitle%3DJNCI%253A%2520Journal%2520of%2520the%2520National%2520Cancer%2520Institute%26atitle%3DTargeting%252BBCR-ABL-Independent%252BTKI%252BResistance%252Bin%252BChronic%252BMyeloid%252BLeukemia%252Bby%252BmTOR%252Band%252BAutophagy%252BInhibition%26aulast%3DMitchell%26aufirst%3DRebecca%26date%3D2018%26date%3D2017%26volume%3D110%26issue%3D5%26spage%3D467%26epage%3D478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hideki  Makinoshima</span>, <span class="hlFld-ContribAuthor ">Shigeki  Umemura</span>, <span class="hlFld-ContribAuthor ">Ayako  Suzuki</span>, <span class="hlFld-ContribAuthor ">Hiroki  Nakanishi</span>, <span class="hlFld-ContribAuthor ">Ami  Maruyama</span>, <span class="hlFld-ContribAuthor ">Hibiki  Udagawa</span>, <span class="hlFld-ContribAuthor ">Sachiyo  Mimaki</span>, <span class="hlFld-ContribAuthor ">Shingo  Matsumoto</span>, <span class="hlFld-ContribAuthor ">Seiji  Niho</span>, <span class="hlFld-ContribAuthor ">Genichiro  Ishii</span>, <span class="hlFld-ContribAuthor ">Masahiro  Tsuboi</span>, <span class="hlFld-ContribAuthor ">Atsushi  Ochiai</span>, <span class="hlFld-ContribAuthor ">Hiroyasu  Esumi</span>, <span class="hlFld-ContribAuthor ">Takehiko  Sasaki</span>, <span class="hlFld-ContribAuthor ">Koichi  Goto</span>, <span class="hlFld-ContribAuthor ">Katsuya  Tsuchihara</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolic Determinants of Sensitivity to Phosphatidylinositol 3-Kinase Pathway Inhibitor in Small-Cell Lung Carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Cancer Research</span><span> <strong>2018,</strong> <em>78 </em>
                                    (9)
                                     , 2179-2190. <a href="https://doi.org/10.1158/0008-5472.CAN-17-2109" title="DOI URL">https://doi.org/10.1158/0008-5472.CAN-17-2109</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/0008-5472.CAN-17-2109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F0008-5472.CAN-17-2109%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Research%26atitle%3DMetabolic%252BDeterminants%252Bof%252BSensitivity%252Bto%252BPhosphatidylinositol%252B3-Kinase%252BPathway%252BInhibitor%252Bin%252BSmall-Cell%252BLung%252BCarcinoma%26aulast%3DMakinoshima%26aufirst%3DHideki%26date%3D2018%26date%3D2018%26volume%3D78%26issue%3D9%26spage%3D2179%26epage%3D2190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaodong  Ma</span>, <span class="hlFld-ContribAuthor ">Xiaoqing  Lv</span>, <span class="hlFld-ContribAuthor ">Jiankang  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Exploiting polypharmacology for improving therapeutic outcome of kinase inhibitors (KIs): An update of recent medicinal chemistry efforts. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>143 </em>, 449-463. <a href="https://doi.org/10.1016/j.ejmech.2017.11.049" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.11.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.11.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.11.049%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DExploiting%252Bpolypharmacology%252Bfor%252Bimproving%252Btherapeutic%252Boutcome%252Bof%252Bkinase%252Binhibitors%252B%252528KIs%252529%25253A%252BAn%252Bupdate%252Bof%252Brecent%252Bmedicinal%252Bchemistry%252Befforts%26aulast%3DMa%26aufirst%3DXiaodong%26date%3D2018%26volume%3D143%26spage%3D449%26epage%3D463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luca  Costantino</span>, <span class="hlFld-ContribAuthor ">Daniela  Barlocco</span>. </span><span class="cited-content_cbyCitation_article-title">Designing Approaches to Multitarget Drugs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 161-205. <a href="https://doi.org/10.1002/9783527674381.ch7" title="DOI URL">https://doi.org/10.1002/9783527674381.ch7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527674381.ch7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527674381.ch7%26sid%3Dliteratum%253Aachs%26atitle%3DDesigning%252BApproaches%252Bto%252BMultitarget%252BDrugs%26aulast%3DCostantino%26aufirst%3DLuca%26date%3D2017%26date%3D2017%26spage%3D161%26epage%3D205%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DDrug%252BSelectivity%26aulast%3DHandler%26aufirst%3DNorbert%26date%3D2017%26volume%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stella  Cascioferro</span>, <span class="hlFld-ContribAuthor ">Barbara  Parrino</span>, <span class="hlFld-ContribAuthor ">Virginia  Spanò</span>, <span class="hlFld-ContribAuthor ">Anna  Carbone</span>, <span class="hlFld-ContribAuthor ">Alessandra  Montalbano</span>, <span class="hlFld-ContribAuthor ">Paola  Barraja</span>, <span class="hlFld-ContribAuthor ">Patrizia  Diana</span>, <span class="hlFld-ContribAuthor ">Girolamo  Cirrincione</span>. </span><span class="cited-content_cbyCitation_article-title">1,3,5-Triazines: A promising scaffold for anticancer drugs development. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>142 </em>, 523-549. <a href="https://doi.org/10.1016/j.ejmech.2017.09.035" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.09.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.09.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.09.035%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3D1%25252C3%25252C5-Triazines%25253A%252BA%252Bpromising%252Bscaffold%252Bfor%252Banticancer%252Bdrugs%252Bdevelopment%26aulast%3DCascioferro%26aufirst%3DStella%26date%3D2017%26volume%3D142%26spage%3D523%26epage%3D549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hua-fu  Zhao</span>, <span class="hlFld-ContribAuthor ">Jing  Wang</span>, <span class="hlFld-ContribAuthor ">Wei  Shao</span>, <span class="hlFld-ContribAuthor ">Chang-peng  Wu</span>, <span class="hlFld-ContribAuthor ">Zhong-ping  Chen</span>, <span class="hlFld-ContribAuthor ">Shing-shun Tony  To</span>, <span class="hlFld-ContribAuthor ">Wei-ping  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the use of PI3K inhibitors for glioblastoma multiforme: current preclinical and clinical development. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer</span><span> <strong>2017,</strong> <em>16 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12943-017-0670-3" title="DOI URL">https://doi.org/10.1186/s12943-017-0670-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12943-017-0670-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12943-017-0670-3%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Buse%252Bof%252BPI3K%252Binhibitors%252Bfor%252Bglioblastoma%252Bmultiforme%25253A%252Bcurrent%252Bpreclinical%252Band%252Bclinical%252Bdevelopment%26aulast%3DZhao%26aufirst%3DHua-fu%26date%3D2017%26date%3D2017%26volume%3D16%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Valery  Vilchez</span>, <span class="hlFld-ContribAuthor ">Lilia  Turcios</span>, <span class="hlFld-ContribAuthor ">David A.  Butterfield</span>, <span class="hlFld-ContribAuthor ">Mihail I.  Mitov</span>, <span class="hlFld-ContribAuthor ">Cristin L.  Coquillard</span>, <span class="hlFld-ContribAuthor ">Ja Anthony  Brandon</span>, <span class="hlFld-ContribAuthor ">Virgilius  Cornea</span>, <span class="hlFld-ContribAuthor ">Roberto  Gedaly</span>, <span class="hlFld-ContribAuthor ">Francesc  Marti</span>. </span><span class="cited-content_cbyCitation_article-title">Evidence of the immunomodulatory role of dual PI3K/mTOR inhibitors in transplantation: an experimental study in mice. </span><span class="cited-content_cbyCitation_journal-name">Transplant International</span><span> <strong>2017,</strong> <em>30 </em>
                                    (10)
                                     , 1061-1074. <a href="https://doi.org/10.1111/tri.12989" title="DOI URL">https://doi.org/10.1111/tri.12989</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/tri.12989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Ftri.12989%26sid%3Dliteratum%253Aachs%26jtitle%3DTransplant%2520International%26atitle%3DEvidence%252Bof%252Bthe%252Bimmunomodulatory%252Brole%252Bof%252Bdual%252BPI3K%25252FmTOR%252Binhibitors%252Bin%252Btransplantation%25253A%252Ban%252Bexperimental%252Bstudy%252Bin%252Bmice%26aulast%3DVilchez%26aufirst%3DValery%26date%3D2017%26date%3D2017%26volume%3D30%26issue%3D10%26spage%3D1061%26epage%3D1074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aisha A.K.  Al-Ashmawy</span>, <span class="hlFld-ContribAuthor ">Fatma A.  Ragab</span>, <span class="hlFld-ContribAuthor ">Khaled M.  Elokely</span>, <span class="hlFld-ContribAuthor ">Manal M.  Anwar</span>, <span class="hlFld-ContribAuthor ">Oscar  Perez-Leal</span>, <span class="hlFld-ContribAuthor ">Mario C.  Rico</span>, <span class="hlFld-ContribAuthor ">John  Gordon</span>, <span class="hlFld-ContribAuthor ">Eugeney  Bichenkov</span>, <span class="hlFld-ContribAuthor ">George  Mateo</span>, <span class="hlFld-ContribAuthor ">Emad M.M.  Kassem</span>, <span class="hlFld-ContribAuthor ">Gehan H.  Hegazy</span>, <span class="hlFld-ContribAuthor ">Magid  Abou-Gharbia</span>, <span class="hlFld-ContribAuthor ">Wayne  Childers</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and SAR of new-di-substituted pyridopyrimidines as ATP-competitive dual PI3Kα/mTOR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (14)
                                     , 3117-3122. <a href="https://doi.org/10.1016/j.bmcl.2017.05.044" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.05.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.05.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.05.044%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252BSAR%252Bof%252Bnew-di-substituted%252Bpyridopyrimidines%252Bas%252BATP-competitive%252Bdual%252BPI3K%2525CE%2525B1%25252FmTOR%252Binhibitors%26aulast%3DAl-Ashmawy%26aufirst%3DAisha%2BA.K.%26date%3D2017%26volume%3D27%26issue%3D14%26spage%3D3117%26epage%3D3122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yipin  Lu</span>, <span class="hlFld-ContribAuthor ">Mark  Knapp</span>, <span class="hlFld-ContribAuthor ">Kenneth  Crawford</span>, <span class="hlFld-ContribAuthor ">Robert  Warne</span>, <span class="hlFld-ContribAuthor ">Robert  Elling</span>, <span class="hlFld-ContribAuthor ">Kelly  Yan</span>, <span class="hlFld-ContribAuthor ">Michael  Doyle</span>, <span class="hlFld-ContribAuthor ">Gwynn  Pardee</span>, <span class="hlFld-ContribAuthor ">Li  Zhang</span>, <span class="hlFld-ContribAuthor ">Sylvia  Ma</span>, <span class="hlFld-ContribAuthor ">Mulugeta  Mamo</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Ornelas</span>, <span class="hlFld-ContribAuthor ">Yue  Pan</span>, <span class="hlFld-ContribAuthor ">Dirksen  Bussiere</span>, <span class="hlFld-ContribAuthor ">Johanna  Jansen</span>, <span class="hlFld-ContribAuthor ">Isabel  Zaror</span>, <span class="hlFld-ContribAuthor ">Albert  Lai</span>, <span class="hlFld-ContribAuthor ">Paul  Barsanti</span>, <span class="hlFld-ContribAuthor ">Janet  Sim</span>. </span><span class="cited-content_cbyCitation_article-title">Rationally Designed PI3Kα Mutants to Mimic ATR and Their Use to Understand Binding Specificity of ATR Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Biology</span><span> <strong>2017,</strong> <em>429 </em>
                                    (11)
                                     , 1684-1704. <a href="https://doi.org/10.1016/j.jmb.2017.04.006" title="DOI URL">https://doi.org/10.1016/j.jmb.2017.04.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmb.2017.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmb.2017.04.006%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Biology%26atitle%3DRationally%252BDesigned%252BPI3K%2525CE%2525B1%252BMutants%252Bto%252BMimic%252BATR%252Band%252BTheir%252BUse%252Bto%252BUnderstand%252BBinding%252BSpecificity%252Bof%252BATR%252BInhibitors%26aulast%3DLu%26aufirst%3DYipin%26date%3D2017%26volume%3D429%26issue%3D11%26spage%3D1684%26epage%3D1704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohiuddin  Gazi</span>, <span class="hlFld-ContribAuthor ">Sausan A.  Moharram</span>, <span class="hlFld-ContribAuthor ">Alissa  Marhäll</span>, <span class="hlFld-ContribAuthor ">Julhash U.  Kazi</span>. </span><span class="cited-content_cbyCitation_article-title">The dual specificity PI3K/mTOR inhibitor PKI-587 displays efficacy against T-cell acute lymphoblastic leukemia (T-ALL). </span><span class="cited-content_cbyCitation_journal-name">Cancer Letters</span><span> <strong>2017,</strong> <em>392 </em>, 9-16. <a href="https://doi.org/10.1016/j.canlet.2017.01.035" title="DOI URL">https://doi.org/10.1016/j.canlet.2017.01.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.canlet.2017.01.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.canlet.2017.01.035%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Letters%26atitle%3DThe%252Bdual%252Bspecificity%252BPI3K%25252FmTOR%252Binhibitor%252BPKI-587%252Bdisplays%252Befficacy%252Bagainst%252BT-cell%252Bacute%252Blymphoblastic%252Bleukemia%252B%252528T-ALL%252529%26aulast%3DGazi%26aufirst%3DMohiuddin%26date%3D2017%26volume%3D392%26spage%3D9%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Azam  Roohi</span>, <span class="hlFld-ContribAuthor ">Mohammad  Hojjat-Farsangi</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in targeting mTOR signaling pathway using small molecule inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Drug Targeting</span><span> <strong>2017,</strong> <em>25 </em>
                                    (3)
                                     , 189-201. <a href="https://doi.org/10.1080/1061186X.2016.1236112" title="DOI URL">https://doi.org/10.1080/1061186X.2016.1236112</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/1061186X.2016.1236112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F1061186X.2016.1236112%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Drug%2520Targeting%26atitle%3DRecent%252Badvances%252Bin%252Btargeting%252BmTOR%252Bsignaling%252Bpathway%252Busing%252Bsmall%252Bmolecule%252Binhibitors%26aulast%3DRoohi%26aufirst%3DAzam%26date%3D2017%26date%3D2016%26volume%3D25%26issue%3D3%26spage%3D189%26epage%3D201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiankang  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaoqing  Lv</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Ma</span>, <span class="hlFld-ContribAuthor ">Yongzhou  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a series of N -(5-(quinolin-6-yl)pyridin-3-yl)benzenesulfonamides as PI3K/mTOR dual inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>127 </em>, 509-520. <a href="https://doi.org/10.1016/j.ejmech.2017.01.016" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.01.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.01.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.01.016%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252Bseries%252Bof%252BN%252B-%2525285-%252528quinolin-6-yl%252529pyridin-3-yl%252529benzenesulfonamides%252Bas%252BPI3K%25252FmTOR%252Bdual%252Binhibitors%26aulast%3DZhang%26aufirst%3DJiankang%26date%3D2017%26volume%3D127%26spage%3D509%26epage%3D520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shan  Xu</span>, <span class="hlFld-ContribAuthor ">Chengyu  Sun</span>, <span class="hlFld-ContribAuthor ">Chen  Chen</span>, <span class="hlFld-ContribAuthor ">Pengwu  Zheng</span>, <span class="hlFld-ContribAuthor ">Yong  Zhou</span>, <span class="hlFld-ContribAuthor ">Hongying  Zhou</span>, <span class="hlFld-ContribAuthor ">Wufu  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of Novel 8-Morpholinoimidazo[1,2-a]pyrazine Derivatives Bearing Phenylpyridine/Phenylpyrimidine-Carboxamides. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2017,</strong> <em>22 </em>
                                    (2)
                                     , 310. <a href="https://doi.org/10.3390/molecules22020310" title="DOI URL">https://doi.org/10.3390/molecules22020310</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules22020310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules22020310%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BNovel%252B8-Morpholinoimidazo%25255B1%25252C2-a%25255Dpyrazine%252BDerivatives%252BBearing%252BPhenylpyridine%25252FPhenylpyrimidine-Carboxamides%26aulast%3DXu%26aufirst%3DShan%26date%3D2017%26date%3D2017%26volume%3D22%26issue%3D2%26spage%3D310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Liu</span>, <span class="hlFld-ContribAuthor ">Wen-zhu  Wan</span>, <span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">Guan-lian  Zhou</span>, <span class="hlFld-ContribAuthor ">Xin-guang  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Recent development of ATP-competitive small molecule phosphatidylinostitol-3-kinase inhibitors as anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2017,</strong> <em>8 </em>
                                    (4)
                                     , 7181-7200. <a href="https://doi.org/10.18632/oncotarget.12742" title="DOI URL">https://doi.org/10.18632/oncotarget.12742</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.12742&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.12742%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DRecent%252Bdevelopment%252Bof%252BATP-competitive%252Bsmall%252Bmolecule%252Bphosphatidylinostitol-3-kinase%252Binhibitors%252Bas%252Banticancer%252Bagents%26aulast%3DLiu%26aufirst%3DYu%26date%3D2017%26date%3D2016%26volume%3D8%26issue%3D4%26spage%3D7181%26epage%3D7200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinsong  Han</span>, <span class="hlFld-ContribAuthor ">Ying  Chen</span>, <span class="hlFld-ContribAuthor ">Chao  Yang</span>, <span class="hlFld-ContribAuthor ">Ting  Liu</span>, <span class="hlFld-ContribAuthor ">Mingping  Wang</span>, <span class="hlFld-ContribAuthor ">Haojie  Xu</span>, <span class="hlFld-ContribAuthor ">Ling  Zhang</span>, <span class="hlFld-ContribAuthor ">Canhui  Zheng</span>, <span class="hlFld-ContribAuthor ">Yunlong  Song</span>, <span class="hlFld-ContribAuthor ">Ju  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based optimization leads to the discovery of NSC765844, a highly potent, less toxic and orally efficacious dual PI3K/mTOR inhibitor. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>122 </em>, 684-701. <a href="https://doi.org/10.1016/j.ejmech.2016.06.030" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.06.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.06.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.06.030%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-based%252Boptimization%252Bleads%252Bto%252Bthe%252Bdiscovery%252Bof%252BNSC765844%25252C%252Ba%252Bhighly%252Bpotent%25252C%252Bless%252Btoxic%252Band%252Borally%252Befficacious%252Bdual%252BPI3K%25252FmTOR%252Binhibitor%26aulast%3DHan%26aufirst%3DJinsong%26date%3D2016%26volume%3D122%26spage%3D684%26epage%3D701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">O  Lindblad</span>, <span class="hlFld-ContribAuthor ">E  Cordero</span>, <span class="hlFld-ContribAuthor ">A  Puissant</span>, <span class="hlFld-ContribAuthor ">L  Macaulay</span>, <span class="hlFld-ContribAuthor ">A  Ramos</span>, <span class="hlFld-ContribAuthor ">N N  Kabir</span>, <span class="hlFld-ContribAuthor ">J  Sun</span>, <span class="hlFld-ContribAuthor ">J  Vallon-Christersson</span>, <span class="hlFld-ContribAuthor ">K  Haraldsson</span>, <span class="hlFld-ContribAuthor ">M T  Hemann</span>, <span class="hlFld-ContribAuthor ">Å  Borg</span>, <span class="hlFld-ContribAuthor ">F  Levander</span>, <span class="hlFld-ContribAuthor ">K  Stegmaier</span>, <span class="hlFld-ContribAuthor ">K  Pietras</span>, <span class="hlFld-ContribAuthor ">L  Rönnstrand</span>, <span class="hlFld-ContribAuthor ">J U  Kazi</span>. </span><span class="cited-content_cbyCitation_article-title">Aberrant activation of the PI3K/mTOR pathway promotes resistance to sorafenib in AML. </span><span class="cited-content_cbyCitation_journal-name">Oncogene</span><span> <strong>2016,</strong> <em>35 </em>
                                    (39)
                                     , 5119-5131. <a href="https://doi.org/10.1038/onc.2016.41" title="DOI URL">https://doi.org/10.1038/onc.2016.41</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/onc.2016.41&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fonc.2016.41%26sid%3Dliteratum%253Aachs%26jtitle%3DOncogene%26atitle%3DAberrant%252Bactivation%252Bof%252Bthe%252BPI3K%25252FmTOR%252Bpathway%252Bpromotes%252Bresistance%252Bto%252Bsorafenib%252Bin%252BAML%26aulast%3DLindblad%26aufirst%3DO%26date%3D2016%26date%3D2016%26volume%3D35%26issue%3D39%26spage%3D5119%26epage%3D5131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chengyu  Sun</span>, <span class="hlFld-ContribAuthor ">Chen  Chen</span>, <span class="hlFld-ContribAuthor ">Shan  Xu</span>, <span class="hlFld-ContribAuthor ">Jianqiang  Wang</span>, <span class="hlFld-ContribAuthor ">Yan  Zhu</span>, <span class="hlFld-ContribAuthor ">Dejia  Kong</span>, <span class="hlFld-ContribAuthor ">Hong  Tao</span>, <span class="hlFld-ContribAuthor ">Mengjia  Jin</span>, <span class="hlFld-ContribAuthor ">Pengwu  Zheng</span>, <span class="hlFld-ContribAuthor ">Wufu  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and anticancer activity of novel 4-morpholino-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidine derivatives bearing chromone moiety. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (16)
                                     , 3862-3869. <a href="https://doi.org/10.1016/j.bmc.2016.06.032" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.06.032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.06.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.06.032%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Banticancer%252Bactivity%252Bof%252Bnovel%252B4-morpholino-7%25252C8-dihydro-5H-thiopyrano%25255B4%25252C3-d%25255Dpyrimidine%252Bderivatives%252Bbearing%252Bchromone%252Bmoiety%26aulast%3DSun%26aufirst%3DChengyu%26date%3D2016%26volume%3D24%26issue%3D16%26spage%3D3862%26epage%3D3869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fei  Lei</span>, <span class="hlFld-ContribAuthor ">Chengyu  Sun</span>, <span class="hlFld-ContribAuthor ">Shan  Xu</span>, <span class="hlFld-ContribAuthor ">Qinqin  Wang</span>, <span class="hlFld-ContribAuthor ">Yiqiang  OuYang</span>, <span class="hlFld-ContribAuthor ">Chen  Chen</span>, <span class="hlFld-ContribAuthor ">Hui  Xia</span>, <span class="hlFld-ContribAuthor ">Linxiao  Wang</span>, <span class="hlFld-ContribAuthor ">Pengwu  Zheng</span>, <span class="hlFld-ContribAuthor ">Wufu  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, biological evaluation and docking studies of novel 2-substituted-4-morpholino-7,8-dihydro-5 H -thiopyrano[4,3- d ]pyrimidine derivatives as dual PI3Kα/mTOR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>116 </em>, 27-35. <a href="https://doi.org/10.1016/j.ejmech.2016.03.033" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.03.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.03.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.03.033%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Bbiological%252Bevaluation%252Band%252Bdocking%252Bstudies%252Bof%252Bnovel%252B2-substituted-4-morpholino-7%25252C8-dihydro-5%252BH%252B-thiopyrano%25255B4%25252C3-%252Bd%252B%25255Dpyrimidine%252Bderivatives%252Bas%252Bdual%252BPI3K%2525CE%2525B1%25252FmTOR%252Binhibitors%26aulast%3DLei%26aufirst%3DFei%26date%3D2016%26volume%3D116%26spage%3D27%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takako  Takeda</span>, <span class="hlFld-ContribAuthor ">Yanli  Wang</span>, <span class="hlFld-ContribAuthor ">Stephen H.  Bryant</span>. </span><span class="cited-content_cbyCitation_article-title">Structural insights of a PI3K/mTOR dual inhibitor with the morpholino-triazine scaffold. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computer-Aided Molecular Design</span><span> <strong>2016,</strong> <em>30 </em>
                                    (4)
                                     , 323-330. <a href="https://doi.org/10.1007/s10822-016-9905-4" title="DOI URL">https://doi.org/10.1007/s10822-016-9905-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10822-016-9905-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10822-016-9905-4%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computer-Aided%2520Molecular%2520Design%26atitle%3DStructural%252Binsights%252Bof%252Ba%252BPI3K%25252FmTOR%252Bdual%252Binhibitor%252Bwith%252Bthe%252Bmorpholino-triazine%252Bscaffold%26aulast%3DTakeda%26aufirst%3DTakako%26date%3D2016%26date%3D2016%26volume%3D30%26issue%3D4%26spage%3D323%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying  Chen</span>, <span class="hlFld-ContribAuthor ">Ling  Zhang</span>, <span class="hlFld-ContribAuthor ">Chao  Yang</span>, <span class="hlFld-ContribAuthor ">Jinsong  Han</span>, <span class="hlFld-ContribAuthor ">Chongqing  Wang</span>, <span class="hlFld-ContribAuthor ">Canhui  Zheng</span>, <span class="hlFld-ContribAuthor ">Youjun  Zhou</span>, <span class="hlFld-ContribAuthor ">Jiaguo  Lv</span>, <span class="hlFld-ContribAuthor ">Yunlong  Song</span>, <span class="hlFld-ContribAuthor ">Ju  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of benzenesulfonamide derivatives as potent PI3K/mTOR dual inhibitors with in vivo efficacies against hepatocellular carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (5)
                                     , 957-966. <a href="https://doi.org/10.1016/j.bmc.2016.01.008" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.01.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.01.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.01.008%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bbenzenesulfonamide%252Bderivatives%252Bas%252Bpotent%252BPI3K%25252FmTOR%252Bdual%252Binhibitors%252Bwith%252Bin%252Bvivo%252Befficacies%252Bagainst%252Bhepatocellular%252Bcarcinoma%26aulast%3DChen%26aufirst%3DYing%26date%3D2016%26volume%3D24%26issue%3D5%26spage%3D957%26epage%3D966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weipeng  Xiong</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Matheson</span>, <span class="hlFld-ContribAuthor ">Mei  Xu</span>, <span class="hlFld-ContribAuthor ">Donald S.  Backos</span>, <span class="hlFld-ContribAuthor ">Taylor S.  Mills</span>, <span class="hlFld-ContribAuthor ">Smita  Salian-Mehta</span>, <span class="hlFld-ContribAuthor ">Katja  Kiseljak-Vassiliades</span>, <span class="hlFld-ContribAuthor ">Philip  Reigan</span>, <span class="hlFld-ContribAuthor ">Margaret E.  Wierman</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Screen Identification of a Mammalian Ste20-like Kinase 4 (MST4) Inhibitor with Therapeutic Potential for Pituitary Tumors. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2016,</strong> <em>15 </em>
                                    (3)
                                     , 412-420. <a href="https://doi.org/10.1158/1535-7163.MCT-15-0703" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-15-0703</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-15-0703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-15-0703%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DStructure-Based%252BScreen%252BIdentification%252Bof%252Ba%252BMammalian%252BSte20-like%252BKinase%252B4%252B%252528MST4%252529%252BInhibitor%252Bwith%252BTherapeutic%252BPotential%252Bfor%252BPituitary%252BTumors%26aulast%3DXiong%26aufirst%3DWeipeng%26date%3D2016%26date%3D2015%26volume%3D15%26issue%3D3%26spage%3D412%26epage%3D420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sai-Jie  Zuo</span>, <span class="hlFld-ContribAuthor ">Sai  Zhang</span>, <span class="hlFld-ContribAuthor ">Shuai  Mao</span>, <span class="hlFld-ContribAuthor ">Xiao-Xiao  Xie</span>, <span class="hlFld-ContribAuthor ">Xue  Xiao</span>, <span class="hlFld-ContribAuthor ">Min-Hnag  Xin</span>, <span class="hlFld-ContribAuthor ">Wei  Xuan</span>, <span class="hlFld-ContribAuthor ">Yuan-Yuan  He</span>, <span class="hlFld-ContribAuthor ">Yong-Xiao  Cao</span>, <span class="hlFld-ContribAuthor ">San-Qi  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Combination of 4-anilinoquinazoline, arylurea and tertiary amine moiety to discover novel anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (2)
                                     , 179-190. <a href="https://doi.org/10.1016/j.bmc.2015.12.001" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.12.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.12.001%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DCombination%252Bof%252B4-anilinoquinazoline%25252C%252Barylurea%252Band%252Btertiary%252Bamine%252Bmoiety%252Bto%252Bdiscover%252Bnovel%252Banticancer%252Bagents%26aulast%3DZuo%26aufirst%3DSai-Jie%26date%3D2016%26volume%3D24%26issue%3D2%26spage%3D179%26epage%3D190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao-Dong  Ma</span>, <span class="hlFld-ContribAuthor ">Ni  Qiu</span>, <span class="hlFld-ContribAuthor ">Bo  Yang</span>, <span class="hlFld-ContribAuthor ">Qiao-Jun  He</span>, <span class="hlFld-ContribAuthor ">Yong-Zhou  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Novel quinoline-derived mTOR inhibitors with remarkable enzymatic and cellular activities: design, synthesis and biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2016,</strong> <em>7 </em>
                                    (2)
                                     , 297-310. <a href="https://doi.org/10.1039/C5MD00401B" title="DOI URL">https://doi.org/10.1039/C5MD00401B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5MD00401B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5MD00401B%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DNovel%252Bquinoline-derived%252BmTOR%252Binhibitors%252Bwith%252Bremarkable%252Benzymatic%252Band%252Bcellular%252Bactivities%25253A%252Bdesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%26aulast%3DMa%26aufirst%3DXiao-Dong%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D2%26spage%3D297%26epage%3D310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">G. Jagadeesh  Kumar</span>, <span class="hlFld-ContribAuthor ">S. Naveen  Kumar</span>, <span class="hlFld-ContribAuthor ">Dinesh  Thummuri</span>, <span class="hlFld-ContribAuthor ">Lavanya Bindu Sree  Adari</span>, <span class="hlFld-ContribAuthor ">V. G. M.  Naidu</span>, <span class="hlFld-ContribAuthor ">Kolupula  Srinivas</span>, <span class="hlFld-ContribAuthor ">V. Jayathirtha  Rao</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and characterization of new s-triazine bearing benzimidazole and benzothiazole derivatives as anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2015,</strong> <em>24 </em>
                                    (12)
                                     , 3991-4001. <a href="https://doi.org/10.1007/s00044-015-1430-9" title="DOI URL">https://doi.org/10.1007/s00044-015-1430-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-015-1430-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-015-1430-9%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DSynthesis%252Band%252Bcharacterization%252Bof%252Bnew%252Bs-triazine%252Bbearing%252Bbenzimidazole%252Band%252Bbenzothiazole%252Bderivatives%252Bas%252Banticancer%252Bagents%26aulast%3DKumar%26aufirst%3DG.%2BJagadeesh%26date%3D2015%26date%3D2015%26volume%3D24%26issue%3D12%26spage%3D3991%26epage%3D4001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohd Rehan</span>. </span><span class="cited-content_cbyCitation_article-title">A structural insight into the inhibitory mechanism of an orally active PI3K/mTOR dual inhibitor, PKI-179 using computational approaches. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2015,</strong> <em>62 </em>, 226-234. <a href="https://doi.org/10.1016/j.jmgm.2015.10.005" title="DOI URL">https://doi.org/10.1016/j.jmgm.2015.10.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2015.10.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2015.10.005%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DA%252Bstructural%252Binsight%252Binto%252Bthe%252Binhibitory%252Bmechanism%252Bof%252Ban%252Borally%252Bactive%252BPI3K%25252FmTOR%252Bdual%252Binhibitor%25252C%252BPKI-179%252Busing%252Bcomputational%252Bapproaches%26aulast%3DMohd%2BRehan%26date%3D2015%26volume%3D62%26spage%3D226%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jia-Lin  Guo</span>, <span class="hlFld-ContribAuthor ">Yun-Yong  Liu</span>, <span class="hlFld-ContribAuthor ">Ya-Zhong  Pei</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of 3-(piperidin-4-yl)isoxazolo[4,5-d]pyrimidine derivatives as novel PI3Kδ inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chinese Chemical Letters</span><span> <strong>2015,</strong> <em>26 </em>
                                    (10)
                                     , 1283-1288. <a href="https://doi.org/10.1016/j.cclet.2015.05.041" title="DOI URL">https://doi.org/10.1016/j.cclet.2015.05.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cclet.2015.05.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cclet.2015.05.041%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Chemical%2520Letters%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B3-%252528piperidin-4-yl%252529isoxazolo%25255B4%25252C5-d%25255Dpyrimidine%252Bderivatives%252Bas%252Bnovel%252BPI3K%2525CE%2525B4%252Binhibitors%26aulast%3DGuo%26aufirst%3DJia-Lin%26date%3D2015%26volume%3D26%26issue%3D10%26spage%3D1283%26epage%3D1288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Prinka  Singla</span>, <span class="hlFld-ContribAuthor ">Vijay  Luxami</span>, <span class="hlFld-ContribAuthor ">Kamaldeep  Paul</span>. </span><span class="cited-content_cbyCitation_article-title">Triazine as a promising scaffold for its versatile biological behavior. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>102 </em>, 39-57. <a href="https://doi.org/10.1016/j.ejmech.2015.07.037" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.07.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.07.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.07.037%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTriazine%252Bas%252Ba%252Bpromising%252Bscaffold%252Bfor%252Bits%252Bversatile%252Bbiological%252Bbehavior%26aulast%3DSingla%26aufirst%3DPrinka%26date%3D2015%26volume%3D102%26spage%3D39%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Suresh  Mohan</span>, <span class="hlFld-ContribAuthor ">Robert  Vander Broek</span>, <span class="hlFld-ContribAuthor ">Sujay  Shah</span>, <span class="hlFld-ContribAuthor ">Danielle F.  Eytan</span>, <span class="hlFld-ContribAuthor ">Matthew L.  Pierce</span>, <span class="hlFld-ContribAuthor ">Sophie G.  Carlson</span>, <span class="hlFld-ContribAuthor ">Jamie F.  Coupar</span>, <span class="hlFld-ContribAuthor ">Jialing  Zhang</span>, <span class="hlFld-ContribAuthor ">Hui  Cheng</span>, <span class="hlFld-ContribAuthor ">Zhong  Chen</span>, <span class="hlFld-ContribAuthor ">Carter  Van Waes</span>. </span><span class="cited-content_cbyCitation_article-title">MEK Inhibitor PD-0325901 Overcomes Resistance to PI3K/mTOR Inhibitor PF-5212384 and Potentiates Antitumor Effects in Human Head and Neck Squamous Cell Carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Clinical Cancer Research</span><span> <strong>2015,</strong> <em>21 </em>
                                    (17)
                                     , 3946-3956. <a href="https://doi.org/10.1158/1078-0432.CCR-14-3377" title="DOI URL">https://doi.org/10.1158/1078-0432.CCR-14-3377</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1078-0432.CCR-14-3377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1078-0432.CCR-14-3377%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Cancer%2520Research%26atitle%3DMEK%252BInhibitor%252BPD-0325901%252BOvercomes%252BResistance%252Bto%252BPI3K%25252FmTOR%252BInhibitor%252BPF-5212384%252Band%252BPotentiates%252BAntitumor%252BEffects%252Bin%252BHuman%252BHead%252Band%252BNeck%252BSquamous%252BCell%252BCarcinoma%26aulast%3DMohan%26aufirst%3DSuresh%26date%3D2015%26date%3D2015%26volume%3D21%26issue%3D17%26spage%3D3946%26epage%3D3956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew J.  Leiker</span>, <span class="hlFld-ContribAuthor ">William  DeGraff</span>, <span class="hlFld-ContribAuthor ">Rajani  Choudhuri</span>, <span class="hlFld-ContribAuthor ">Anastasia L.  Sowers</span>, <span class="hlFld-ContribAuthor ">Angela  Thetford</span>, <span class="hlFld-ContribAuthor ">John A.  Cook</span>, <span class="hlFld-ContribAuthor ">Carter  Van Waes</span>, <span class="hlFld-ContribAuthor ">James B.  Mitchell</span>. </span><span class="cited-content_cbyCitation_article-title">Radiation Enhancement of Head and Neck Squamous Cell Carcinoma by the Dual PI3K/mTOR Inhibitor PF-05212384. </span><span class="cited-content_cbyCitation_journal-name">Clinical Cancer Research</span><span> <strong>2015,</strong> <em>21 </em>
                                    (12)
                                     , 2792-2801. <a href="https://doi.org/10.1158/1078-0432.CCR-14-3279" title="DOI URL">https://doi.org/10.1158/1078-0432.CCR-14-3279</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1078-0432.CCR-14-3279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1078-0432.CCR-14-3279%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Cancer%2520Research%26atitle%3DRadiation%252BEnhancement%252Bof%252BHead%252Band%252BNeck%252BSquamous%252BCell%252BCarcinoma%252Bby%252Bthe%252BDual%252BPI3K%25252FmTOR%252BInhibitor%252BPF-05212384%26aulast%3DLeiker%26aufirst%3DAndrew%2BJ.%26date%3D2015%26date%3D2015%26volume%3D21%26issue%3D12%26spage%3D2792%26epage%3D2801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoqing  Lv</span>, <span class="hlFld-ContribAuthor ">Huazhou  Ying</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Ma</span>, <span class="hlFld-ContribAuthor ">Ni  Qiu</span>, <span class="hlFld-ContribAuthor ">Peng  Wu</span>, <span class="hlFld-ContribAuthor ">Bo  Yang</span>, <span class="hlFld-ContribAuthor ">Yongzhou  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel 4-alkynyl-quinoline derivatives as PI3K/mTOR dual inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>99 </em>, 36-50. <a href="https://doi.org/10.1016/j.ejmech.2015.05.025" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.05.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.05.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.05.025%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252B4-alkynyl-quinoline%252Bderivatives%252Bas%252BPI3K%25252FmTOR%252Bdual%252Binhibitors%26aulast%3DLv%26aufirst%3DXiaoqing%26date%3D2015%26volume%3D99%26spage%3D36%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zebo  Huang</span>, <span class="hlFld-ContribAuthor ">Yinxia  Wu</span>, <span class="hlFld-ContribAuthor ">Xin  Zhou</span>, <span class="hlFld-ContribAuthor ">Jiaqi  Qian</span>, <span class="hlFld-ContribAuthor ">Wei  Zhu</span>, <span class="hlFld-ContribAuthor ">Yongqian  Shu</span>, <span class="hlFld-ContribAuthor ">Ping  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Clinical efficacy of mTOR inhibitors in solid tumors: a systematic review. </span><span class="cited-content_cbyCitation_journal-name">Future Oncology</span><span> <strong>2015,</strong> <em>11 </em>
                                    (11)
                                     , 1687-1699. <a href="https://doi.org/10.2217/fon.15.70" title="DOI URL">https://doi.org/10.2217/fon.15.70</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/fon.15.70&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Ffon.15.70%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Oncology%26atitle%3DClinical%252Befficacy%252Bof%252BmTOR%252Binhibitors%252Bin%252Bsolid%252Btumors%25253A%252Ba%252Bsystematic%252Breview%26aulast%3DHuang%26aufirst%3DZebo%26date%3D2015%26volume%3D11%26issue%3D11%26spage%3D1687%26epage%3D1699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao-Meng  Wang</span>, <span class="hlFld-ContribAuthor ">Min-Hang  Xin</span>, <span class="hlFld-ContribAuthor ">Jing  Xu</span>, <span class="hlFld-ContribAuthor ">Bo-Rui  Kang</span>, <span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">She-Min  Lu</span>, <span class="hlFld-ContribAuthor ">San-Qi  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and antitumor activities evaluation of m-(4-morpholinoquinazolin-2-yl)benzamides in vitro and in vivo. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>96 </em>, 382-395. <a href="https://doi.org/10.1016/j.ejmech.2015.04.037" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.04.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.04.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.04.037%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bantitumor%252Bactivities%252Bevaluation%252Bof%252Bm-%2525284-morpholinoquinazolin-2-yl%252529benzamides%252Bin%2525C2%2525A0vitro%252Band%252Bin%2525C2%2525A0vivo%26aulast%3DWang%26aufirst%3DXiao-Meng%26date%3D2015%26volume%3D96%26spage%3D382%26epage%3D395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heloisa P.  Soares</span>, <span class="hlFld-ContribAuthor ">Ming  Ming</span>, <span class="hlFld-ContribAuthor ">Michelle  Mellon</span>, <span class="hlFld-ContribAuthor ">Steven H.  Young</span>, <span class="hlFld-ContribAuthor ">Liang  Han</span>, <span class="hlFld-ContribAuthor ">James  Sinnet-Smith</span>, <span class="hlFld-ContribAuthor ">Enrique  Rozengurt</span>. </span><span class="cited-content_cbyCitation_article-title">Dual PI3K/mTOR Inhibitors Induce Rapid Overactivation of the MEK/ERK Pathway in Human Pancreatic Cancer Cells through Suppression of mTORC2. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2015,</strong> <em>14 </em>
                                    (4)
                                     , 1014-1023. <a href="https://doi.org/10.1158/1535-7163.MCT-14-0669" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-14-0669</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-14-0669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-14-0669%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DDual%252BPI3K%25252FmTOR%252BInhibitors%252BInduce%252BRapid%252BOveractivation%252Bof%252Bthe%252BMEK%25252FERK%252BPathway%252Bin%252BHuman%252BPancreatic%252BCancer%252BCells%252Bthrough%252BSuppression%252Bof%252BmTORC2%26aulast%3DSoares%26aufirst%3DHeloisa%2BP.%26date%3D2015%26date%3D2015%26volume%3D14%26issue%3D4%26spage%3D1014%26epage%3D1023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pierfausto  Seneci</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Unselective Autophagy of Cellular Aggregates. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 95-133. <a href="https://doi.org/10.1016/B978-0-12-801944-3.00004-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-801944-3.00004-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-801944-3.00004-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-801944-3.00004-7%26sid%3Dliteratum%253Aachs%26atitle%3DTargeting%252BUnselective%252BAutophagy%252Bof%252BCellular%252BAggregates%26aulast%3DSeneci%26aufirst%3DPierfausto%26date%3D2015%26spage%3D95%26epage%3D133%26pub%3DElsevier%26atitle%3DChemical%252BModulators%252Bof%252BProtein%252BMisfolding%252Band%252BNeurodegenerative%252BDisease%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guo-Rui  Gao</span>, <span class="hlFld-ContribAuthor ">Jia-Li  Liu</span>, <span class="hlFld-ContribAuthor ">De-Sheng  Mei</span>, <span class="hlFld-ContribAuthor ">Jian  Ding</span>, <span class="hlFld-ContribAuthor ">Ling-Hua  Meng</span>, <span class="hlFld-ContribAuthor ">Wen-Hu  Duan</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of acylhydrazone derivatives as PI3K inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chinese Chemical Letters</span><span> <strong>2015,</strong> <em>26 </em>
                                    (1)
                                     , 118-120. <a href="https://doi.org/10.1016/j.cclet.2014.10.016" title="DOI URL">https://doi.org/10.1016/j.cclet.2014.10.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cclet.2014.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cclet.2014.10.016%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Chemical%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bacylhydrazone%252Bderivatives%252Bas%252BPI3K%252Binhibitors%26aulast%3DGao%26aufirst%3DGuo-Rui%26date%3D2015%26volume%3D26%26issue%3D1%26spage%3D118%26epage%3D120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lucia  Lisi</span>, <span class="hlFld-ContribAuthor ">Paola  Aceto</span>, <span class="hlFld-ContribAuthor ">Pierluigi  Navarra</span>, <span class="hlFld-ContribAuthor ">Cinzia  Dello Russo</span>. </span><span class="cited-content_cbyCitation_article-title">mTOR Kinase: A Possible Pharmacological Target in the Management of Chronic Pain. </span><span class="cited-content_cbyCitation_journal-name">BioMed Research International</span><span> <strong>2015,</strong> <em>2015 </em>, 1-13. <a href="https://doi.org/10.1155/2015/394257" title="DOI URL">https://doi.org/10.1155/2015/394257</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2015/394257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2015%2F394257%26sid%3Dliteratum%253Aachs%26jtitle%3DBioMed%2520Research%2520International%26atitle%3DmTOR%252BKinase%25253A%252BA%252BPossible%252BPharmacological%252BTarget%252Bin%252Bthe%252BManagement%252Bof%252BChronic%252BPain%26aulast%3DLisi%26aufirst%3DLucia%26date%3D2015%26volume%3D2015%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaodong  Zhao</span>, <span class="hlFld-ContribAuthor ">Qiu  Tan</span>, <span class="hlFld-ContribAuthor ">Zhitao  Zhang</span>, <span class="hlFld-ContribAuthor ">Yu  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">1,3,5-Triazine inhibitors of histone deacetylases: synthesis and biological activity. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2014,</strong> <em>23 </em>
                                    (12)
                                     , 5188-5196. <a href="https://doi.org/10.1007/s00044-014-1084-z" title="DOI URL">https://doi.org/10.1007/s00044-014-1084-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-014-1084-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-014-1084-z%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3D1%25252C3%25252C5-Triazine%252Binhibitors%252Bof%252Bhistone%252Bdeacetylases%25253A%252Bsynthesis%252Band%252Bbiological%252Bactivity%26aulast%3DZhao%26aufirst%3DXiaodong%26date%3D2014%26date%3D2014%26volume%3D23%26issue%3D12%26spage%3D5188%26epage%3D5196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fangbin  Han</span>, <span class="hlFld-ContribAuthor ">Songwen  Lin</span>, <span class="hlFld-ContribAuthor ">Peng  Liu</span>, <span class="hlFld-ContribAuthor ">Jing  Tao</span>, <span class="hlFld-ContribAuthor ">Chongqin  Yi</span>, <span class="hlFld-ContribAuthor ">Heng  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and structure–activity relationships of PI3K/mTOR dual inhibitors from a series of 2-amino-4-methylpyrido[2,3- d ]pyrimidine derivatives. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (18)
                                     , 4538-4541. <a href="https://doi.org/10.1016/j.bmcl.2014.07.073" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.07.073</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.07.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.07.073%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bstructure%2525E2%252580%252593activity%252Brelationships%252Bof%252BPI3K%25252FmTOR%252Bdual%252Binhibitors%252Bfrom%252Ba%252Bseries%252Bof%252B2-amino-4-methylpyrido%25255B2%25252C3-%252Bd%252B%25255Dpyrimidine%252Bderivatives%26aulast%3DHan%26aufirst%3DFangbin%26date%3D2014%26volume%3D24%26issue%3D18%26spage%3D4538%26epage%3D4541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kelly  Brooks</span>, <span class="hlFld-ContribAuthor ">Max  Ranall</span>, <span class="hlFld-ContribAuthor ">Loredana  Spoerri</span>, <span class="hlFld-ContribAuthor ">Alex  Stevenson</span>, <span class="hlFld-ContribAuthor ">Gency  Gunasingh</span>, <span class="hlFld-ContribAuthor ">Sandra  Pavey</span>, <span class="hlFld-ContribAuthor ">Fred  Meunier</span>, <span class="hlFld-ContribAuthor ">Thomas J.  Gonda</span>, <span class="hlFld-ContribAuthor ">Brian  Gabrielli</span>. </span><span class="cited-content_cbyCitation_article-title">Decatenation checkpoint-defective melanomas are dependent on PI3K for survival. </span><span class="cited-content_cbyCitation_journal-name">Pigment Cell & Melanoma Research</span><span> <strong>2014,</strong> <em>27 </em>
                                    (5)
                                     , 813-821. <a href="https://doi.org/10.1111/pcmr.12268" title="DOI URL">https://doi.org/10.1111/pcmr.12268</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/pcmr.12268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fpcmr.12268%26sid%3Dliteratum%253Aachs%26jtitle%3DPigment%2520Cell%2520%2526%2520Melanoma%2520Research%26atitle%3DDecatenation%252Bcheckpoint-defective%252Bmelanomas%252Bare%252Bdependent%252Bon%252BPI3K%252Bfor%252Bsurvival%26aulast%3DBrooks%26aufirst%3DKelly%26date%3D2014%26date%3D2014%26volume%3D27%26issue%3D5%26spage%3D813%26epage%3D821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chen  Chen</span>, <span class="hlFld-ContribAuthor ">Cheng Yu  Sun</span>, <span class="hlFld-ContribAuthor ">Shan  Xu</span>, <span class="hlFld-ContribAuthor ">Yuan Biao  Tu</span>, <span class="hlFld-ContribAuthor ">Peng Wu  Zheng</span>, <span class="hlFld-ContribAuthor ">Wu Fu  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of One Novel Thieno[2,3-D]Pyrimidine Derivative Bearing a Sulfonylurea Moiety. </span><span class="cited-content_cbyCitation_journal-name">Advanced Materials Research</span><span> <strong>2014,</strong> <em>1015 </em>, 577-580. <a href="https://doi.org/10.4028/www.scientific.net/AMR.1015.577" title="DOI URL">https://doi.org/10.4028/www.scientific.net/AMR.1015.577</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4028/www.scientific.net/AMR.1015.577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4028%2Fwww.scientific.net%2FAMR.1015.577%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Materials%2520Research%26atitle%3DSynthesis%252Bof%252BOne%252BNovel%252BThieno%25255B2%25252C3-D%25255DPyrimidine%252BDerivative%252BBearing%252Ba%252BSulfonylurea%252BMoiety%26aulast%3DChen%26aufirst%3DChen%26date%3D2014%26date%3D2014%26volume%3D1015%26spage%3D577%26epage%3D580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hai-Jing  Zhong</span>, <span class="hlFld-ContribAuthor ">Ka-Ho  Leung</span>, <span class="hlFld-ContribAuthor ">Li-Juan  Liu</span>, <span class="hlFld-ContribAuthor ">Lihua  Lu</span>, <span class="hlFld-ContribAuthor ">Daniel Shiu-Hin  Chan</span>, <span class="hlFld-ContribAuthor ">Chung-Hang  Leung</span>, <span class="hlFld-ContribAuthor ">Dik-Lung  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Antagonism of mTOR Activity by a Kinetically Inert Rhodium(III) Complex. </span><span class="cited-content_cbyCitation_journal-name">ChemPlusChem</span><span> <strong>2014,</strong> <em>79 </em>
                                    (4)
                                     , 508-511. <a href="https://doi.org/10.1002/cplu.201400014" title="DOI URL">https://doi.org/10.1002/cplu.201400014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cplu.201400014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcplu.201400014%26sid%3Dliteratum%253Aachs%26jtitle%3DChemPlusChem%26atitle%3DAntagonism%252Bof%252BmTOR%252BActivity%252Bby%252Ba%252BKinetically%252BInert%252BRhodium%252528III%252529%252BComplex%26aulast%3DZhong%26aufirst%3DHai-Jing%26date%3D2014%26date%3D2014%26volume%3D79%26issue%3D4%26spage%3D508%26epage%3D511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Teng  Shao</span>, <span class="hlFld-ContribAuthor ">Juan  Wang</span>, <span class="hlFld-ContribAuthor ">Jian-Gang  Chen</span>, <span class="hlFld-ContribAuthor ">Xiao-Meng  Wang</span>, <span class="hlFld-ContribAuthor ">Huan  Li</span>, <span class="hlFld-ContribAuthor ">Yi-Ping  Li</span>, <span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">Guang-De  Yang</span>, <span class="hlFld-ContribAuthor ">Qi-Bing  Mei</span>, <span class="hlFld-ContribAuthor ">San-Qi  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 2-methoxy-3-phenylsulfonamino-5-(quinazolin-6-yl or quinolin-6-yl)benzamides as novel PI3K inhibitors and anticancer agents by bioisostere. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>75 </em>, 96-105. <a href="https://doi.org/10.1016/j.ejmech.2014.01.053" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.01.053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.01.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.01.053%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B2-methoxy-3-phenylsulfonamino-5-%252528quinazolin-6-yl%252Bor%252Bquinolin-6-yl%252529benzamides%252Bas%252Bnovel%252BPI3K%252Binhibitors%252Band%252Banticancer%252Bagents%252Bby%252Bbioisostere%26aulast%3DShao%26aufirst%3DTeng%26date%3D2014%26volume%3D75%26spage%3D96%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amparo  Ruiz-Carretero</span>, <span class="hlFld-ContribAuthor ">José Ramón  Ramírez</span>, <span class="hlFld-ContribAuthor ">Ana  Sánchez-Migallón</span>, <span class="hlFld-ContribAuthor ">Antonio  de la Hoz</span>. </span><span class="cited-content_cbyCitation_article-title">Microwave-assisted selective and efficient synthesis of 1,3,5-triazinyl mono and bisureas. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2014,</strong> <em>70 </em>
                                    (9)
                                     , 1733-1739. <a href="https://doi.org/10.1016/j.tet.2014.01.043" title="DOI URL">https://doi.org/10.1016/j.tet.2014.01.043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2014.01.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2014.01.043%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DMicrowave-assisted%252Bselective%252Band%252Befficient%252Bsynthesis%252Bof%252B1%25252C3%25252C5-triazinyl%252Bmono%252Band%252Bbisureas%26aulast%3DRuiz-Carretero%26aufirst%3DAmparo%26date%3D2014%26volume%3D70%26issue%3D9%26spage%3D1733%26epage%3D1739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dhruvin R  Shah</span>, <span class="hlFld-ContribAuthor ">Rahul P  Modh</span>, <span class="hlFld-ContribAuthor ">Kishor H  Chikhalia</span>. </span><span class="cited-content_cbyCitation_article-title">Privileged
              s
              -triazines: structure and pharmacological applications. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2014,</strong> <em>6 </em>
                                    (4)
                                     , 463-477. <a href="https://doi.org/10.4155/fmc.13.212" title="DOI URL">https://doi.org/10.4155/fmc.13.212</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.13.212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.13.212%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DPrivileged%252Bs%252B-triazines%25253A%252Bstructure%252Band%252Bpharmacological%252Bapplications%26aulast%3DShah%26aufirst%3DDhruvin%2BR%26date%3D2014%26volume%3D6%26issue%3D4%26spage%3D463%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Songwen  Lin</span>, <span class="hlFld-ContribAuthor ">Fangbin  Han</span>, <span class="hlFld-ContribAuthor ">Peng  Liu</span>, <span class="hlFld-ContribAuthor ">Jing  Tao</span>, <span class="hlFld-ContribAuthor ">Xuechao  Zhong</span>, <span class="hlFld-ContribAuthor ">Xiujie  Liu</span>, <span class="hlFld-ContribAuthor ">Chongqin  Yi</span>, <span class="hlFld-ContribAuthor ">Heng  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of novel 7-amino-5-methyl-1,6-naphthyridin-2(1H)-one derivatives as potent PI3K/mTOR dual inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (3)
                                     , 790-793. <a href="https://doi.org/10.1016/j.bmcl.2013.12.112" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.12.112</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.12.112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.12.112%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252Bnovel%252B7-amino-5-methyl-1%25252C6-naphthyridin-2%2525281H%252529-one%252Bderivatives%252Bas%252Bpotent%252BPI3K%25252FmTOR%252Bdual%252Binhibitors%26aulast%3DLin%26aufirst%3DSongwen%26date%3D2014%26volume%3D24%26issue%3D3%26spage%3D790%26epage%3D793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William A.  Denny</span>, <span class="hlFld-ContribAuthor ">Gordon W.  Rewcastle</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitors of the Phosphatidylinositol 3-Kinase Pathway. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 449-478. <a href="https://doi.org/10.1016/B978-0-12-396521-9.00015-2" title="DOI URL">https://doi.org/10.1016/B978-0-12-396521-9.00015-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-396521-9.00015-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-396521-9.00015-2%26sid%3Dliteratum%253Aachs%26atitle%3DInhibitors%252Bof%252Bthe%252BPhosphatidylinositol%252B3-Kinase%252BPathway%26aulast%3DDenny%26aufirst%3DWilliam%2BA.%26date%3D2014%26spage%3D449%26epage%3D478%26pub%3DElsevier%26atitle%3DCancer%252BDrug%252BDesign%252Band%252BDiscovery%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.  Mortlock</span>, <span class="hlFld-ContribAuthor ">K.  Foote</span>, <span class="hlFld-ContribAuthor ">J.  Kettle</span>, <span class="hlFld-ContribAuthor ">B.  Aquila</span>. </span><span class="cited-content_cbyCitation_article-title">Kinase Inhibitors in Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,<a href="https://doi.org/10.1016/B978-0-12-409547-2.11033-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.11033-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.11033-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.11033-9%26sid%3Dliteratum%253Aachs%26atitle%3DKinase%252BInhibitors%252Bin%252BCancer%26aulast%3DMortlock%26aufirst%3DA.%26date%3D2014%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2014%26volume%3D409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">MEI HONG  ZHANG</span>, <span class="hlFld-ContribAuthor ">HONG TAO  MAN</span>, <span class="hlFld-ContribAuthor ">XIAO DAN  ZHAO</span>, <span class="hlFld-ContribAuthor ">NI  DONG</span>, <span class="hlFld-ContribAuthor ">SHI LIANG  MA</span>. </span><span class="cited-content_cbyCitation_article-title">Estrogen receptor-positive breast cancer molecular signatures and therapeutic potentials (Review). </span><span class="cited-content_cbyCitation_journal-name">Biomedical Reports</span><span> <strong>2014,</strong> <em>2 </em>
                                    (1)
                                     , 41-52. <a href="https://doi.org/10.3892/br.2013.187" title="DOI URL">https://doi.org/10.3892/br.2013.187</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3892/br.2013.187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3892%2Fbr.2013.187%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedical%2520Reports%26atitle%3DEstrogen%252Breceptor-positive%252Bbreast%252Bcancer%252Bmolecular%252Bsignatures%252Band%252Btherapeutic%252Bpotentials%252B%252528Review%252529%26aulast%3DZHANG%26aufirst%3DMEI%2BHONG%26date%3D2014%26date%3D2013%26volume%3D2%26issue%3D1%26spage%3D41%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">G.  Jagadeesh Kumar</span>, <span class="hlFld-ContribAuthor ">H. V. S.  Sriramkumar Bomma</span>, <span class="hlFld-ContribAuthor ">E.  Srihari</span>, <span class="hlFld-ContribAuthor ">Shweta  Shrivastava</span>, <span class="hlFld-ContribAuthor ">V. G. M.  Naidu</span>, <span class="hlFld-ContribAuthor ">Kolupula  Srinivas</span>, <span class="hlFld-ContribAuthor ">V.  Jayathirtha Rao</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and anticancer activity of some new s-triazine derivatives. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2013,</strong> <em>22 </em>
                                    (12)
                                     , 5973-5981. <a href="https://doi.org/10.1007/s00044-013-0584-6" title="DOI URL">https://doi.org/10.1007/s00044-013-0584-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-013-0584-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-013-0584-6%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DSynthesis%252Band%252Banticancer%252Bactivity%252Bof%252Bsome%252Bnew%252Bs-triazine%252Bderivatives%26aulast%3DJagadeesh%2BKumar%26aufirst%3DG.%26date%3D2013%26date%3D2013%26volume%3D22%26issue%3D12%26spage%3D5973%26epage%3D5981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenjuan  Yang</span>, <span class="hlFld-ContribAuthor ">Mao  Shu</span>, <span class="hlFld-ContribAuthor ">Yuanqiang  Wang</span>, <span class="hlFld-ContribAuthor ">Rui  Wang</span>, <span class="hlFld-ContribAuthor ">Yong  Hu</span>, <span class="hlFld-ContribAuthor ">Lingxin  Meng</span>, <span class="hlFld-ContribAuthor ">Zhihua  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">3D-QSAR and docking studies of 3-Pyridine heterocyclic derivatives as potent PI3K/mTOR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2013,</strong> <em>1054-1055 </em>, 107-116. <a href="https://doi.org/10.1016/j.molstruc.2013.09.049" title="DOI URL">https://doi.org/10.1016/j.molstruc.2013.09.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2013.09.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2013.09.049%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3D3D-QSAR%252Band%252Bdocking%252Bstudies%252Bof%252B3-Pyridine%252Bheterocyclic%252Bderivatives%252Bas%252Bpotent%252BPI3K%25252FmTOR%252Binhibitors%26aulast%3DYang%26aufirst%3DWenjuan%26date%3D2013%26volume%3D1054-1055%26spage%3D107%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoqing  Lv</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Ma</span>, <span class="hlFld-ContribAuthor ">Yongzhou  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Furthering the design and the discovery of small molecule ATP-competitive mTOR inhibitors as an effective cancer treatment. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2013,</strong> <em>8 </em>
                                    (8)
                                     , 991-1012. <a href="https://doi.org/10.1517/17460441.2013.800479" title="DOI URL">https://doi.org/10.1517/17460441.2013.800479</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/17460441.2013.800479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F17460441.2013.800479%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DFurthering%252Bthe%252Bdesign%252Band%252Bthe%252Bdiscovery%252Bof%252Bsmall%252Bmolecule%252BATP-competitive%252BmTOR%252Binhibitors%252Bas%252Ban%252Beffective%252Bcancer%252Btreatment%26aulast%3DLv%26aufirst%3DXiaoqing%26date%3D2013%26date%3D2013%26volume%3D8%26issue%3D8%26spage%3D991%26epage%3D1012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gaetano  Santulli</span>, <span class="hlFld-ContribAuthor ">Hana  Totary-Jain</span>. </span><span class="cited-content_cbyCitation_article-title">Tailoring mTOR-based therapy: molecular evidence and clinical challenges. </span><span class="cited-content_cbyCitation_journal-name">Pharmacogenomics</span><span> <strong>2013,</strong> <em>14 </em>
                                    (12)
                                     , 1517-1526. <a href="https://doi.org/10.2217/pgs.13.143" title="DOI URL">https://doi.org/10.2217/pgs.13.143</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/pgs.13.143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Fpgs.13.143%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacogenomics%26atitle%3DTailoring%252BmTOR-based%252Btherapy%25253A%252Bmolecular%252Bevidence%252Band%252Bclinical%252Bchallenges%26aulast%3DSantulli%26aufirst%3DGaetano%26date%3D2013%26volume%3D14%26issue%3D12%26spage%3D1517%26epage%3D1526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Xuan</span>, <span class="hlFld-ContribAuthor ">Wen  Ding</span>, <span class="hlFld-ContribAuthor ">Hong-xiang  Hui</span>, <span class="hlFld-ContribAuthor ">San-qi  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and cytotoxic activity of diaryl urea derivatives with a 4-methylpiperazinylcarbonyl moiety. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2013,</strong> <em>22 </em>
                                    (8)
                                     , 3857-3862. <a href="https://doi.org/10.1007/s00044-012-0398-y" title="DOI URL">https://doi.org/10.1007/s00044-012-0398-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-012-0398-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-012-0398-y%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DSynthesis%252Band%252Bcytotoxic%252Bactivity%252Bof%252Bdiaryl%252Burea%252Bderivatives%252Bwith%252Ba%252B4-methylpiperazinylcarbonyl%252Bmoiety%26aulast%3DXuan%26aufirst%3DWei%26date%3D2013%26date%3D2012%26volume%3D22%26issue%3D8%26spage%3D3857%26epage%3D3862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark E.  Welker</span>, <span class="hlFld-ContribAuthor ">George  Kulik</span>. </span><span class="cited-content_cbyCitation_article-title">Recent syntheses of PI3K/Akt/mTOR signaling pathway inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (14)
                                     , 4063-4091. <a href="https://doi.org/10.1016/j.bmc.2013.04.083" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.04.083</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.04.083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.04.083%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Bsyntheses%252Bof%252BPI3K%25252FAkt%25252FmTOR%252Bsignaling%252Bpathway%252Binhibitors%26aulast%3DWelker%26aufirst%3DMark%2BE.%26date%3D2013%26volume%3D21%26issue%3D14%26spage%3D4063%26epage%3D4091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William A  Denny</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphoinositide 3-kinase α inhibitors: a patent review. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2013,</strong> <em>23 </em>
                                    (7)
                                     , 789-799. <a href="https://doi.org/10.1517/13543776.2013.779673" title="DOI URL">https://doi.org/10.1517/13543776.2013.779673</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2013.779673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2013.779673%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DPhosphoinositide%252B3-kinase%252B%2525CE%2525B1%252Binhibitors%25253A%252Ba%252Bpatent%252Breview%26aulast%3DDenny%26aufirst%3DWilliam%2BA%26date%3D2013%26date%3D2013%26volume%3D23%26issue%3D7%26spage%3D789%26epage%3D799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brent A.  McLean</span>, <span class="hlFld-ContribAuthor ">Pavel  Zhabyeyev</span>, <span class="hlFld-ContribAuthor ">Edith  Pituskin</span>, <span class="hlFld-ContribAuthor ">Ian  Paterson</span>, <span class="hlFld-ContribAuthor ">Mark J.  Haykowsky</span>, <span class="hlFld-ContribAuthor ">Gavin Y.  Oudit</span>. </span><span class="cited-content_cbyCitation_article-title">PI3K Inhibitors as Novel Cancer Therapies: Implications for Cardiovascular Medicine. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cardiac Failure</span><span> <strong>2013,</strong> <em>19 </em>
                                    (4)
                                     , 268-282. <a href="https://doi.org/10.1016/j.cardfail.2013.02.005" title="DOI URL">https://doi.org/10.1016/j.cardfail.2013.02.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cardfail.2013.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cardfail.2013.02.005%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cardiac%2520Failure%26atitle%3DPI3K%252BInhibitors%252Bas%252BNovel%252BCancer%252BTherapies%25253A%252BImplications%252Bfor%252BCardiovascular%252BMedicine%26aulast%3DMcLean%26aufirst%3DBrent%2BA.%26date%3D2013%26volume%3D19%26issue%3D4%26spage%3D268%26epage%3D282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amit B.  Patel</span>, <span class="hlFld-ContribAuthor ">Rahul V.  Patel</span>, <span class="hlFld-ContribAuthor ">Premlata  Kumari</span>, <span class="hlFld-ContribAuthor ">Dhanji P.  Rajani</span>, <span class="hlFld-ContribAuthor ">Kishor H.  Chikhalia</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of potential antitubercular and antimicrobial s-triazine-based scaffolds via Suzuki cross-coupling reaction. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2013,</strong> <em>22 </em>
                                    (1)
                                     , 367-381. <a href="https://doi.org/10.1007/s00044-012-0041-y" title="DOI URL">https://doi.org/10.1007/s00044-012-0041-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-012-0041-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-012-0041-y%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DSynthesis%252Bof%252Bpotential%252Bantitubercular%252Band%252Bantimicrobial%252Bs-triazine-based%252Bscaffolds%252Bvia%252BSuzuki%252Bcross-coupling%252Breaction%26aulast%3DPatel%26aufirst%3DAmit%2BB.%26date%3D2013%26date%3D2012%26volume%3D22%26issue%3D1%26spage%3D367%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jin-Fu  Dong</span>, <span class="hlFld-ContribAuthor ">Xin  Yu</span>, <span class="hlFld-ContribAuthor ">Cheng-Qing  Ning</span>, <span class="hlFld-ContribAuthor ">Liang  Hu</span>, <span class="hlFld-ContribAuthor ">Nie-Fang  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Selective mono-arylation in palladium-catalyzed cross-coupling reaction of dichlorotriazines with phenylboronate ester derivatives. </span><span class="cited-content_cbyCitation_journal-name">Chinese Chemical Letters</span><span> <strong>2013,</strong> <em>24 </em>
                                    (1)
                                     , 41-44. <a href="https://doi.org/10.1016/j.cclet.2012.12.004" title="DOI URL">https://doi.org/10.1016/j.cclet.2012.12.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cclet.2012.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cclet.2012.12.004%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Chemical%2520Letters%26atitle%3DSelective%252Bmono-arylation%252Bin%252Bpalladium-catalyzed%252Bcross-coupling%252Breaction%252Bof%252Bdichlorotriazines%252Bwith%252Bphenylboronate%252Bester%252Bderivatives%26aulast%3DDong%26aufirst%3DJin-Fu%26date%3D2013%26volume%3D24%26issue%3D1%26spage%3D41%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Fjm901830p&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Fjm901830p%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-6%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text&amp;citedByCount=121&amp;pagesCount=2&amp;pageNumber=-1" title="Load all citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="”true”" class="icon-angle-double-down"></i><span>Load all citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/medium/jm-2009-01830p_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/large/jm-2009-01830p_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901830p&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/medium/jm-2009-01830p_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/large/jm-2009-01830p_0010.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Previously known phosphatidylinositol-3-kinase inhibitors and selective mammalian target of rapamycin inhibitor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/large/jm-2009-01830p_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901830p&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/medium/jm-2009-01830p_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/large/jm-2009-01830p_0008.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Methods To Prepare <b>8</b>−<b>30</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/large/jm-2009-01830p_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901830p&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/medium/jm-2009-01830p_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/large/jm-2009-01830p_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Docking of compound <b>8</b> in PI3Kγ homology model. Hydrogen bonds are shown by blue dashes. The morpholine forms a hydrogen bond to the hinge region Val851. The urea forms three hydrogen bonds to Asp810 and Lys802. The critical salt bridge between the catalytic Lys802 and Asp805 is shown in purple.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/large/jm-2009-01830p_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901830p&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/medium/jm-2009-01830p_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/large/jm-2009-01830p_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Detailed of interactions of compound <b>9</b> with PI3K-α and mTOR: overlay of the homology models of PI3Kα (green ribbons and carbons) and mTOR (magenta ribbons and carbons) with the predicted binding mode of compound <b>9</b>. Conserved residues are Val851 (Val2240 in mTOR) and Lys802 (Lys2187) and are therefore only labeled. Several residue differences near the urea-R groups (in this case R = CH<sub>3</sub>) are Asp805-Glu2190, Gly804-His2189, and Asn803-Gly2188.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/large/jm-2009-01830p_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901830p&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/medium/jm-2009-01830p_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/large/jm-2009-01830p_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Surface representation of the ATP binding site around <b>26</b>, illustrating that substitutions coming off the urea extend into the solvent.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/large/jm-2009-01830p_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901830p&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/medium/jm-2009-01830p_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/large/jm-2009-01830p_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. In vitro phosphoblot studies. MDA-361 tumor line was exposed to <b>26</b> for 4 h.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/large/jm-2009-01830p_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901830p&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/medium/jm-2009-01830p_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/large/jm-2009-01830p_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Compound <b>26</b> in vivo biomarker profile at 25 mg/kg, iv, single dose. Tumor tissue from the MDA-361 xenograft model was examined for p-Akt suppression and induction of cleaved PARP at different time points. The p70 pS6K and pS6 panels show suppression of phosphorylation of these mTOR effector proteins.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/large/jm-2009-01830p_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901830p&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/medium/jm-2009-01830p_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/large/jm-2009-01830p_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Efficacy profile of compound <b>26</b> in MDA-361 xenograft model. Shown is the tumor regression caused by <b>26</b> at 20 mg/kg, iv, on days 1, 5, 9 and by paclitaxel (Taxol) at 60 mg/kg, ip (single dose). <i>Y</i> axis represents tumor volume in mm<sup>3</sup>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/large/jm-2009-01830p_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901830p&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/medium/jm-2009-01830p_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/large/jm-2009-01830p_0007.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Orthotopic model for compound <b>26</b> in H1975 (non-small-cell lung carcinoma). Compound <b>26</b> was given once weekly for 7 weeks at 25 mg/kg. The <i>Y</i> axis represents % survival (Kaplan−Meier plot).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901830p/production/images/large/jm-2009-01830p_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901830p&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i37">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85377" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85377" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 27 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Vivanco, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyers, C. L.</span><span> </span><span class="NLM_article-title">The phosphatidylinositol-3-kinase Akt pathway in human cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">489</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm901830p&amp;key=10.1038%2Fnrc839" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm901830p&amp;key=12094235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm901830p&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvFKltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=489-501&author=I.+Vivancoauthor=C.+L.+Sawyers&title=The+phosphatidylinositol-3-kinase+Akt+pathway+in+human+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">The phosphatidylinositol 3-Kinase-AKT pathway in human cancer</span></div><div class="casAuthors">Vivanco, Igor; Sawyers, Charles L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">489-501</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  One signal that is overactivated in a wide range of tumor types is the prodn. of a phospholipid, phosphatidylinositol (3,4,5) trisphosphate, by phosphatidylinositol 3-kinase (PI3K).  This lipid and the protein kinase that is activated by it, AKT, trigger a cascade of responses, from cell growth and proliferation to survival and motility, that drive tumor progression.  Small-mol. therapeutics that block PI3K signaling might deal a severe blow to cancer cells by blocking many aspects of the tumor-cell phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzAQ-0qeD7pLVg90H21EOLACvtfcHk0lhf3B5rs_t_3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkvFKltLs%253D&md5=c6762d32f9f1281632f4ccdbcd29268c</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1038%2Fnrc839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc839%26sid%3Dliteratum%253Aachs%26aulast%3DVivanco%26aufirst%3DI.%26aulast%3DSawyers%26aufirst%3DC.%2BL.%26atitle%3DThe%2520phosphatidylinositol-3-kinase%2520Akt%2520pathway%2520in%2520human%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D489%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J. J.</span><span> </span><span class="NLM_article-title">Targeting the phosphoinositide 3-kinase pathway in cancer</span> <span class="citation_source-journal">Nat. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">627</span><span class="NLM_x">–</span> <span class="NLM_lpage">644</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm901830p&amp;key=10.1038%2Fnrd2926" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm901830p&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1Wgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=627-644&author=P.+Liuauthor=H.+Chengauthor=T.+M.+Robertsauthor=J.+J.+Zhao&title=Targeting+the+phosphoinositide+3-kinase+pathway+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the phosphoinositide 3-kinase pathway in cancer</span></div><div class="casAuthors">Liu, Pixu; Cheng, Hailing; Roberts, Thomas M.; Zhao, Jean J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">627-644</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The phosphoinositide 3-kinase (PI3K) pathway is a key signal transduction system that links oncogenes and multiple receptor classes to many essential cellular functions, and is perhaps the most commonly activated signalling pathway in human cancer.  This pathway therefore presents both an opportunity and a challenge for cancer therapy.  Even as inhibitors that target PI3K isoforms and other major nodes in the pathway, including AKT and mammalian target of rapamycin (mTOR), reach clin. trials, major issues remain.  Here, we highlight recent progress that has been made in our understanding of the PI3K pathway and discuss the potential of and challenges for the development of therapeutic agents that target this pathway in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUk9T-ZoNDtLVg90H21EOLACvtfcHk0lhf3B5rs_t_3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1Wgtb4%253D&md5=fdc94abd15178a9dbe7c56dafbfb7787</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1038%2Fnrd2926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2926%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DRoberts%26aufirst%3DT.%2BM.%26aulast%3DZhao%26aufirst%3DJ.%2BJ.%26atitle%3DTargeting%2520the%2520phosphoinositide%25203-kinase%2520pathway%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%26date%3D2009%26volume%3D8%26spage%3D627%26epage%3D644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Lempiainen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halazonetis, T. D.</span><span> </span><span class="NLM_article-title">Emerging common themes in regulation of PIKKS and PI3Ks</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">3067</span><span class="NLM_x">–</span> <span class="NLM_lpage">3073</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2009&pages=3067-3073&author=H.+Lempiainenauthor=T.+D.+Halazonetis&title=Emerging+common+themes+in+regulation+of+PIKKS+and+PI3Ks"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLempiainen%26aufirst%3DH.%26aulast%3DHalazonetis%26aufirst%3DT.%2BD.%26atitle%3DEmerging%2520common%2520themes%2520in%2520regulation%2520of%2520PIKKS%2520and%2520PI3Ks%26jtitle%3DEMBO%2520J.%26date%3D2009%26volume%3D28%26spage%3D3067%26epage%3D3073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Yap, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walton, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynand, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">deBono, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Targeting the PI3K-Akt-mTor pathway, progress, pitfalls and promises</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">393</span><span class="NLM_x">–</span> <span class="NLM_lpage">414</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm901830p&amp;key=10.1016%2Fj.coph.2008.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm901830p&amp;key=18721898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm901830p&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFCktL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=393-414&author=T.+A.+Yapauthor=M.+D.+Garrettauthor=M.+I.+Waltonauthor=F.+Raynandauthor=J.+S.+deBonoauthor=P.+Workman&title=Targeting+the+PI3K-Akt-mTor+pathway%2C+progress%2C+pitfalls+and+promises"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promises</span></div><div class="casAuthors">Yap, Timothy A.; Garrett, Michelle D.; Walton, Mike I.; Raynaud, Florence; de Bono, Johann S.; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">393-412</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The strategy of drugging the cancer kinome' has led to the successful development and regulatory approval of several novel mol. targeted agents.  The spotlight is now shifting to the phosphatidylinositide 3-kinase (PI3K)-AKT-mammalian target of rapamycin (mTOR) pathway as a key potential target.  This review details the role of the pathway in oncogenesis and the rationale for inhibiting its vital components.  The focus will be on the progress made in the development of novel therapies for cancer treatment, with emphasis placed on agents that have entered clin. development.  Strategies involving horizontal and vertical blockade of the pathway, as well as the use of biomarkers to select appropriate patients and to provide proof of target modulation will also be highlighted.  Finally, we discuss the issues and limitations involved with targeting the PI3K-AKT-mTOR pathway, and predict what the future may hold for these novel anticancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnmwezNSKUfbVg90H21EOLACvtfcHk0lhf3B5rs_t_3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCktL7E&md5=b6a4f3c01a6776977d61cde8222d7201</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2008.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2008.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DYap%26aufirst%3DT.%2BA.%26aulast%3DGarrett%26aufirst%3DM.%2BD.%26aulast%3DWalton%26aufirst%3DM.%2BI.%26aulast%3DRaynand%26aufirst%3DF.%26aulast%3DdeBono%26aufirst%3DJ.%2BS.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DTargeting%2520the%2520PI3K-Akt-mTor%2520pathway%252C%2520progress%252C%2520pitfalls%2520and%2520promises%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2008%26volume%3D8%26spage%3D393%26epage%3D414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Bellacosa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dicristofano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, J. R.</span><span> </span><span class="NLM_article-title">Activation of Akt kinases in cancer: implications for therapeutic targetting</span> <span class="citation_source-journal">Adv. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">86</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2005&pages=29-86&author=A.+Bellacosaauthor=C.+C.+Kumarauthor=A.+Dicristofanoauthor=J.+R.+Testa&title=Activation+of+Akt+kinases+in+cancer%3A+implications+for+therapeutic+targetting"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBellacosa%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DC.%2BC.%26aulast%3DDicristofano%26aufirst%3DA.%26aulast%3DTesta%26aufirst%3DJ.%2BR.%26atitle%3DActivation%2520of%2520Akt%2520kinases%2520in%2520cancer%253A%2520implications%2520for%2520therapeutic%2520targetting%26jtitle%3DAdv.%2520Cancer%2520Res.%26date%3D2005%26volume%3D94%26spage%3D29%26epage%3D86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Manning, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span> </span><span class="NLM_article-title">Akt/PKB signaling: navigating down stream</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">1261</span><span class="NLM_x">–</span> <span class="NLM_lpage">1274</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=1261-1274&author=B.+D.+Manningauthor=L.+C.+Cantley&title=Akt%2FPKB+signaling%3A+navigating+down+stream"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DB.%2BD.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DAkt%252FPKB%2520signaling%253A%2520navigating%2520down%2520stream%26jtitle%3DCell%26date%3D2007%26volume%3D129%26spage%3D1261%26epage%3D1274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Engelman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span> </span><span class="NLM_article-title">The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism</span> <span class="citation_source-journal">Nat. Rev. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">606</span><span class="NLM_x">–</span> <span class="NLM_lpage">619</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm901830p&amp;key=10.1038%2Fnrg1879" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm901830p&amp;key=16847462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm901830p&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvFCnu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=606-619&author=J.+A.+Engelmanauthor=J.+Luoauthor=L.+C.+Cantley&title=The+evolution+of+phosphatidylinositol+3-kinases+as+regulators+of+growth+and+metabolism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism</span></div><div class="casAuthors">Engelman, Jeffrey A.; Luo, Ji; Cantley, Lewis C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Genetics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">606-619</span>CODEN:
                <span class="NLM_cas:coden">NRGAAM</span>;
        ISSN:<span class="NLM_cas:issn">1471-0056</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Phosphatidylinositol 3-kinases (PI3Ks) evolved from a single enzyme that regulates vesicle trafficking in unicellular eukaryotes into a family of enzymes that regulate cellular metab. and growth in multicellular organisms.  In this review, we examine how the PI3K pathway has evolved to control these fundamental processes, and how this pathway is in turn regulated by intricate feedback and crosstalk mechanisms.  In light of the recent advances in our understanding of the function of PI3Ks in the pathogenesis of diabetes and cancer, we discuss the exciting therapeutic opportunities for targeting this pathway to treat these diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphucxYJIwcQLVg90H21EOLACvtfcHk0lgY2TgTog-W_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvFCnu7Y%253D&md5=cd9eb85158710db6b33336af4e0a8cfe</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrg1879&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrg1879%26sid%3Dliteratum%253Aachs%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DThe%2520evolution%2520of%2520phosphatidylinositol%25203-kinases%2520as%2520regulators%2520of%2520growth%2520and%2520metabolism%26jtitle%3DNat.%2520Rev.%2520Genet.%26date%3D2006%26volume%3D7%26spage%3D606%26epage%3D619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Hennessy, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ram, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span> </span><span class="NLM_article-title">Exploiting the PI3K/Akt pathway for cancer drug discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">988</span><span class="NLM_x">–</span> <span class="NLM_lpage">1004</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm901830p&amp;key=10.1038%2Fnrd1902" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm901830p&amp;key=16341064" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm901830p&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1yktbjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=988-1004&author=B.+T.+Hennessyauthor=D.+L.+Smithauthor=P.+T.+Ramauthor=Y.+Luauthor=G.+B.+Mills&title=Exploiting+the+PI3K%2FAkt+pathway+for+cancer+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery</span></div><div class="casAuthors">Hennessy, Bryan T.; Smith, Debra L.; Ram, Prahlad T.; Lu, Yiling; Mills, Gordon B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">988-1004</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Evolving studies with several different targeted therapeutic agents are demonstrating that patients with genomic alterations of the target, including amplification, translocation and mutation, are more likely to respond to the therapy.  Recent studies indicate that numerous components of the phosphatidylinositol-3-kinase (PI3K)/AKT pathway are targeted by amplification, mutation and translocation more frequently than any other pathway in cancer patients, with resultant activation of the pathway.  This warrants exploiting the PI3K/AKT pathway for cancer drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq40Fg-hLrrMbVg90H21EOLACvtfcHk0lgY2TgTog-W_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1yktbjI&md5=faecabc3a6799137d133afb37d139ceb</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrd1902&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1902%26sid%3Dliteratum%253Aachs%26aulast%3DHennessy%26aufirst%3DB.%2BT.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DRam%26aufirst%3DP.%2BT.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DMills%26aufirst%3DG.%2BB.%26atitle%3DExploiting%2520the%2520PI3K%252FAkt%2520pathway%2520for%2520cancer%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D988%26epage%3D1004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Maehama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, J. E.</span><span> </span><span class="NLM_article-title">The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-triphosphate</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">13375</span><span class="NLM_x">–</span> <span class="NLM_lpage">13378</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=13375-13378&author=T.+Maehamaauthor=J.+E.+Dixon&title=The+tumor+suppressor%2C+PTEN%2FMMAC1%2C+dephosphorylates+the+lipid+second+messenger%2C+phosphatidylinositol+3%2C4%2C5-triphosphate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaehama%26aufirst%3DT.%26aulast%3DDixon%26aufirst%3DJ.%2BE.%26atitle%3DThe%2520tumor%2520suppressor%252C%2520PTEN%252FMMAC1%252C%2520dephosphorylates%2520the%2520lipid%2520second%2520messenger%252C%2520phosphatidylinositol%25203%252C4%252C5-triphosphate%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D13375%26epage%3D13378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Ali, I. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schriml, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, M.</span><span> </span><span class="NLM_article-title">Mutational spectra of PTEN/MMACI gene: a tumor suppressor with lipid phosphatase activity</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">1922</span><span class="NLM_x">–</span> <span class="NLM_lpage">1932</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm901830p&amp;key=10.1093%2Fjnci%2F91.22.1922" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm901830p&amp;key=10564676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm901830p&amp;key=1%3ACAS%3A528%3ADyaK1MXotVaitr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1999&pages=1922-1932&author=I.+U.+Aliauthor=L.+M.+Schrimlauthor=M.+Dean&title=Mutational+spectra+of+PTEN%2FMMACI+gene%3A+a+tumor+suppressor+with+lipid+phosphatase+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity</span></div><div class="casAuthors">Ali, Iqbal Unnisa; Schriml, Lynn M.; Dean, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">1922-1932</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review with 120 refs.  PTEN/MMAC1 (phosphatase, tensin homolog/mutated in multiple advanced cancers) is a tumor suppressor protein that has sequence homol. with dual-specificity phosphatases, which are capable of dephosphorylating both tyrosine phosphate and serine/threonine phosphate residues on proteins.  The in vivo function of PTEN/MMAC1 appears to be dephosphorylation of phosphotidylinositol 3,4,5-triphosphate.  The PTEN/MMAC1 gene is mutated in the germline of patients with rare autosomal dominant cancer syndromes and in subsets of specific cancers.  Here we review the mutational spectra of the PTEN/MMAC1 gene in tumors from various tissues, esp. endometrium, brain, prostate, and ovary, in which the gene is inactivated very frequently.  Germline and somatic mutations in the PTEN/MMAC1 gene occur mostly in the protein coding region and involve the phosphatase domain and poly(A)6 stretches.  Compared with germline alterations found in the PTEN/MMAC1 gene, there is a substantially increased frequency of frameshift mutations in tumors.  Glioblastomas and endometrial carcinomas appear to have distinct mutational spectra, probably reflecting differences in the underlying mechanisms of inactivation of the PTEN/MMAC1 gene in the two tissue types.  Also, depending on the tissue type, the gene appears to be involved in the initiation or the progression of cancers.  Further understanding of PTEN/MMAC1 gene mutations in different tumors and the physiol. consequences of these mutations is likely to open up new therapeutic opportunities for targeting this crit. gene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox1hhrBuiMKrVg90H21EOLACvtfcHk0lgWGDGdQy1gTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXotVaitr4%253D&md5=2b00e89439f512e96d9089d0f7312c28</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F91.22.1922&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F91.22.1922%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DI.%2BU.%26aulast%3DSchriml%26aufirst%3DL.%2BM.%26aulast%3DDean%26aufirst%3DM.%26atitle%3DMutational%2520spectra%2520of%2520PTEN%252FMMACI%2520gene%253A%2520a%2520tumor%2520suppressor%2520with%2520lipid%2520phosphatase%2520activity%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1999%26volume%3D91%26spage%3D1922%26epage%3D1932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Shayesteh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldocchi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godfrey, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinkel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, J. W.</span><span> </span><span class="NLM_article-title">PIK3CA is implicated as an oncogene in ovarian cancer</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">102</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm901830p&amp;key=10.1038%2F5042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm901830p&amp;key=9916799" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm901830p&amp;key=1%3ACAS%3A528%3ADyaK1MXltlWjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1999&pages=99-102&author=L.+Shayestehauthor=W.+Kuoauthor=R.+Baldocchiauthor=T.+Godfreyauthor=C.+Collinsauthor=D.+Pinkelauthor=B.+Powellauthor=G.+B.+Millsauthor=J.+W.+Gray&title=PIK3CA+is+implicated+as+an+oncogene+in+ovarian+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">PIK3CA is implicated as an oncogene in ovarian cancer</span></div><div class="casAuthors">Shayesteh, Laleh; Lu, Yiling; Kuo, Wen-Lin; Baldocchi, Russell; Godfrey, Tony; Collins, Colin; Pinkel, Daniel; Powell, Bethan; Mills, Gordon B.; Gray, Joe W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">99-102</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">Ovarian cancer is the leading cause of death from gynecol. malignancy and the 4th leading cause of cancer death among American women, yet little is known about its mol. etiol.  Studies using comparative genomic hybridization (CGH) have revealed several regions of recurrent, abnormal, DNA sequence copy no. that may encode genes involved in the genesis or progression of the disease.  A region at 3q26 was increased in copy no. in 40% of ovarian and other cancers contains PIK3CA, which encodes the p110α catalytic subunit of phosphatidylinositol 3-kinase (PI3-kinase).  The assocn. between PIK3CA copy no. and PI3-kinase activity makes PIK3CA a candidate oncogene because a broad range of cancer-related functions were assocd. with PI3-kinase mediated signalling.  These include proliferation, glucose transport and catabolism, cell adhesion, apoptosis, RAS signalling6 and oncogenic transformation.  Downstream effectors of PI3-kinase, AKT1 and AKT2, were amplified or activated in human tumors, including ovarian cancer.  We show that PIK3CA is frequently increased in copy no. in ovarian cancers, that the increased copy no. is assocd. with increased PIK3CA transcription, p110α protein expression, and PI3-kinase activity and that treatment with the PI3-kinase inhibitor LY294002 decreases proliferation and increases apoptosis.  These observations suggest PIK3CA is an oncogene that has an important role in ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYnLbYYzMTtrVg90H21EOLACvtfcHk0lgWGDGdQy1gTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltlWjtw%253D%253D&md5=e46ad55fb14c5465bf7ce86fb5a9cca0</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2F5042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F5042%26sid%3Dliteratum%253Aachs%26aulast%3DShayesteh%26aufirst%3DL.%26aulast%3DKuo%26aufirst%3DW.%26aulast%3DBaldocchi%26aufirst%3DR.%26aulast%3DGodfrey%26aufirst%3DT.%26aulast%3DCollins%26aufirst%3DC.%26aulast%3DPinkel%26aufirst%3DD.%26aulast%3DPowell%26aufirst%3DB.%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DGray%26aufirst%3DJ.%2BW.%26atitle%3DPIK3CA%2520is%2520implicated%2520as%2520an%2520oncogene%2520in%2520ovarian%2520cancer%26jtitle%3DNat.%2520Genet.%26date%3D1999%26volume%3D21%26spage%3D99%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Samuels, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silliman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ptak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szabo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazdar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riggins, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markowitz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velculescu, V. E.</span><span> </span><span class="NLM_article-title">High frequency mutations of the PIK3CA gene in human cancers</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">554</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2004&pages=554&author=Y.+Samuelsauthor=Z.+Wangauthor=A.+Bardelliauthor=N.+Sillimanauthor=J.+Ptakauthor=S.+Szaboauthor=H.+Yanauthor=A.+Gazdarauthor=S.+M.+Powellauthor=G.+J.+Rigginsauthor=J.+K.+Wilsonauthor=S.+Markowitzauthor=K.+W.+Kinzlerauthor=B.+Vogelsteinauthor=V.+E.+Velculescu&title=High+frequency+mutations+of+the+PIK3CA+gene+in+human+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSamuels%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DBardelli%26aufirst%3DA.%26aulast%3DSilliman%26aufirst%3DN.%26aulast%3DPtak%26aufirst%3DJ.%26aulast%3DSzabo%26aufirst%3DS.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DGazdar%26aufirst%3DA.%26aulast%3DPowell%26aufirst%3DS.%2BM.%26aulast%3DRiggins%26aufirst%3DG.%2BJ.%26aulast%3DWilson%26aufirst%3DJ.%2BK.%26aulast%3DMarkowitz%26aufirst%3DS.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26atitle%3DHigh%2520frequency%2520mutations%2520of%2520the%2520PIK3CA%2520gene%2520in%2520human%2520cancers%26jtitle%3DScience%26date%3D2004%26volume%3D30%26spage%3D554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Parsons, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuels, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummins, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Long, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silliman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ptak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szabo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markowitz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lengauer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velculescu, V. E.</span><span> </span><span class="NLM_article-title">Colorectal cancer: mutations in a signaling pathway</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">436</span><span class="NLM_x">, </span> <span class="NLM_fpage">792</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436&publication_year=2005&pages=792&author=D.+W.+Parsonsauthor=T.+L.+Wangauthor=Y.+Samuelsauthor=A.+Bardelliauthor=J.+M.+Cumminsauthor=L.+De+Longauthor=N.+Sillimanauthor=J.+Ptakauthor=S.+Szaboauthor=J.+K.+Wilsonauthor=S.+Markowitzauthor=K.+W.+Kinzlerauthor=B.+Vogelsteinauthor=C.+Lengauerauthor=V.+E.+Velculescu&title=Colorectal+cancer%3A+mutations+in+a+signaling+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParsons%26aufirst%3DD.%2BW.%26aulast%3DWang%26aufirst%3DT.%2BL.%26aulast%3DSamuels%26aufirst%3DY.%26aulast%3DBardelli%26aufirst%3DA.%26aulast%3DCummins%26aufirst%3DJ.%2BM.%26aulast%3DDe%2BLong%26aufirst%3DL.%26aulast%3DSilliman%26aufirst%3DN.%26aulast%3DPtak%26aufirst%3DJ.%26aulast%3DSzabo%26aufirst%3DS.%26aulast%3DWilson%26aufirst%3DJ.%2BK.%26aulast%3DMarkowitz%26aufirst%3DS.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DLengauer%26aufirst%3DC.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26atitle%3DColorectal%2520cancer%253A%2520mutations%2520in%2520a%2520signaling%2520pathway%26jtitle%3DNature%26date%3D2005%26volume%3D436%26spage%3D792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Vogt, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bader, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S.</span><span> </span><span class="NLM_article-title">PI3-kinase hidden potential revealed</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">946</span><span class="NLM_x">–</span> <span class="NLM_lpage">949</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=946-949&author=P.+K.+Vogtauthor=A.+G.+Baderauthor=S.+Kang&title=PI3-kinase+hidden+potential+revealed"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVogt%26aufirst%3DP.%2BK.%26aulast%3DBader%26aufirst%3DA.%2BG.%26aulast%3DKang%26aufirst%3DS.%26atitle%3DPI3-kinase%2520hidden%2520potential%2520revealed%26jtitle%3DCell%2520Cycle%26date%3D2006%26volume%3D5%26spage%3D946%26epage%3D949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F.</span><span> </span><span class="NLM_article-title">l. Drugging the PI3 kinome</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">794</span><span class="NLM_x">–</span> <span class="NLM_lpage">796</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=794-796&author=P.+Workmanauthor=P.+A.+Clarkeauthor=S.+Guillardauthor=F.+Raynaud&title=l.+Drugging+the+PI3+kinome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DGuillard%26aufirst%3DS.%26aulast%3DRaynaud%26aufirst%3DF.%26atitle%3Dl.%2520Drugging%2520the%2520PI3%2520kinome%26jtitle%3DNat.%2520Biotechnol.%26date%3D2006%26volume%3D24%26spage%3D794%26epage%3D796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Fan, Q. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldenberg, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mostov, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokoe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, W. A.</span><span> </span><span class="NLM_article-title">A dual PI3 kinase/mTor inhibitor reveals emergent efficacy in glioma</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=341-349&author=Q.+W.+Fanauthor=Z.+A.+Knightauthor=D.+D.+Goldenbergauthor=W.+Yuauthor=K.+E.+Mostovauthor=D.+Stokoeauthor=K.+M.+Shokatauthor=W.+A.+Weiss&title=A+dual+PI3+kinase%2FmTor+inhibitor+reveals+emergent+efficacy+in+glioma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DQ.%2BW.%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DGoldenberg%26aufirst%3DD.%2BD.%26aulast%3DYu%26aufirst%3DW.%26aulast%3DMostov%26aufirst%3DK.%2BE.%26aulast%3DStokoe%26aufirst%3DD.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DWeiss%26aufirst%3DW.%2BA.%26atitle%3DA%2520dual%2520PI3%2520kinase%252FmTor%2520inhibitor%2520reveals%2520emergent%2520efficacy%2520in%2520glioma%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D9%26spage%3D341%26epage%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Vlahos, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matter, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, R. F.</span><span> </span><span class="NLM_article-title">A specific inhibitor of phosphatidylinositol-3-kinase, 2-(4-morpholinyl)-8-phenyl-4<i>H</i>-1-benzopyran-4-one (LY294002)</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">269</span><span class="NLM_x">, </span> <span class="NLM_fpage">5241</span><span class="NLM_x">–</span> <span class="NLM_lpage">5248</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=5241-5248&author=C.+J.+Vlahosauthor=W.+F.+Matterauthor=K.+Y.+Huiauthor=R.+F.+Brown&title=A+specific+inhibitor+of+phosphatidylinositol-3-kinase%2C+2-%284-morpholinyl%29-8-phenyl-4H-1-benzopyran-4-one+%28LY294002%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVlahos%26aufirst%3DC.%2BJ.%26aulast%3DMatter%26aufirst%3DW.%2BF.%26aulast%3DHui%26aufirst%3DK.%2BY.%26aulast%3DBrown%26aufirst%3DR.%2BF.%26atitle%3DA%2520specific%2520inhibitor%2520of%2520phosphatidylinositol-3-kinase%252C%25202-%25284-morpholinyl%2529-8-phenyl-4H-1-benzopyran-4-one%2520%2528LY294002%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1994%26volume%3D269%26spage%3D5241%26epage%3D5248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Yaguchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koshimizu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirono, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamori, T.</span><span> </span><span class="NLM_article-title">Antitumor activity of ZSTK474, a new phosphatidylinositol-3-kinase inhibitor</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">545</span><span class="NLM_x">–</span> <span class="NLM_lpage">556</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm901830p&amp;key=10.1093%2Fjnci%2Fdjj133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm901830p&amp;key=16622124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm901830p&amp;key=1%3ACAS%3A528%3ADC%252BD28XjslOjsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2006&pages=545-556&author=S.+Yaguchiauthor=Y.+Fukuiauthor=I.+Koshimizuauthor=H.+Yoshimiauthor=T.+Matsunoauthor=H.+Goudaauthor=S.+Hironoauthor=K.+Yamazakiauthor=T.+Yamori&title=Antitumor+activity+of+ZSTK474%2C+a+new+phosphatidylinositol-3-kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor Activity of ZSTK474, a New Phosphatidylinositol 3-Kinase Inhibitor</span></div><div class="casAuthors">Yaguchi, Shin-ichi; Fukui, Yasuhisa; Koshimizu, Ichiro; Yoshimi, Hisashi; Matsuno, Toshiyuki; Gouda, Hiroaki; Hirono, Shuichi; Yamazaki, Kanami; Yamori, Takao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">545-556</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background: We previously synthesized a novel s-triazine deriv., ZSTK474 [2-(2-difluoromethylbenzimidazol-1-yl)-4,6-dimorpholino-1,3,5-triazine], that strongly inhibited the growth of tumor cells.  We identified its mol. target, investigated its effects on cellular signaling pathways, and examd. its antitumor efficacy and toxicity in vivo.  Methods: We used COMPARE anal. of chemosensitivity measurements from 39 human cancer cell lines and identified phosphatidylinositol 3-kinase (PI3K) as a mol. target for ZSTK474.  PI3K was immunopptd. from A549 cell lysates, and its activity was measured by assessing the incorporation of 32P into phosphatidylinositol.  We used the crystal structure of the PI3K-LY294002 complex to model the binding of ZSTK474 to PI3K (where LY294002 is a known PI3K inhibitor).  PI3K downstream activity was analyzed by immunoblotting.  Antitumor activity of ZSTK474 was examd. against A549, PC-3, and WiDr xenografts in nude mice.  Phosphorylation of Akt, a serine/threonine protein kinase and a major signaling component downstream of PI3K, was assessed in vivo by immunohistochem.  Results: PI3K was identified as a mol. target for ZSTK474 by COMPARE anal.  We confirmed that ZSTK474 directly inhibited PI3K activity more efficiently than the PI3K inhibitor LY294002.  At concns. of 1 μM, ZSTK474 and LY2194002 reduced PI3K activity to 4.7% (95% confidence interval [CI] = 3.2% to 6.1%) and 44.6% (95% CI = 38.9% to 50.3%), resp., of the untreated control level.  Mol. modeling of the PI3K-ZSTK474 complex indicated that ZSTK474 could bind to the ATP-binding pocket of PI3K.  ZSTK474 inhibited phosphorylation of signaling components downstream from PI3K, such as Akt and glycogen synthase kinase 3β, and mediated a decrease in cyclin D1 levels.  ZSTK474 administered orally to mice had strong antitumor activity against human cancer xenografts without toxic effects in crit. organs.  Akt phosphorylation was reduced in xenograft tumors after oral administration of ZSTK474.  Conclusion: ZSTK474 is a new PI3K inhibitor with strong antitumor activity against human cancer xenografts without toxic effects in crit. organs.  ZSTK474 merits further investigation as an anticancer drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG0v8LFKdruLVg90H21EOLACvtfcHk0lj6CQdGbZzI-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjslOjsLw%253D&md5=a2593024975536089ab2ee7e53234ebc</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjj133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjj133%26sid%3Dliteratum%253Aachs%26aulast%3DYaguchi%26aufirst%3DS.%26aulast%3DFukui%26aufirst%3DY.%26aulast%3DKoshimizu%26aufirst%3DI.%26aulast%3DYoshimi%26aufirst%3DH.%26aulast%3DMatsuno%26aufirst%3DT.%26aulast%3DGouda%26aufirst%3DH.%26aulast%3DHirono%26aufirst%3DS.%26aulast%3DYamazaki%26aufirst%3DK.%26aulast%3DYamori%26aufirst%3DT.%26atitle%3DAntitumor%2520activity%2520of%2520ZSTK474%252C%2520a%2520new%2520phosphatidylinositol-3-kinase%2520inhibitor%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2006%26volume%3D98%26spage%3D545%26epage%3D556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Kong, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamori, T.</span><span> </span><span class="NLM_article-title">ZSTK474 is an ATP-competitive inhibitor of class I phosphatidylinositol-3-kinase isoform</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">1638</span><span class="NLM_x">–</span> <span class="NLM_lpage">1642</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm901830p&amp;key=10.1111%2Fj.1349-7006.2007.00580.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm901830p&amp;key=17711503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm901830p&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtF2qtbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2007&pages=1638-1642&author=D.+Kongauthor=T.+Yamori&title=ZSTK474+is+an+ATP-competitive+inhibitor+of+class+I+phosphatidylinositol-3-kinase+isoform"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">ZSTK474 is an ATP-competitive inhibitor of class I phosphatidylinositol 3 kinase isoforms</span></div><div class="casAuthors">Kong, Dexin; Yamori, Takao</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1638-1642</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1347-9032</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Asia Pty Ltd.</span>)
        </div><div class="casAbstract">Class I phosphatidylinositol 3 kinases (PI3K) phosphorylate phosphatidylinositol 4,5-bisphosphate to generate phosphatidylinositol 3,4,5-trisphosphate.  These mols. play an important role in fundamental cellular responses.  Four isoforms of class I PI3K are known to have different functions, and abnormalities in their activities have been related to various diseases such as cancer and inflammation.  We previously identified a novel PI3K inhibitor, ZSTK474, which showed potent antitumor activity in vivo against a human cancer xenograft without observable toxicity.  However, the mode of its mol. action was not investigated in detail.  Our previous study only suggested that ZSTK474 possibly competes with ATP for the ATP-binding pocket of PI3Kγ.  In the present study, we have used an in vitro homogeneous time-resolved fluorescence kinase assay to examine whether ZSTK474 is indeed an ATP-competing inhibitor of PI3K, and also to det. whether the inhibitory activity of ZSTK474 was isoform-specific.  Lineweaver-Burk plot anal. revealed that ZSTK474 inhibits all four PI3K isoforms in an ATP-competitive manner.  Among all of the PI3K isoforms, PI3Kδ was inhibited most potently by ZSTK474 with a Ki of 1.8 nM, and the other isoforms were inhibited at higher doses.  We have also used a kinase activity ELISA to det. whether ZSTK474 inhibits mammalian target of rapamycin, a key kinase acting downstream of PI3K to promote protein synthesis and cell proliferation.  Even at a concn. of 100 μM, ZSTK474 inhibited mammalian target of rapamycin activity rather weakly.  These results indicate that ZSTK474 is an ATP-competitive pan-class I PI3K inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpN82wpwPzvvLVg90H21EOLACvtfcHk0lj6CQdGbZzI-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtF2qtbzI&md5=02f89fcfcdda97438724700eb3a3499a</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2007.00580.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2007.00580.x%26sid%3Dliteratum%253Aachs%26aulast%3DKong%26aufirst%3DD.%26aulast%3DYamori%26aufirst%3DT.%26atitle%3DZSTK474%2520is%2520an%2520ATP-competitive%2520inhibitor%2520of%2520class%2520I%2520phosphatidylinositol-3-kinase%2520isoform%26jtitle%3DCancer%2520Sci.%26date%3D2007%26volume%3D98%26spage%3D1638%26epage%3D1642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Folkes, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmadi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alderto, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alix, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Box, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuckowree, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depledge, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancox, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kugendradas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lensun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivero, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pergl-Wilson, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saghir, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salphati, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ultsch, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallweber, H. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weismann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhyvoloup, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zvelebil, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuttleworth, S. J.</span><span> </span><span class="NLM_article-title">The identification of 2-(1<i>H</i>-indazol-4-yl)-6-(4-methane sulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-<i>d</i>]pyrimidine (GDC-0941) as a potent, selective, orally bio-available inhibitor of class I PI3 kinase for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5522</span><span class="NLM_x">–</span> <span class="NLM_lpage">5532</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800295d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5522-5532&author=A.+J.+Folkesauthor=K.+Ahmadiauthor=W.+K.+Aldertoauthor=S.+Alixauthor=S.+J.+Bakerauthor=G.+Boxauthor=I.+S.+Chuckowreeauthor=P.+A.+Clarkeauthor=P.+Depledgeauthor=S.+A.+Ecclesauthor=L.+S.+Friedmanauthor=A.+Hayesauthor=T.+C.+Hancoxauthor=A.+Kugendradasauthor=L.+Lensunauthor=P.+Mooreauthor=A.+G.+Oliveroauthor=J.+Pangauthor=S.+Patelauthor=G.+H.+Pergl-Wilsonauthor=F.+I.+Raynaudauthor=A.+Robsonauthor=N.+Saghirauthor=L.+Salphatiauthor=S.+Sohalauthor=M.+H.+Ultschauthor=M.+Valentiauthor=H.+J.+A.+Wallweberauthor=N.+C.+Wanauthor=C.+Weismannauthor=P.+Workmanauthor=A.+Zhyvoloupauthor=M.+J.+Zvelebilauthor=S.+J.+Shuttleworth&title=The+identification+of+2-%281H-indazol-4-yl%29-6-%284-methane+sulfonyl-piperazin-1-ylmethyl%29-4-morpholin-4-yl-thieno%5B3%2C2-d%5Dpyrimidine+%28GDC-0941%29+as+a+potent%2C+selective%2C+orally+bio-available+inhibitor+of+class+I+PI3+kinase+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm800295d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800295d%26sid%3Dliteratum%253Aachs%26aulast%3DFolkes%26aufirst%3DA.%2BJ.%26aulast%3DAhmadi%26aufirst%3DK.%26aulast%3DAlderto%26aufirst%3DW.%2BK.%26aulast%3DAlix%26aufirst%3DS.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DChuckowree%26aufirst%3DI.%2BS.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DDepledge%26aufirst%3DP.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DFriedman%26aufirst%3DL.%2BS.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DHancox%26aufirst%3DT.%2BC.%26aulast%3DKugendradas%26aufirst%3DA.%26aulast%3DLensun%26aufirst%3DL.%26aulast%3DMoore%26aufirst%3DP.%26aulast%3DOlivero%26aufirst%3DA.%2BG.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DPergl-Wilson%26aufirst%3DG.%2BH.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DRobson%26aufirst%3DA.%26aulast%3DSaghir%26aufirst%3DN.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSohal%26aufirst%3DS.%26aulast%3DUltsch%26aufirst%3DM.%2BH.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%2BA.%26aulast%3DWan%26aufirst%3DN.%2BC.%26aulast%3DWeismann%26aufirst%3DC.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DZhyvoloup%26aufirst%3DA.%26aulast%3DZvelebil%26aufirst%3DM.%2BJ.%26aulast%3DShuttleworth%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520identification%2520of%25202-%25281H-indazol-4-yl%2529-6-%25284-methane%2520sulfonyl-piperazin-1-ylmethyl%2529-4-morpholin-4-yl-thieno%255B3%252C2-d%255Dpyrimidine%2520%2528GDC-0941%2529%2520as%2520a%2520potent%252C%2520selective%252C%2520orally%2520bio-available%2520inhibitor%2520of%2520class%2520I%2520PI3%2520kinase%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5522%26epage%3D5532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Stauffer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maira, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Echeverria, C.</span><span> </span><span class="NLM_article-title">Imidazo[4,5-<i>c</i>]quinolines as inhibitors of the PI3K/PKB-pathway</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1027</span><span class="NLM_x">–</span> <span class="NLM_lpage">1030</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1027-1030&author=F.+Staufferauthor=S.+M.+Mairaauthor=P.+Furetauthor=C.+Garcia-Echeverria&title=Imidazo%5B4%2C5-c%5Dquinolines+as+inhibitors+of+the+PI3K%2FPKB-pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStauffer%26aufirst%3DF.%26aulast%3DMaira%26aufirst%3DS.%2BM.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26atitle%3DImidazo%255B4%252C5-c%255Dquinolines%2520as%2520inhibitors%2520of%2520the%2520PI3K%252FPKB-pathway%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1027%26epage%3D1030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Maira, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brueggen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritsch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brachmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chene, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Pover, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schemaker, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Echeverria, C.</span><span> </span><span class="NLM_article-title">Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1851</span><span class="NLM_x">–</span> <span class="NLM_lpage">1863</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=16&amp;doi=10.1021%2Fjm901830p&amp;key=10.1158%2F1535-7163.MCT-08-0017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=8&amp;doi=10.1021%2Fjm901830p&amp;key=18606717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Fjm901830p&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslCgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=1851-1863&author=S.+M.+Mairaauthor=F.+Staufferauthor=J.+Brueggenauthor=P.+Furetauthor=C.+Schnellauthor=C.+Fritschauthor=S.+Brachmannauthor=P.+Cheneauthor=A.+De+Poverauthor=K.+Schemakerauthor=D.+Fabbroauthor=D.+Gabrielauthor=M.+Simonenauthor=L.+Murphyauthor=P.+Finanauthor=W.+Sellersauthor=C.+Garcia-Echeverria&title=Identification+and+characterization+of+NVP-BEZ235%2C+a+new+orally+available+dual+phosphatidylinositol+3-kinase%2Fmammalian+target+of+rapamycin+inhibitor+with+potent+in+vivo+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19b</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity</span></div><div class="casAuthors">Maira, Sauveur-Michel; Stauffer, Frederic; Brueggen, Josef; Furet, Pascal; Schnell, Christian; Fritsch, Christine; Brachmann, Saskia; Chene, Patrick; De Pover, Alain; Schoemaker, Kevin; Fabbro, Doriano; Gabriel, Daniela; Simonen, Marjo; Murphy, Leon; Finan, Peter; Sellers, William; Garcia-Echeverria, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1851-1863</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin inhibitor (mTOR) pathway is often constitutively activated in human tumor cells, providing unique opportunities for anticancer therapeutic intervention.  NVP-BEZ235 is an imidazo[4,5-c]quinoline deriv. that inhibits PI3K and mTOR kinase activity by binding to the ATP-binding cleft of these enzymes.  In cellular settings using human tumor cell lines, this mol. is able to effectively and specifically block the dysfunctional activation of the PI3K pathway, inducing G1 arrest.  The cellular activity of NVP-BEZ235 translates well in in vivo models of human cancer.  Thus, the compd. was well tolerated, displayed disease stasis when administered orally, and enhanced the efficacy of other anticancer agents when used in in vivo combination studies.  Ex vivo pharmacokinetic/pharmacodynamic analyses of tumor tissues showed a time-dependent correlation between compd. concn. and PI3K/Akt pathway inhibition.  Collectively, the preclin. data show that NVP-BEZ235 is a potent dual PI3K/mTOR modulator with favorable pharmaceutical properties.  NVP-BEZ235 is currently in phase I clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyO784qv52vrVg90H21EOLACvtfcHk0ljORd2TOoq18g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslCgtb4%253D&md5=5b1979e134dd12065198d86dbc11ce15</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0017%26sid%3Dliteratum%253Aachs%26aulast%3DMaira%26aufirst%3DS.%2BM.%26aulast%3DStauffer%26aufirst%3DF.%26aulast%3DBrueggen%26aufirst%3DJ.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DSchnell%26aufirst%3DC.%26aulast%3DFritsch%26aufirst%3DC.%26aulast%3DBrachmann%26aufirst%3DS.%26aulast%3DChene%26aufirst%3DP.%26aulast%3DDe%2BPover%26aufirst%3DA.%26aulast%3DSchemaker%26aufirst%3DK.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DGabriel%26aufirst%3DD.%26aulast%3DSimonen%26aufirst%3DM.%26aulast%3DMurphy%26aufirst%3DL.%26aulast%3DFinan%26aufirst%3DP.%26aulast%3DSellers%26aufirst%3DW.%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520NVP-BEZ235%252C%2520a%2520new%2520orally%2520available%2520dual%2520phosphatidylinositol%25203-kinase%252Fmammalian%2520target%2520of%2520rapamycin%2520inhibitor%2520with%2520potent%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D1851%26epage%3D1863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Garlich, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dey, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murali, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kundra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, H.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durden, D. L.</span><span> </span><span class="NLM_article-title">A vascular targeted pan phosphoinositide 3-kinase inhibitor prodrug, SF1126, with antitumor and antiangiogenic activity</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">206</span><span class="NLM_x">–</span> <span class="NLM_lpage">215</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=206-215&author=J.+R.+Garlichauthor=P.+Deauthor=N.+Deyauthor=J.+D.+Suauthor=X.+Pengauthor=A.+Millerauthor=R.+Muraliauthor=Y.+Luauthor=G.+B.+Millsauthor=V.+Kundraauthor=H.-K.+Shuauthor=Q.+Pengauthor=D.+L.+Durden&title=A+vascular+targeted+pan+phosphoinositide+3-kinase+inhibitor+prodrug%2C+SF1126%2C+with+antitumor+and+antiangiogenic+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarlich%26aufirst%3DJ.%2BR.%26aulast%3DDe%26aufirst%3DP.%26aulast%3DDey%26aufirst%3DN.%26aulast%3DSu%26aufirst%3DJ.%2BD.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DMiller%26aufirst%3DA.%26aulast%3DMurali%26aufirst%3DR.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DKundra%26aufirst%3DV.%26aulast%3DShu%26aufirst%3DH.-K.%26aulast%3DPeng%26aufirst%3DQ.%26aulast%3DDurden%26aufirst%3DD.%2BL.%26atitle%3DA%2520vascular%2520targeted%2520pan%2520phosphoinositide%25203-kinase%2520inhibitor%2520prodrug%252C%2520SF1126%252C%2520with%2520antitumor%2520and%2520antiangiogenic%2520activity%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D206%26epage%3D215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zask, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheijen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malwitz, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooijmans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svenson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span> </span><span class="NLM_article-title">ATP-competitive inhibitors of the mammalian target of rapamycin: design and synthesis of highly potent and selective pyrazolopyrimidines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5013</span><span class="NLM_x">–</span> <span class="NLM_lpage">5016</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900851f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5013-5016&author=A.+Zaskauthor=J.+C.+Verheijenauthor=K.+Curranauthor=J.+Kaplanauthor=D.+J.+Richardauthor=P.+Nowakauthor=D.+J.+Malwitzauthor=N.+Brooijmansauthor=J.+Bardauthor=K.+Svensonauthor=J.+Lucasauthor=L.+Toral-Barzaauthor=W.+G.+Zhangauthor=I.+Hollanderauthor=J.+J.+Gibbonsauthor=R.+T.+Abrahamauthor=S.+Ayral-Kaloustianauthor=T.+S.+Mansourauthor=K.+Yu&title=ATP-competitive+inhibitors+of+the+mammalian+target+of+rapamycin%3A+design+and+synthesis+of+highly+potent+and+selective+pyrazolopyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1021%2Fjm900851f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900851f%26sid%3Dliteratum%253Aachs%26aulast%3DZask%26aufirst%3DA.%26aulast%3DVerheijen%26aufirst%3DJ.%2BC.%26aulast%3DCurran%26aufirst%3DK.%26aulast%3DKaplan%26aufirst%3DJ.%26aulast%3DRichard%26aufirst%3DD.%2BJ.%26aulast%3DNowak%26aufirst%3DP.%26aulast%3DMalwitz%26aufirst%3DD.%2BJ.%26aulast%3DBrooijmans%26aufirst%3DN.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DSvenson%26aufirst%3DK.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DW.%2BG.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DGibbons%26aufirst%3DJ.%2BJ.%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26aulast%3DYu%26aufirst%3DK.%26atitle%3DATP-competitive%2520inhibitors%2520of%2520the%2520mammalian%2520target%2520of%2520rapamycin%253A%2520design%2520and%2520synthesis%2520of%2520highly%2520potent%2520and%2520selective%2520pyrazolopyrimidines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5013%26epage%3D5016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zask, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheijen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooijmans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu., K.</span><span> </span><span class="NLM_article-title">Morpholine derivatives greatly enhance the selectivity of mammalian target of rapamycin (mTOR) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7942</span><span class="NLM_x">–</span> <span class="NLM_lpage">7945</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901415x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=32&amp;doi=10.1021%2Fjm901830p&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVWrtb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7942-7945&author=A.+Zaskauthor=J.+Kaplanauthor=J.+C.+Verheijenauthor=D.+J.+Richardauthor=K.+Curranauthor=N.+Brooijmansauthor=E.+M.+Bennettauthor=L.+Toral-Barzaauthor=I.+Hollanderauthor=S.+Ayral-Kaloustianauthor=K.+Yu.&title=Morpholine+derivatives+greatly+enhance+the+selectivity+of+mammalian+target+of+rapamycin+%28mTOR%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21bR"><div class="casContent"><span class="casTitleNuber">21b</span><div class="casTitle"><span class="NLM_cas:atitle">Morpholine Derivatives Greatly Enhance the Selectivity of Mammalian Target of Rapamycin (mTOR) Inhibitors</span></div><div class="casAuthors">Zask, Arie; Kaplan, Joshua; Verheijen, Jeroen C.; Richard, David J.; Curran, Kevin; Brooijmans, Natasja; Bennett, Eric M.; Toral-Barza, Lourdes; Hollander, Irwin; Ayral-Kaloustian, Semiramis; Yu, Ker</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7942-7945</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dramatic improvements in mTOR-targeting selectivity were achieved by replacing morpholine in pyrazolopyrimidine inhibitors with bridged morpholines.  Analogs I [R1 = (R)- or (S)-3-methyl-4-morpholinyl, 2-methyl-4-morpholinyl, 8-oxa-3-azabicyclo[3.2.1]octan-3-yl, etc.; R2 = Me, Et, cyclopropyl, FCH2CH2, 3-pyridyl, 4-pyridyl; R3 = F3CCH2, 1-methoxycarbonyl-4-piperidinyl, 1-ethoxycarbonyl-4-piperidinyl, 3-pyridylmethyl] with subnanomolar mTOR IC50 values and up to 26000-fold selectivity vs. PI3Kα were prepd.  Chiral morpholines gave inhibitors whose enantiomers had different selectivity and potency profiles.  Mol. modeling suggests that a single amino acid difference between PI3K and mTOR (Phe961Leu) accounts for the profound selectivity seen by creating a deeper pocket in mTOR that can accommodate bridged morpholines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK2HnMHqTHqbVg90H21EOLACvtfcHk0lgdUKrnd1LhMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVWrtb3J&md5=5ef1eee5aa79531970049d3d26b46eb2</span></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1021%2Fjm901415x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901415x%26sid%3Dliteratum%253Aachs%26aulast%3DZask%26aufirst%3DA.%26aulast%3DKaplan%26aufirst%3DJ.%26aulast%3DVerheijen%26aufirst%3DJ.%2BC.%26aulast%3DRichard%26aufirst%3DD.%2BJ.%26aulast%3DCurran%26aufirst%3DK.%26aulast%3DBrooijmans%26aufirst%3DN.%26aulast%3DBennett%26aufirst%3DE.%2BM.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DYu.%26aufirst%3DK.%26atitle%3DMorpholine%2520derivatives%2520greatly%2520enhance%2520the%2520selectivity%2520of%2520mammalian%2520target%2520of%2520rapamycin%2520%2528mTOR%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7942%26epage%3D7945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Dehnhardt, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatesan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delos Santos, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dos Santos, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bursavich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellingboe, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khafizova, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooijmans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldberg, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhary, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span> </span><span class="NLM_article-title">Lead optimization of N3 substituted-7-morpholino-triazolopyrimidines as dual phosphoinositide 3-kinase and mammalian target of rapamycin inhibitors: discovery of PKI-402</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">798</span><span class="NLM_x">–</span> <span class="NLM_lpage">810</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9014982" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=798-810&author=C.+M.+Dehnhardtauthor=A.+M.+Venkatesanauthor=Z.+Chenauthor=E.+Delos+Santosauthor=O.+Dos+Santosauthor=M.+Bursavichauthor=A.+M.+Gilbertauthor=J.+W.+Ellingboeauthor=S.+Ayral-Kaloustianauthor=G.+Khafizovaauthor=N.+Brooijmansauthor=R.+Mallonauthor=I.+Hollanderauthor=L.+Feldbergauthor=J.+Lucasauthor=I.+Chaudharyauthor=K.+Yuauthor=J.+Gibbonsauthor=R.+Abrahamauthor=T.+S.+Mansour&title=Lead+optimization+of+N3+substituted-7-morpholino-triazolopyrimidines+as+dual+phosphoinositide+3-kinase+and+mammalian+target+of+rapamycin+inhibitors%3A+discovery+of+PKI-402"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21c&amp;dbid=16384&amp;doi=10.1021%2Fjm9014982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9014982%26sid%3Dliteratum%253Aachs%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26aulast%3DVenkatesan%26aufirst%3DA.%2BM.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DDelos%2BSantos%26aufirst%3DE.%26aulast%3DDos%2BSantos%26aufirst%3DO.%26aulast%3DBursavich%26aufirst%3DM.%26aulast%3DGilbert%26aufirst%3DA.%2BM.%26aulast%3DEllingboe%26aufirst%3DJ.%2BW.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DKhafizova%26aufirst%3DG.%26aulast%3DBrooijmans%26aufirst%3DN.%26aulast%3DMallon%26aufirst%3DR.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DFeldberg%26aufirst%3DL.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DChaudhary%26aufirst%3DI.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DGibbons%26aufirst%3DJ.%26aulast%3DAbraham%26aufirst%3DR.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26atitle%3DLead%2520optimization%2520of%2520N3%2520substituted-7-morpholino-triazolopyrimidines%2520as%2520dual%2520phosphoinositide%25203-kinase%2520and%2520mammalian%2520target%2520of%2520rapamycin%2520inhibitors%253A%2520discovery%2520of%2520PKI-402%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D798%26epage%3D810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldberg, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, S. F.</span><span> </span><span class="NLM_article-title">A directly labelled TR-FRET assay for monitoring phosphoinositide-3-kinase activity</span> <span class="citation_source-journal">Comb. Chem. High Throughput Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">565</span><span class="NLM_x">–</span> <span class="NLM_lpage">570</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm901830p&amp;key=10.2174%2F138620706777935360" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm901830p&amp;key=16925516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm901830p&amp;key=1%3ACAS%3A528%3ADC%252BD28XosVKrtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=565-570&author=X.+Yangauthor=P.+Liauthor=L.+Feldbergauthor=S.+C.+Kimauthor=M.+Bowmanauthor=I.+Hollanderauthor=R.+Mallonauthor=S.+F.+Wolf&title=A+directly+labelled+TR-FRET+assay+for+monitoring+phosphoinositide-3-kinase+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">A directly labeled TR-FRET assay for monitoring phosphoinositide-3-kinase activity</span></div><div class="casAuthors">Yang, Xiaoke; Li, Puyao; Feldberg, Larry; Kim, Steven C.; Bowman, Michael; Hollander, Irwin; Mallon, Robert; Wolf, Stanley F.</div><div class="citationInfo"><span class="NLM_cas:title">Combinatorial Chemistry & High Throughput Screening</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">565-570</span>CODEN:
                <span class="NLM_cas:coden">CCHSFU</span>;
        ISSN:<span class="NLM_cas:issn">1386-2073</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Phosphoinositide 3-kinases (PI3Ks) comprise a family of kinases that transfer the terminal phosphate of ATP to phosphoinositides at the 3-hydroxyl of the inositol ring to form phosphoinositide (3,4,5)-triphosphate (PIP3).  The PI3Ks have been shown to play key roles in cell growth, motility, morphol., and survival and thus are of interest as targets in anti-inflammatory and anti-oncogenic drug development.  To facilitate identification of novel and selective inhibitors of PI3Ks, we have developed a TR-FRET assay that uses directly labeled reagents.  The assay makes use of the high affinity binding of phosphoinositides to a pleckstrin homol. (PH) domain in the general receptor for phosphoinositides 1 (Grp1) protein.  It monitors PIP3 produced from the enzymic reaction by measuring its competition with Bodipy-FL-labeled PIP3 for binding to terbium chelate-labeled Grp1.  By using directly labeled reagents, this assay configuration offers higher sensitivity and faster binding/dissocn. kinetics than existing non-radioactive assays, which are crit. for competitive assay formats.  The assay is homogeneous, robust (Z' = 0.88), and simple and, thus, compatible with high throughput screening (HTS) processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3gMlKxLJcJLVg90H21EOLACvtfcHk0lgdUKrnd1LhMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XosVKrtb0%253D&md5=def2c27a291077edddd2047918779826</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.2174%2F138620706777935360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138620706777935360%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DFeldberg%26aufirst%3DL.%26aulast%3DKim%26aufirst%3DS.%2BC.%26aulast%3DBowman%26aufirst%3DM.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DMallon%26aufirst%3DR.%26aulast%3DWolf%26aufirst%3DS.%2BF.%26atitle%3DA%2520directly%2520labelled%2520TR-FRET%2520assay%2520for%2520monitoring%2520phosphoinositide-3-kinase%2520activity%26jtitle%3DComb.%2520Chem.%2520High%2520Throughput%2520Screening%26date%3D2006%26volume%3D9%26spage%3D565%26epage%3D570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamison, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larocque, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">332</span><span class="NLM_x">, </span> <span class="NLM_fpage">304</span><span class="NLM_x">–</span> <span class="NLM_lpage">310</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Toral-Barza%2C+L.%3B+Zhang%2C+W.+G.%3B+Lamison%2C+C.%3B+Larocque%2C+J.%3B+Gibbons%2C+J.%3B+Yu%2C+K.Biochem.+Biophys.+Res.+Commun.+2005%2C+332%2C+304%E2%80%93310"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DW.%2BG.%26aulast%3DLamison%26aufirst%3DC.%26aulast%3DLarocque%26aufirst%3DJ.%26aulast%3DGibbons%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DK.%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2005%26volume%3D332%26spage%3D304%26epage%3D310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Yu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Discafani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skotnicki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frost, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J.</span> <span class="citation_source-journal">Endocr-Relat. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">258</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm901830p&amp;key=10.1677%2Ferc.0.0080249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm901830p&amp;key=11566616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm901830p&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotlCqsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Yu%2C+K.%3B+Toral-Barza%2C+L.%3B+Discafani%2C+C.%3B+Zhang%2C+W.+G.%3B+Skotnicki%2C+J.%3B+Frost%2C+P.%3B+Gibbons%2C+J.Endocr-Relat.+Cancer+2001%2C+8%2C+249%E2%80%93258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer</span></div><div class="casAuthors">Yu, K.; Toral-Barza, L.; Discafani, C.; Zhang, W-G.; Skotnicki, J.; Frost, P.; Gibbons, J. J.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine-Related Cancer</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">249-258</span>CODEN:
                <span class="NLM_cas:coden">ERCAE9</span>;
        ISSN:<span class="NLM_cas:issn">1351-0088</span>.
    
            (<span class="NLM_cas:orgname">Society for Endocrinology</span>)
        </div><div class="casAbstract">The mammalian target of rapamycin (mTOR) is a central regulator of G1 cell cycle protein synthesis that precedes commitment to normal cellular replication.  We have studied the effect of cell cycle inhibitor-779 (CCI-779), a rapamycin ester that inhibits mTOR function, on the proliferation of a panel of breast cancer cell lines.  Six of eight lines studied were sensitive (IC50≤50 nM) and two lines were resistant (IC50>1.0 μM) to CCI-779.  Sensitive lines were estrogen dependent (MCF-7, BT-474, T-47D), or lacked expression of the tumor suppressor PTEN (MDA-MB-468, BT-549), and/or overexpressed the Her-2/neu oncogene (SKBR-3, BT-474).  Resistant lines (MDA-MB-435, MDA-MB-231) shared none of these properties.  CCI-779 (50 nM) inhibited mTOR function in both a sensitive and a resistant line.  In nu/nu mouse xenografts, CCI-779 inhibited growth of MDA-MB-468 (sensitive) but not MDA-MB-435 resistant tumors.  Treatment of sensitive lines with CCI-779 resulted in a decrease in D-type cyclin and c-myc levels and an increase in p27kip-1 levels.  There was good correlation between activation of the Akt pathway and sensitivity to CCI-779.  Amplification of mTOR-regulated p70S6 kinase, which is downstream of Akt, may also have conferred CCI-779 sensitivity to MCF-7 cells.  Taken together, the data suggest that mTOR may be a good target for breast cancer therapy, esp. in tumors with Akt activation resulting from either growth factor dependency or loss of PTEN function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3hbuBzWiqyLVg90H21EOLACvtfcHk0lhcB2AP0BrHcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotlCqsbw%253D&md5=2ed58571e559ee799da2e9a2e9fd3600</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1677%2Ferc.0.0080249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1677%252Ferc.0.0080249%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DK.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DDiscafani%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.%2BG.%26aulast%3DSkotnicki%26aufirst%3DJ.%26aulast%3DFrost%26aufirst%3DP.%26aulast%3DGibbons%26aufirst%3DJ.%26jtitle%3DEndocr-Relat.%2520Cancer%26date%3D2001%26volume%3D8%26spage%3D249%26epage%3D258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Venkatesan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehnhardt, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delos Santos, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dos Santos, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bursavich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellingboe, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khafizova, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooijmans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldberg, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span> </span><span class="NLM_article-title">Novel Imidazolopyrimidines as dual PI3-kinase, mTOR inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">653</span><span class="NLM_x">–</span> <span class="NLM_lpage">657</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=653-657&author=A.+M.+Venkatesanauthor=C.+M.+Dehnhardtauthor=Z.+Chenauthor=E.+Delos+Santosauthor=O.+Dos+Santosauthor=M.+Bursavichauthor=A.+M.+Gilbertauthor=J.+W.+Ellingboeauthor=S.+Ayral-Kaloustianauthor=G.+Khafizovaauthor=N.+Brooijmansauthor=R.+Mallonauthor=I.+Hollanderauthor=L.+Feldbergauthor=J.+Lucasauthor=K.+Yuauthor=J.+Gibbonsauthor=R.+Abrahamauthor=T.+S.+Mansour&title=Novel+Imidazolopyrimidines+as+dual+PI3-kinase%2C+mTOR+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatesan%26aufirst%3DA.%2BM.%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DDelos%2BSantos%26aufirst%3DE.%26aulast%3DDos%2BSantos%26aufirst%3DO.%26aulast%3DBursavich%26aufirst%3DM.%26aulast%3DGilbert%26aufirst%3DA.%2BM.%26aulast%3DEllingboe%26aufirst%3DJ.%2BW.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DKhafizova%26aufirst%3DG.%26aulast%3DBrooijmans%26aufirst%3DN.%26aulast%3DMallon%26aufirst%3DR.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DFeldberg%26aufirst%3DL.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DGibbons%26aufirst%3DJ.%26aulast%3DAbraham%26aufirst%3DR.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26atitle%3DNovel%2520Imidazolopyrimidines%2520as%2520dual%2520PI3-kinase%252C%2520mTOR%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D653%26epage%3D657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Chen, Z.; Venkatesan, A. M.; Dehnhardt, C. M.; Ayral-Kaloustian, S.; Mansour, T. S.; Brooijmans, N.; Mallon, R.; Hollander, I.; Yu, K.</span><span> </span><span class="NLM_article-title">Discovery of Novel Pyrrolo[3,2-<i>d</i>]pyrimidine Derivatives as PI#-Kinase Inhibitors</span>. Presented at the 238th National Meeting of the American Chemical Society, Washington, D.C., August 16−20,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=Z.+Chen&author=A.+M.+Venkatesan&author=C.+M.+Dehnhardt&author=S.+Ayral-Kaloustian&author=T.+S.+Mansour&author=N.+Brooijmans&author=R.+Mallon&author=I.+Hollander&author=K.+Yu&title=Discovery+of+Novel+Pyrrolo%5B3%2C2-d%5Dpyrimidine+Derivatives+as+PI%23-Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26atitle%3DDiscovery%2520of%2520Novel%2520Pyrrolo%255B3%252C2-d%255Dpyrimidine%2520Derivatives%2520as%2520PI%2523-Kinase%2520Inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Kaplan, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, P.</span><span> </span><span class="NLM_article-title">Nonparametric estimation from incomplete observations</span> <span class="citation_source-journal">J. Am. Stat. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1958</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">481</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm901830p&amp;key=10.2307%2F2281868" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1958&pages=457-481&author=E.+L.+Kaplanauthor=P.+Meier&title=Nonparametric+estimation+from+incomplete+observations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.2307%2F2281868&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2307%252F2281868%26sid%3Dliteratum%253Aachs%26aulast%3DKaplan%26aufirst%3DE.%2BL.%26aulast%3DMeier%26aufirst%3DP.%26atitle%3DNonparametric%2520estimation%2520from%2520incomplete%2520observations%26jtitle%3DJ.%2520Am.%2520Stat.%2520Assoc.%26date%3D1958%26volume%3D53%26spage%3D457%26epage%3D481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3IBE" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3IBE','PDB','3IBE'); return false;">PDB: 3IBE</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm901830p&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Fjm901830p%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-6%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm901830p" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677b2c2b8d1d1955","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
